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Summary 
 Gliotoxin is an epipolythiodioxopiperazine produced by the 
opportunistic fungal pathogen Aspergillus fumigatus. It contains an intact 
disulphide bridge, which mediates its toxic effects via redox cycling. Gliotoxin 
biosynthesis is directed by the gli gene cluster, and knowledge of the 
biosynthetic pathway which leads to gliotoxin formation is limited, although L-
Phe and L-Ser are known amino acid precursors and gliT is a gliotoxin 
oxidoreductase responsible for self-protection and disulphide bridge closure. 
Deletion of gliG, herein shown to be an epoxide-conjugating glutathione s-
transferase, from the gli cluster results in loss of gliG expression and the 
complete abrogation of gliotoxin biosynthesis. Instead, this deletion mutant, A. 
fumigatus !gliG, secretes a 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione (262.1026 u), herein identified and structurally 
characterized for the first time, which is proposed to be a shunt metabolite 
formed in the absence of gliG. This putative shunt metabolite contains a 
hydroxyl group at C-6, consistent with a gliotoxin biosynthetic pathway 
involving thiolation, which is mediated by the addition of the glutathione thiol 
group to a reactive acyl imine intermediate. A new reduction and alkylation 
assay, which uses sodium borohydride and 5’-iodoacetamidofluorescein to label 
gliotoxin, yields a stable, labelled gliotoxin product, di-acetamidofluorescein-
gliotoxin (GT-(AF)2; 1103.47 Da). This species is readily detectable by RP-
HPLC and exhibits a 6.8-fold increase in molar absorptivity compared to 
gliotoxin, which results in a higher sensitivity of detection (50 ng; 125 pmol). 
Unlike gliotoxin, GT-(AF)2 is detectable by MALDI-ToF MS. 6-benzyl-6-
hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione cannot be alkylated and 
so is devoid of thiols or a disulphide bridge. Complementation of gliG restored 
gliG expression and gliotoxin production which coincided with the 
disappearance of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-
dione. In addition, gliG was confirmed, unlike gliT, not to be involved in self-
protection against gliotoxin. It is over 75 years since gliotoxin was discovered. 
The work presented herein provides the first evidential support of the thiolation 
mechanism leading to gliotoxin biosynthesis, in addition to confirming a novel 
biosynthetic role for a glutathione s-transferase in fungi.  
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Introduction 
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1. Chapter 1 Introduction 
1.1 Aspergillus fumigatus – General description  
The genus Aspergillus is a member of the ascomycete class of fungi. 
Aspergillus contains almost 200 species and less than 10 % of these are 
pathogenic (Hohl and Feldmesser, 2007). Among the disease-causing 
Aspergilli, Aspergillus fumigatus is the most pathogenic followed by A. flavus, 
A. terreus, A. niger and the model organism A. nidulans (Dagenais and Keller, 
2009). It is an ubiquitous saprophytic fungus whose ecological niche is in the 
soil or decaying vegetation (Latge, 1999). The environmental habitat of this 
fungus results in it playing a significant role in global carbon and nitrogen 
recycling (Latge, 1999).  
A . fumigatus produces small hydrophobic airborne spores (conidia) which 
are the infectious propagule of this pathogen (Figure 1.1) (Dagenais and Keller, 
2009). The conidial head produces thousands of spores which are grey-green in 
colour (Latge, 1999). Each spore is between 2 – 3 µm in diameter which keeps 
them buoyant in the environment (Latge, 1999). Conidia are estimated to be 
present at concentrations of 1 – 100 conidia / m
3
 (Denning et al., 2002). The 
small spore size means that A. fumigatus can bypass the mucociliary clearance 
mechanism upon inhalation. Therefore, it can penetrate deep into the alveoli of 
the lungs (Hohl and Feldmesser, 2007). A. fumigatus can grow rapidly on 
minimal agar plates which contain carbon (e.g., glucose), nitrogen (e.g., nitrate) 
and trace elements (Figure 1.1) (Brakhage and Langfelder, 2002). Germination 
of A. fumigatus induces the development of septate hyphae. A. fumigatus is a 
thermophilic fungus, which helps it survive in its ecological niche and within 
 2 
the mammalian host. This thermotolerance helps the fungus to grow in 
temperatures up to 55 °C and for the conidia to withstand temperatures of up to 
70 °C (Latge, 1999).  
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Figure 1.1. Images of A. fumigatus. (A) Light microscope image of A. fumigatus conidiophores dispersing thousands of conidia. (B) Scanning 
electron microscopy (SEM) of A. fumigatus conidial head about to release asexual conidia. (C) Image of A. fumigatus  grown on minimal agar in 
a laboratory, the distinctive powdery grey – green colony morphology is observed (Images from www.aspergillus.org.uk)  
 
    A                B              C 
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The life cycle of A. fumigatus is as follows; (i) conidia are released from 
conidiophores, (ii) conidia germinate into septate mycelia and (iii) mycelia 
produce conidiophores and the cycle continues. This fungus has traditionally 
been considered an asexual organism, reproducing via haploid conidia. 
Genomic analysis confirmed that A. fumigatus contained the mating-type 
(MAT) genes associated with sexual reproduction and it also possessed genes 
associated with pheromone production and detection (Galagan et al., 2005; 
Nierman et al., 2005; Paoletti et al., 2005). Recently, the teleomorph 
(Neosartorya fumigata) has been discovered, confirming that sexual 
reproduction occurs in this fungus (O'Gorman et al., 2009).  
 
1.2 The pathobiology of A. fumigatus  
A. fumigatus is an opportunistic fungal pathogen and is the most common 
mold pathogen of humans (Denning et al., 2002). Unusually, this pathogen 
causes both invasive infection in immunocompromised individuals and allergic 
disease in a patient cohort with atopic immune systems (Denning et al., 2002). 
In modern European teaching hospitals, A. fumigatus is responsible for 4 % of 
hospital deaths and it is the number one cause of death for leukaemia and bone 
marrow transplant patients (Denning et al., 2002). The incidence of A. 
fumigatus infection has increased over the last 20 years. This can be attributed 
to the increase in patient transplants, the extensive use of immunosuppressive 
therapies and the increase in individuals infected with HIV or AIDS (Hohl and 
Feldmesser, 2007; Dagenais and Keller, 2009).  
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The primary route of A. fumigatus infection is inhalation through the 
airways. Due to the presence of conidia in the environment, it is believed that 
humans will inhale at least several hundred of these spores per day (Latge, 
1999). The small size of the conidia enable them to traverse the terminal 
respiratory airways and descend deep into the pulmonary alveoli (Ben-Ami et 
al., 2010). In immunocompetent individuals, elimination of inhaled conidia is 
mediated via alveolar macrophages that kill the conidia in an NADPH oxidase 
dependent manner and by polymorphonuclear leucocytes (PMNL) (Hohl and 
Feldmesser, 2007). In the warm and humid environment like that in the 
pulmonary alveoli, conidia that have evaded the immune response (IR) begin to 
germinate (Hohl and Feldmesser, 2007). A. fumigatus hyphae are too large to be 
engulfed by macrophages so PMNL usually target the hyphae. PMNL function 
by releasing antimicrobial peptides and reactive oxygen intermediates (Ben-Ami 
et al., 2010). Dying PMNL release nuclear DNA in the formation of a neutrophil 
extracellular trap (NET) (Bruns et al., 2010). This NET is complexed with 
fungicidal proteins that restricts hyphal growth (Bruns et al., 2010). The 
incidence of aspergillosis in neutropenic patients is indicative of the importance 
in the PMNL mediated IR.  
An infection by an Aspergillus spp is called aspergillosis and pulmonary 
infection of A. fumigatus can be classified into three categories depending on 
the site of infection; (i) allergic bronchopulmonary aspergillosis (ABPA), (ii) 
aspergilloma and (iii) invasive aspergillosis (IA) (Latge, 1999). ABPA is a 
hypersensitivity disorder and has long been associated with individuals who 
suffer with asthma and cystic fibrosis, as these conditions are both associated 
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with excess amounts of viscous mucous. This allows for A. fumigatus to 
germinate and elicit a persistent inflammatory response (Latge, 1999).  
Aspergilloma or “fungus ball” occurs in pre-existing lung cavities. The 
aspergilloma is a spherical mass of hyphae held in place by a proteinaceous 
matrix. Sporulating structures are located to the periphery of the fungal mass 
and chest radiographs usually identify the large fungal ball (Daly and Kavanagh, 
2001). Haemoptysis is a common symptom of aspergilloma, this is where there 
is a disruption of the blood vessels in the wall of the cavity or in the bronchial 
artery supply caused by the fungus (Latge, 1999). It occurs centimetres from the 
fungus and can be fatal. Treatment of this infection is usually performed by the 
surgical removal of the aspergilloma and this usually carries a high mortality 
rate (Latge, 1999).  
Invasive aspergillosis (IA) is the most fatal form of infection by A. 
fumigatus and the primary host immunodeficiencies (e.g., neutropenia) are the 
main reason for the significance of this infection (Thornton, 2010). IA is most 
commonly seen in the lungs, however dissemination to other body tissue is 
known. Diagnosis of this infection is usually mediated by a biopsy or with 
sputum culturing, however correct species identification can be problematic 
which in part is associated with the recovery of clinical samples (Tarrand et al., 
2005). Treatment with antifungal therapy is usually performed with 
voriconazole or Amphotericin B (AmpB) (Sherif and Segal, 2010). However, 
mortality rates are usually between 40 – 90 % in high-risk populations (Lin et 
al., 2001; Dagenais and Keller, 2009). Investigation into the molecular basis of 
pathogenicity was made possible through the availability of the full genome 
sequence of A. fumigatus (Nierman et al., 2005) (Section 1.3). 
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1.3 A. fumigatus genome 
The complete genome sequence of A. fumigatus AF293 was published in 
2005 (Nierman et al., 2005). The genome is 24.9 Mb consisting of eight 
chromosomes, which contain 9,926, predicted genes. The average gene length is 
1,431 bp and the genome consists of 50.1 % coding sequences (Nierman et al., 
2005). The Central Aspergillus Data REpository (CADRE) (Mabey et al., 2004) 
is an online resource available for the extraction of genomic data from eight 
Aspergillus spp (A. clavatus, A. flavus, A. nidulans, A. niger, A. oryzae, A. 
terreus and A. fumigatus; AF293, A1163) and the closely related N. fischeri. 
CADRE identifies each gene with a unique CADRE identification number and 
information on gene classification (known, putative or unknown function). 
CADRE provides in silico gene information including, splice variants, genomic 
alignments of orthologues and associated paralogues. Transcript information 
details the exon location, cDNA sequence, predicted protein sequence and a 
summary of key domain features (www.cadre-genomes.org.uk). 
Comparative genomic analysis (CGA) compared the genomes of A. 
fumigatus with A. oryzae and A. nidulans (Figure 1.2) (Galagan et al., 2005) in 
an attempt to identify the genes associated with the pathogenicity of A. 
fumigatus. A. fumigatus contained the smallest genome in comparison to A. 
oryzae (37 Mb) and A. nidulans (30 Mb). More than 500 genes were found to be 
A. fumigatus specific (Galagan et al., 2005) and most of these genes had no 
known function. A. fumigatus specific allergens were also identified (e.g. 
ribotoxin) (Galagan et al., 2005). Sub-telomeric regions of A. fumigatus and A. 
nidulans were both enriched for predicted secondary metabolite (SM) gene 
clusters (Galagan et al., 2005). In A. fumigatus eight SM clusters were located 
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within 100 kb of the nearest telomere (Galagan et al., 2005). Furthermore, over 
30 % of the predicted non-ribosomal peptide synthetases (NRPS) and 
polyketide synthases (PKS) in A. fumigatus and A. nidulans are located within 
100 kb of a telomere, which corresponds to a 5.5 – fold enrichment (Galagan et 
al., 2005). Rapid rearrangement of sub-telomeric regions may be responsible for 
species-specific evolution of these genes. The notable absence of common 
telomere-associated SM clusters between A. fumigatus and A. nidulans may 
account for the difference in virulence between these two Aspergilli spp 
(Galagan et al., 2005). Overall, CGA revealed that orthologous proteins of the 
three Aspergilli shared approximately 70 % amino acid identity. The relatedness 
of these Aspergilli is similar to the relationship of mammals and fish, an 
evolutionary divergence that took place over 450 million years ago (Galagan et 
al., 2005). 
Further CGA was performed with two (N. fischeri and A. clavatus) of the 
most closely related species to A. fumigatus (Figure 1.2) (Fedorova et al., 
2008). N. fischeri contained the largest genome, 32.6 mb, which may be 
attributed to the larger number of transposable elements within this genome 
(Fedorova et al., 2008). A. fumigatus contains 818 species-specific genes when 
compared to the other two genomes. At least 20 % of these genes are involved 
in carbohydrate and chitin catabolism, transport, detoxification, secondary 
metabolism and other functions which may help with environmental or host 
adaptation (Fedorova et al., 2008). This suggests that adaptation to the human 
host requires a high degree of catabolic flexibility (Moran et al., 2011).     
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Figure 1.2. The three most closely related Aspergilli, A. fumigatus, N. fischeri 
and A. clavatus. (Fedorova et al., 2008). CGA of A. fumigatus to A. nidulans 
and A. oryzae indicates the same evolutionary distance as humans and fish.  
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A. fumigatus-specific genes showed a bias towards telomeric location 
(Fedorova et al., 2008). Fedorova et al. (2008) suggest that telomeric regions 
may function as “gene dumps/factories” and that A. fumigatus may contain an 
elaborate genetic mechanism that facilitates adaptation to either the environment 
or host. More importantly, the location of these genes within subtelomeric 
regions would place them under the control of LaeA, which is the global 
regulator of SM (Bok and Keller, 2004). 
 
1.4  A. fumigatus virulence and toxins 
A. fumigatus pathogenicity depends on various factors, which the fungus 
uses in the infection process. In theory, the loss of such factors would reduce the 
virulence of the fungus without affecting normal growth. Virulence factors are 
defined as pathogen determinants of the fungus which cause damage within the 
host (Casadevall, 2005) and they have the ability to overwhelm the host’s 
defence. A. fumigatus possesses a repertoire of genes responsible for the 
virulence of this pathogen (Abad et al., 2010). The general consensus now, is 
that A. fumigatus does not contain one single virulence factor and that 
pathogenicity is multigenic (Wezensky and Cramer, 2011). These genes are 
involved in thermotolerance, conidial surface, cell wall 
composition/maintenance, pigment biosynthesis, toxin production, nutrient 
acquisition during infection, signalling, metabolism and allergens (Latge, 1999; 
Hohl and Feldmesser, 2007; Abad et al., 2010).  
A. fumigatus is the most common cause of invasive human disease out of 
all the environmental filamentous fungi (Dagenais and Keller, 2009) and it is 
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believed that this virulence may be augmented by the number of SM clusters 
contained in the genome (Nierman et al., 2005). Generally, genes controlling 
secondary metabolism are clustered within the genome (Nierman et al., 2005). 
Secondary metabolism will be discussed in more detail in Section 1.5.  
 
1.5 Secondary Metabolism  
There are several groups of fungal SMs categorised based on the class of 
enzyme involved in their biosynthesis. They are (i) peptides, (ii) alkaloids, (iii) 
terpenes and (iv) polyketides (Keller et al., 2005). Initially, the genome of A. 
fumigatus was believed to contain 26 SM gene clusters (Nierman et al., 2005). 
This number was later revised to 22 (Perrin et al., 2007) and the genome has 
now been predicted to contain 30 SM clusters (Khaldi et al., 2010). The SM 
clusters contain genes such as PKS, NRPS and dimethylallyl tryptophan 
synthase (DMATS) (Table 1.1). SM produced by A. fumigatus include 
gliotoxin, fumagillin, fumitremorgin, gibberellin, helvolic acid and aflatoxin 
(Nierman et al., 2005). Cluster location is dispersed throughout the genome, as 
mentioned earlier, with a bias towards telomeric regions (Fedorova et al., 2008). 
It is believed that the number of SM produced by A. fumigatus augments the 
virulence of this pathogen. The transcription factor, LaeA, was implicated in the 
regulation of SM in Aspergillus spp (Bok and Keller, 2004) and the deletion of 
laeA  attenuated the virulence of A. fumigatus in a murine aspergillosis model 
(Bok and Keller, 2004; Bok et al., 2005). It is believed that the pathogenesis of 
A. fumigatus involves cross talk between SM and the immune state of the host 
(Ben-Ami et al., 2010).  
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Table 1.1. Secondary metabolite gene types in A. fumigatus (AF293) (Nierman 
et al., 2005).  
Gene Type A. fumigatus 
Polyketide synthase 14 
Non-ribosomal peptide synthetase 14 
Fatty acid synthase 1 
Dimethylallyl tryptophan synthase 7 
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1.6 Epipolythiodioxopiperazine type toxins (ETP) 
ETP are a class of SM which are characterised by a disulphide bridge that 
spans a dioxopiperazine ring which has been formed by two amino acids (Fox 
and Howlett, 2008). These toxins are produced by a phylogenetically diverse 
range of filamentous fungi, including A. fumigatus (Figure 1.3) (Patron et al., 
2007). At least 14 different ETP are known and almost all of these are produced 
by ascomycetes (Patron et al., 2007). Gene clusters responsible for the 
biosynthesis of ETP have been identified in A. fumigatus and L. maculans, 
which are responsible for the production of gliotoxin and sirodesmin, 
respectively (Gardiner et al., 2004; Gardiner and Howlett, 2005; Cramer et al., 
2006; Kupfahl et al., 2006; Sugui et al., 2007; Spikes et al., 2008). ETP clusters 
have been inherited relatively intact and are believed to have a single origin 
(Patron et al., 2007). Their distribution throughout the ascomycetes is 
discontinuous, where in two related species one will produce the toxin and the 
other will not (e.g., A. fumigatus produces gliotoxin and A. nidulans does not). 
Gliotoxin is the best characterised ETP and will be discussed in Section 1.7. 
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Figure 1.3. Comparative phylogenetic analysis of putative ETP clusters in 
ascomycetes. Each arrow indicates an individual gene (white text on black 
background) within the cluster, with best matches to the annotated non-
ribosomal peptide synthetase (P), thioredoxin reductase (T), methyl transferases 
(M and N), glutathione s-transferase (G), cytochrome P450 monooxygenase (C), 
aminocyclopropane carboxylic acid synthase (I), dipeptidase (J), as well as a 
transcriptional regulator (Z) and a transporter (A). Genes believed to be 
involved in the modification of side chains of ETP are noted (black text on 
white background). Genes with grey shading are believed to flank the ETP 
cluster, but are thought to play no role in ETP biosynthesis. Hypothetical genes 
or genes with no match to ETP genes are indicated with no lettering. Second 
ETP type clusters have been identified in A. fumigatus, N. fischeri and A. 
terreus. However, these second clusters do not contain the full suite of genes 
present in the first cluster (Patron et al., 2007).  
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1.7 Gliotoxin  
Gliotoxin, an ETP (326 Da) produced by A. fumigatus is characterised by 
a disulphide bridge which spans a diketopiperazine (DKP) ring, and contains the 
aromatic amino acid – phenylalanine as well as serine (Figure 1.4) (Gardiner 
and Howlett, 2005; Gardiner et al., 2005b; Patron et al., 2007). It is the best 
characterised and most potent SM produced by A. fumigatus (Kwon-Chung and 
Sugui, 2009). The activity of this toxin is mediated through the disulphide 
bridge. Gliotoxin was first isolated from a Trichoderma spp in 1936 (Weindling 
and Emerson, 1936). It was named in 1943 after isolation from Gliocladium 
fimbriatum (Johnson et al., 1943). Its potent anti-fungal activity was originally 
investigated in 1936 (Weindling and Emerson, 1936). Further antimicrobial 
analysis confirmed gliotoxin to be an active bacteriostatic agent and again 
confirmed its anti-fungal activity (Waksman and Woodruff, 1942; Johnson et 
al., 1943). This body of work confirmed its inhibition of growth on various 
fungal and bacteria spp (e.g., Staphylococcus aureus, Neisseria catarrhalis, 
Pseudomonas fluorescens and Blastomycoides dermitidis) (Johnson et al., 
1943). These authors concluded that a concentration of gliotoxin at 10 µg/ml 
was sufficient to stop the growth of all microorganisms tested (Johnson et al., 
1943). These early investigations into the antimicrobial activity of gliotoxin 
contributed to significant knowledge of the structure of the toxin and of the 
biosynthetic processes behind its synthesis.  
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Figure 1.4. The structure of gliotoxin (C13H14N2O4S2) (Weindling and 
Emerson, 1936; Johnson et al., 1943; Gardiner and Howlett, 2005).  
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Various analyses were performed to elucidate the structure and activity of 
gliotoxin after it was identified. Johnson and co-workers used a combination of 
elemental analysis and crystallisation to investigate the compound solubility. 
Optical activity of gliotoxin and decomposition point studies were also 
performed (Johnson et al., 1943). The molecular formula of gliotoxin was 
confirmed to be C13H14N2O4S2  (Johnson et al., 1943). This was a revision on 
the original formula reported by Weindling and Emerson (1936). Full structure 
elucidation was confirmed using x-ray crystallography in 1966 (Beecham et al., 
1966) and NMR in 1990 (Kaouadji et al., 1990). The complete organic 
synthesis was reported approximately 50 years after it was originally isolated 
(Fukuyama et al., 1981). 
Initially, much of the emphasis focused on the structure and activity of 
gliotoxin, however, very little was known about the complex biosynthesis of 
this toxin. Feeding experiments using radiolabelled isotopes were performed 
twenty years after gliotoxin was isolated and demonstrated that phenylalanine 
and serine are the amino acid precursors in gliotoxin formation (Suhadolnik and 
Chenoweth, 1958; Winstead and Suhadolnik, 1960). However, neither of these 
amino acids contain a sulphur atom meaning the origin of the reactive 
disulphide bridge remained elusive. Chemical synthesis of gliotoxin using 
radiolabelled methionine, cysteine and sodium sulphate show these amino 
acids/reagents can act as a source to donate sulphur for the disulphide bridge, 
however synthetic generation does not reflect the in vivo biosynthesis 
(Suhadolnik and Chenoweth, 1958; Gardiner et al., 2005b). Investigation into 
the enzymatic biosynthesis of gliotoxin was not performed until approximately 
seventy years after it was first isolated (Cramer et al., 2006). This was made 
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possible by advances in fungal molecular biology (Brakhage and Langfelder, 
2002; Ruiz-Diez, 2002; Meyer, 2008; Kuck and Hoff, 2010) and with the 
identification of a gene cluster in A. fumigatus which was proposed to be 
responsible for gliotoxin biosynthesis (Figure 1.5) (Gardiner and Howlett, 
2005). Functional genomics has confirmed function to some of the genes within 
this cluster and this will be discussed in detail in Section 1.7.2. 
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Figure 1.5. The biosynthetic gene clusters for gliotoxin and sirodesmin PL in A. 
fumigatus and L. maculans, respectively. Predicted enzyme function is given for 
most genes (Gardiner and Howlett, 2005).  
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1.7.1 Gliotoxin Toxicity 
Gliotoxin has a pleiotropic effect in mammalian cell lines including 
inhibition of macrophage phagocytosis, mast cell activation, cytotoxic T-cell 
response, monocyte apotosis and mitogen-activated T-cell proliferation 
(Mullbacher and Eichner, 1984; Eichner et al., 1986; Yamada et al., 2000; 
Stanzani et al., 2005). It has also been demonstrated that gliotoxin inhibits 
NADPH oxidase assembly (Tsunawaki et al., 2004), suppresses reactive oxygen 
species (ROS) production and weakens neutrophil phagocytosis (Orciuolo et al., 
2007). More recently, gliotoxin has been implicated in the inhibition of 
angiogenesis, which will be discussed in Section 1.7.2. (Ben-Ami et al., 2009). 
The toxicity of gliotoxin is mediated via the disulphide bridge through two 
modes of action (i) redox cycling between the oxidized and reduced 
conformation leads to the generation of ROS which are deleterious to the host 
cells (Figure 1.6) and, (ii) interaction with thiol residues on proteins resulting in 
their inactivation (Hurne et al., 2000; Gardiner et al., 2005b). Gliotoxin toxicity 
can be inhibited by the addition of reducing agents such as glutathione and 
dithiothreitol, which prevent redox cycling and subsequent ROS generation 
(Gardiner and Howlett, 2005; Gardiner et al., 2005b). Although the deleterious 
effects of gliotoxin have been heavily investigated over the last seventy years 
(Mullbacher and Eichner, 1984; Eichner et al., 1986; Waring et al., 1988a; 
Waring et al., 1988b; Waring et al., 1994; Waring et al., 1995; Waring and 
Beaver, 1996; Waring et al., 1997; Yamada et al., 2000; Tsunawaki et al., 2004; 
Stanzani et al., 2005), the in vivo origin of the disulphide bridge remains 
unknown. As this confers the potent toxicity of gliotoxin it poses a functional 
genomics challenge. 
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Figure 1.6. Redox cycling between oxidized and reduced gliotoxin leads to the 
generation of ROS. (Gardiner and Howlett, 2005).  
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1.7.2 Gliotoxin-mediated inhibition of angiogenesis  
More recently, gliotoxin has been suggested as a potent inhibitor of 
angiogenesis (Ben-Ami et al., 2009). During infection, A. fumigatus encounters 
various microenvironments which require the fungus to grow under different 
stress conditions during pathogenesis (Wezensky and Cramer, 2011). These 
stress conditions include; temperature, oxidative stress, pH changes and the 
availability of macro and micro-nutrients (Latge, 1999; Latge, 2001; Latge and 
Calderone, 2002; Rhodes, 2006; Askew, 2008; Dagenais and Keller, 2009). One 
stress condition that has been overlooked is reduced oxygen levels or hypoxia. 
Hypoxic environments usually exist at the site of A. fumigatus infection and 
affect both the fungus and the host (Hall and Denning, 1994; Wezensky and 
Cramer, 2011). A. fumigatus has the ability to grow in hypoxic conditions where 
the oxygen level is 0.1 % however, it does not grow in anaerobic conditions 
(Hall and Denning, 1994). At low oxygen levels the metabolism of A. fumigatus 
switches from aerobic to anaerobic respiration (Willger et al., 2009), which 
results in the detection of ethanol in broncheoalveolar lavage fluid from A. 
fumigatus infected neutropenic mice (Wezensky and Cramer, 2011). It is 
believed that the ability of A. fumigatus to grow in hypoxic environments is due 
to the multigenic virulence of this pathogen (Wezensky and Cramer, 2011). 
Adaptation to hypoxic environments in fungi is mediated by the membrane-
bound transcription factors, sterol regulatory element binding proteins 
(SREBPs) (Bien and Espenshade, 2010). Hypoxic microenvironments also 
effects the response of the host to A. fumigatus infection and the main regulator 
of this is hypoxia inducible factor-1! (HIF-1!) (Wezensky and Cramer, 2011). 
HIF is the central regulator of hypoxic gene expression in mammals (Schofield 
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and Ratcliffe, 2005; Gordan and Simon, 2007). One of the main physiological 
responses to tissue hypoxia in the host is angiogenesis (Ben-Ami et al., 2009). 
Invasion of pulmonary tissue by A. fumigatus causes the induction of pro-
angiogenic signaling pathways, such as pro-inflammatory cytokines and 
reactive oxygen intermediates (ROI) to induce neovascularisation (Ben-Ami et 
al., 2010). Chemokines recruit PMNLs to the site of infection where they 
release hydrogen peroxide (H2O2) and other ROI which upregulate NF-"B 
(Ben-Ami et al., 2010). NF-"B then induces other pro-angiogenic factors. As 
the host mounts an immune response, A. fumigatus begins to transcribe suites of 
SM clusters at the onset of invasive aspergillosis (McDonagh et al., 2008). In 
particular, the transcription of the gliotoxin gene cluster is up-regulated during 
the initiation of invasive aspergillosis (McDonagh et al., 2008). Gliotoxin 
directly downregulates the expression of NF-"B by inhibiting the proteasomal 
degradation of I"B!, which stabilizes the NF-"B-I"B! complex thus 
preventing nuclear translocation of NF-"B (Kroll et al., 1999). Gliotoxin also 
suppresses PMNL oxidative burst (Tsunawaki et al., 2004) and it detoxifies the 
H2O2 secreted by PMNL via the thioredoxin redox system (Choi et al., 2007). 
The consequences of gliotoxin production to the host is inhibition of 
angiogenesis (Ben-Ami et al., 2009) (Figure 1.7). 
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Figure 1.7. Induction of pro- and anti-angiogenic signals during invasive 
aspergillosis. Inner dashed circles represent infected tissue and the outer dashed 
circle represents hypo-perfused pulmonary tissue. Endothelial cells, 
macrophages and PMNLs secrete pro-angiogenic factors shown on the left hand 
side. The anti-angiogenic factors of gliotoxin are shown on the right hand side. 
(TNF: tumor necrosis factor, IL8: interleukin 8, VEGF: vascular endothelial 
growth factor, FGF: fibroblast growth factor) (Ben-Ami et al., 2010). 
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1.7.3 Gliotoxin biosynthetic gene cluster 
Gliotoxin biosynthesis is directed by a multi-functional gene cluster 
(Figure 1.5). CGA with another epipolythiodioxopiperazine toxin cluster, 
encoding sirodesmin PL produced by the plant pathogen Leptosphaeria 
maculans, identified a 12-membered putative gene cluster in A. fumigatus 
predicted to be responsible for gliotoxin biosynthesis (Figure 1.5) (Gardiner et 
al., 2004; Gardiner and Howlett, 2005; Schrettl et al., 2010). The cluster is 
comprised of the core “backbone” enzyme (gliP), the non-ribosomal peptide 
synthetase (NRPS), the transcriptional regulator (gliZ), and a predicted 
transporter (gliA ) (Gardiner and Howlett, 2005; Khaldi et al., 2010). The rest of 
the cluster is filled with putative “decorating” enzymes responsible for 
modification of gliotoxin biosynthetic intermediates (Gardiner and Howlett, 
2005; Khaldi et al., 2010).  
Production of gliotoxin is mediated via the NRPS, gliP (Balibar and 
Walsh, 2006; Cramer et al., 2006; Kupfahl et al., 2006; Sugui et al., 2007; 
Spikes et al., 2008). NRPS are composed of discrete domains; adenylation (A), 
thiolation (T) or peptidyl carrier protein (PCP) and condensation (C) domains 
(Stack et al., 2007). When all of these are grouped together they are generally 
referred to as a single module (Stack et al., 2007). Each module is responsible 
for incorporation of a single amino acid into a growing peptide product. Initial 
characterisation of gliP used recombinant expression to confirm that the A1 
domain of GliP is responsible for recognition and incorporation of L-
phenylalanine and that the A2 domain is responsible for recognition and 
activation of L-serine into the peptide product (Balibar and Walsh, 2006). These 
authors also demonstrate that a cyclised diketopiperazine composed of 
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phenylalanine-serine (cyclo-(L-phenylalanyl-L-seryl), is slowly released from 
GliP after biosynthesis and they postulated that further modification of the 
cyclised DKP may occur while tethered in situ (Figure 1.8) (Gardiner and 
Howlett, 2005; Balibar and Walsh, 2006). Further functional studies on A. 
fumigatus gliP confirmed that it was essential for gliotoxin production and 
absence of this gene resulted in gliotoxin deficient strains (Cramer et al., 2006; 
Kupfahl et al., 2006; Sugui et al., 2007; Spikes et al., 2008). Coordinated 
expression of constituent genes within the cluster was associated with gliotoxin 
production (Cramer et al., 2006). These A. fumigatus #gliP strains will be 
discussed in more detail in Chapter 4.  
CGA identified a transcriptional regulator within the gliotoxin cluster. A. 
fumigatus gliZ was predicted to encode a Zn2Cys6 binuclear transcription factor 
(Gardiner and Howlett, 2005; Bok et al., 2006). Functional analysis of gliZ 
confirmed it as the transcriptional regulator of the gene cluster and disruption of 
this gene also abolished gliotoxin biosynthesis (Bok et al., 2006). A. fumigatus 
gliZ was required for the expression of gliI, which has been postulated to be a 
biosynthetic enzyme required for gliotoxin production (Gardiner and Howlett, 
2005; Bok et al., 2006). However, no functional analysis has been reported to 
date on A. fumigatus gliI to support this. An A. fumigatus multi-copy gliZ strain 
exhibited an increase in gliotoxin production. Bok et al. (2006) also state A. 
fumigatus #gliZ and the complemented strain A. fumigatus gliZ
C
 affected the 
production of other unknown SM. A. fumigatus gliZ
C
 also showed helvolic acid 
production, which was not detected in either A. fumigatus #gliZ strain or the 
wild-type strain (Bok et al., 2006). However, no additional information on these 
effects that gliZ has on other SM is available. 
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Figure 1.8. Proposed biosynthetic pathway for gliotoxin biosynthesis. The only confirmed intermediate is the cyclo-(L-phenylalanine-L-seryl) 
(Balibar and Walsh, 2006). A. fumigatus gliT has been confirmed as the enzyme responsible for the closure of the disulphide bridge (Scharf et 
al., 2010; Schrettl et al., 2010). The remaining pathway is unknown and requires experimental validation to identify the genuine biosynthetic 
intermediates (Gardiner and Howlett, 2005).  
+ 
Cyclo-L-Phenylalanyl-L-Seryl Gliotoxin 
    Phenylalanine 
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The gliotoxin cluster contains a putative major facilitator superfamily 
(MFS) type efflux pump gene, A. fumigatus gliA . A. fumigatus gliA  shares 
orthology with a gene from the L. maculans sirodesmin gene cluster sirA . L. 
maculans sirA  is an ATP binding cassette (ABC) transporter. Gene deletion of 
sirA  from L. maculans resulted in increased secretion of sirodesmin (Gardiner et 
al., 2005a). The L. maculans sirA  mutant strain exhibited increased sensitivity 
to both exogenous sirodesmin and gliotoxin (Gardiner et al., 2005a). 
Interestingly, the restoration of A. fumigatus gliA  into the L. maculans !sirA  
strain abolished the sensitivity in L. maculans !sirA  to gliotoxin and not 
sirodesmin (Gardiner et al., 2005a) and the inability of gliA  to provide 
resistance to sirodesmin is believed to be related to the difference in transporter 
type or to the conformation of sirodesmin and gliotoxin (Gardiner et al., 2005a).  
More recently, gliT has been shown to completely protect A. fumigatus 
against auto-toxicity of exogenous gliotoxin. Gliotoxin secretion was abolished 
in independent A. fumigatus !gliT studies (Scharf et al., 2010; Schrettl et al., 
2010). A. fumigatus gliT is the key enzyme responsible for gliotoxin 
oxidoreductase activity. This activity confirms that gliT is responsible for the 
last biosynthetic step in gliotoxin biosynthesis, disulphide bridge formation 
something which had been speculated upon before experimental validation 
(Howlett, 2008). Transformation of gliT into gliotoxin-naïve strains such as A. 
nidulans and Saccharomyces cerevisiae rendered the strains resistant to 
gliotoxin, and gliT was also shown to be independently regulated compared to 
other gli cluster components (Schrettl et al., 2010). Sequence analysis 
performed during gliT functional analysis identified an additional gene (gliH) 
belonging to the gliotoxin cluster (Schrettl et al., 2010). A. fumigatus gliH is 
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located adjacent to gliT. This brought the total number of genes in the cluster to 
13.  
Although some investigation into the function of several genes within the 
gliotoxin cluster has been performed, very little is known about the genes 
involved in “decorating” the gliotoxin intermediates. To date, recombinant gliP 
studies have confirmed the enzyme to be responsible for biosynthesis of cyclo-
L-phenylalanyl-L-seryl, however the native intermediate was not identified in 
culture supernatant (Balibar and Walsh, 2006). Simultaneously, biochemical 
and enzymatic studies performed on recombinant gliT and gliotoxin sensitivity 
experiments on !gliT confirmed it to be a gliotoxin oxidoreductase (Scharf et 
al., 2010; Schrettl et al., 2010). However, reduced gliotoxin or dithiogliotoxin 
was not identified in A. fumigatus culture supernatants. These functional studies 
have confirmed the genes responsible for the very first and last biosynthetic step 
in gliotoxin formation, yet no genes have been confirmed to be involved in 
gliotoxin intermediate modification. Without isolation of native on or off-
pathway intermediates, the biosynthesis behind gliotoxin formation and more 
importantly the mode of sulphur incorporation, remains purely speculative 
(Figure 1.8) 
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1.7.4 A. fumigatus gliG  
Among the genes with unconfirmed function within the gliotoxin cluster 
is a glutathione s-transferase (GST), gliG (CADRE Identification number: 
AFUA_6G09690). GST are commonly known as detoxification enzymes, which 
are responsible for elimination of harmful xenobiotics via a glutathione-
conjugation mechanism (Sheehan et al., 2001). GST will be described in more 
detail in Section 1.8. Phylogenetic analysis on the origin and distribution of ETP 
in fungi identified 11 orthologues of A. fumigatus gliG (Patron et al., 2007). 
Prior to the work described in this thesis, the role of A. fumigatus gliG within 
gliotoxin biosynthesis was unknown and although its possible role has received 
some attention, it is just conjecture without experimental validation (Gardiner et 
al., 2004; Howlett, 2008). The non-enzymatic formation of glutathione-
gliotoxin conjugates (Bernardo et al., 2001) and the importance of glutathione 
(GSH) for the intracellular accumulation of gliotoxin in target cells (Bernardo et 
al., 2003) have both been addressed in this speculation (Gardiner et al., 2004). 
Gardiner et al. (2004) postulated that ETP-GSH conjugates may accumulate 
during biosynthesis of gliotoxin and that degradation of these conjugates may be 
performed by the reverse reaction of a GST. These authors also stated that the 
role of L. maculans sirG, a paralogue to A. fumigatus gliG, predicted to be 
involved in auto-detoxification may function instead as a biosynthetic enzyme. 
The incorporation of sulphur atoms into a biosynthetic intermediate of gliotoxin 
is believed to be performed by an enzyme that forms or breaks bonds between 
carbon and sulphur (Howlett, 2008). Both A. fumigatus gliG and gliI have been 
linked to performing this function (Howlett, 2008).  
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1.8 Glutathione s-transferase  
1.8.1 General Information 
Glutathione s-transferases (GST) (EC 2.5.1.18) are phase II detoxification 
enzymes (Hayes et al., 2005). These enzymes function by catalysing the 
nucleophilic attack of glutathione (GSH: !-Glu-Cys-Gly) on non-polar 
compounds that contain an electrophilic carbon, nitrogen or sulphur atom 
(Hayes et al., 2005). This process results in a more soluble, non-toxic derivative, 
which can be compartmentalised into vacuoles or excreted from these 
compartments via an ATP-dependent vacuolar pump (Klein et al., 2002; Frova, 
2006). They also function in the cellular elimination of hydrophobic compounds 
(e.g., heme, drugs and carcinogens) through a covalent/non-covalent interaction 
(Shankar et al., 2005; Kulinskii and Kolesnichenko, 2009). This mechanism 
allows GST to metabolise toxic xenobiotics. GST are universal enzymes and are 
found in almost all organisms from eubacteria to mammals (Kulinskii and 
Kolesnichenko, 2009). The best characterised GST are the mammalian kind 
which consist of four different families, cytosolic, mitochondrial, microsomal 
and the bacterial fosfomycin-resistance kind (Dourado et al., 2008; Morel et al., 
2009). The cytosolic classes (alpha, pi and mu) are the most extensively studied 
and abundant kind of GST (Dourado et al., 2008). Advances in molecular 
biology over recent years have revealed broader roles for this class of enzyme. 
Evidence that GST are involved in the biosynthesis and metabolism of 
prostaglandins (Jakobsson et al., 1999), steroids (Johansson and Mannervik, 
2001) and leukotrienes (Anuradha et al., 2000) has been uncovered. They have 
also been identified to play a role in the management of toxic products 
generated by lipid oxidation and s-glutathionylated proteins generated by 
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oxidative stress (Alin et al., 1985; Awasthi et al., 2004; Listowsky, 2005). GST 
have also been implemented in the ability to acquire resistance to 
chemotherapeutic agents (Tew, 1994; Hayes and Pulford, 1995; Lo and Ali-
Osman, 2007). Recently, GST have been identified in the control of cell 
signaling pathways that control cell proliferation and apoptosis (Adler et al., 
1999; Cho et al., 2001; Ruscoe et al., 2001; Romero et al., 2006).  
 
1.8.2 GST classification 
GST classification is subdivided into an ever-increasing number of classes 
based on (i) sequence similarity and subsequent immunological reactivity, (ii) 
substrate specificity and (iii) structural characteristics (Sheehan et al., 2001; 
Hayes et al., 2005). With respect to sequence similarity, the general concept is 
that GST with more than 40 % similarity are grouped within a class and those 
with less that 25 % identity are assigned to a separate class (Frova, 2006). 
Structural similarities are primarily concerned with the N-terminus as this tends 
to be better conserved within a class. This region contains an important part of 
the active site (Morel et al., 2009). The N-terminus contains either one of the 
catalytically active tyrosine, serine or cysteine residues, which are responsible 
for interaction with the thiol group of GSH (Frova, 2006). Immunological 
reactivity of GST showed that antisera generated against a particular class of 
GST will cross-react with the same class from another species (Bowyer and 
Denning, 2007). No cross-reactivity is observed between GST classes, even if 
they are derived from the same species (Hayes and Mantle, 1986; Sheehan et al., 
2001). Substrate specificity is often used to distinguish GST, however, broad 
and overlapping values do not give the ideal distinction between classes as some 
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of the other classification methods (Sheehan et al., 2001). Structural 
characteristics such as the formation of stable dimers of subunits within a class, 
and the inability to dimerize with subunits from another class, show the class-
specific conserved architecture that helps define GST classification (Frova, 
2006). 
Some GST function can overlap with the thiol-dependent peroxidases 
(e.g., peroxiredoxins and glutathione peroxidases) in the reduction of by-
products of oxidative stress (Morel et al., 2009). Most GST classification has 
focused on the function and diversity in animals and plants (Dixon et al., 2010) 
and an extensive amount literature is available on this area (Hayes et al., 2005; 
Kulinskii and Kolesnichenko, 2009). It is beyond the scope of this work to 
discuss the classification of all GST so this chapter will focus on microbial 
GST, and specifically fungal ones.  
 
1.8.3 Fungal GST 
Fungal GST classification is not as well-defined as that in mammals 
(Morel et al., 2009), most of the classification has been performed on the yeasts 
and data indicate that GST function is mainly concerned with protection against 
oxidative stress damage, heavy metals and antifungal compounds (Choi et al., 
1998; Veal et al., 2002; Garcera et al., 2006). Ascomycetes and basidiomycetes 
contain a higher number of GST in comparison to the yeasts (Morel et al., 2009) 
and this is most likely due to the saprophytic nature of some of these fungi and 
their involvement in the degradation of organic matter (Morel et al., 2009).  
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As more fungal genomes are sequenced (Galagan et al., 2005; Nierman et 
al., 2005; Fedorova et al., 2008) fungal GST classification will improve and the 
divergence of functional relationships amongst the GST will become apparent. 
In contrast to the cytosolic class of mammalian GST, fungal GST, which also 
have several classes, rarely group with the pre-existing classes (McGoldrick et 
al., 2005). Classification in S. cerevisiae identified the omega, GTT (glutathione 
transferase), Ure2p, MAK16 and EFB! classes (Wickner et al., 1987; Koonin et 
al., 1994; Choi et al., 1998; Rai et al., 2003; Garcera et al., 2006). McGoldrick 
et al. (2005) screened 67 GST-like sequences from 21 fungal species and 
comparative multiple sequence alignment revealed five clusters of GST-like 
proteins. These were identified as cluster 1, 2, EFIB!, Ure2p and MAK16, with 
the last three previously identified and related to the GST superfamily 
(McGoldrick et al., 2005). Cluster 1 was later shown to contain GTT1 from S. 
cerevisiae and cluster 2 contained a Ure2p like GST from A. nidulans (Morel et 
al., 2009). A further amendment to the fungal GST classification split the GTT 
class into GTT1 and GTT2, both of which are fungal specific (Morel et al., 
2009). The addition of a new class called GTE (glutathione transferase etherase-
related), which shared sequence homology to the bacterial etherases, brought the 
fungal GST class number to seven in total (Morel et al., 2009). These are 
omega, GTT1, GTT2, Ure2p, EFIB!, MAK16 and GTE (McGoldrick et al., 
2005; Morel et al., 2009).  
 
 36 
1.8.4 GST and detoxification 
Fungi are continuously exposed to non-nutritional chemical species, 
which can be harmful to the organism and can cause toxic side effects (Sheehan 
et al., 2001). Naturally generated toxic compounds produced by fungi include 
toxins (e.g., aflatoxin) or ROS such as the superoxide radicals and hydrogen 
peroxide. Detoxification processes involve the elimination of these toxic 
xenobiotics (Sheehan et al., 2001). This process can be broken down into three 
phases; phase I, phase II and phase III (Figure 1.9). Phase I involves the 
activation of xenobiotics by the introduction of reactive functional groups. This 
phase is normally catalysed by the cytochrome P450 system, which is normally 
responsible for oxidation reactions (Jancova et al., 2010). Phase II involves the 
conjugation of activated xenobiotics to a water-soluble substrate, such as GSH. 
Conjugation to GSH is the major phase II reaction in many species (Jancova et 
al., 2010). GST play a critical role in this process where they catalyse the 
reaction with the thiolate group of GSH. This neutralises the electrophilic site 
and increases the water solubility of the product prior to detoxification (Habig 
and Jakoby, 1981; Sheehan et al., 2001). Phase III is where the soluble 
conjugated xenobiotics are pumped out of the cell. Followed by further 
metabolic activity and downstream pathways to eliminate the compound (Hayes 
and McLellan, 1999).  
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Figure 1.9 
Figure 1.9. Schematic overview of the three phase enzymic detoxification process. Phase I, involves the cytochrome P450 activation of 
xenobiotics with a functional group. Phase II, the activated xenobiotic is neutralised by conjugation through functional groups. Phase III, 
conjugated xenobiotics are pumped out of the cell and eventually eliminated (Sheehan et al., 2001). 
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1.8.5 Functionally characterised fungal GST  
Fungal GST, specifically from ascomycetes, are poorly characterised in 
comparison to their mammalian counterparts. Fungal GST characterisation has 
predominantly come from the yeasts where they have been implicated in the 
protection against oxidative stress, heavy metal damage and antifungal toxicity 
(Choi et al., 1998; Veal et al., 2002; Garcera et al., 2006) and this range of roles 
indicates the functional diversity of these enzymes. In particular, yeast GST 
characterisation has mostly been performed on S. cerevisiae (Morel et al., 
2009). To date seven proteins in S. cerevisiae have been confirmed to have GST 
activity (Ma et al., 2009). Early characterisation of S. cerevisiae GST identified 
two of this class of enzyme, GTTI and GTT2 (Choi et al., 1998), both of which 
exhibited GST activity against 1-chloro-2,4-dinitrobenzene (CDNB) substrate, 
yet they both have divergent physiological functions. GTT1 catalyses the 
reduction of hydroperoxides while GTT2 is involved in cadmium (Cd) 
detoxification, where it catalyses the conjugation of GSH-Cd conjugates 
(Adamis et al., 2004; Herrero et al., 2006). Both GST are crucial in the 
oxidative stress response to H2O2 (Mariani et al., 2008).  
Two glutaredoxins (Grx1 and Grx2) have also been identified in S. 
cerevisiae (Collinson et al., 2002; Collinson and Grant, 2003). Both exhibited 
GST activity against DCNB and CDNB, which indicates an overlapping 
function between glutaredoxins and GST (Collinson et al., 2002; Collinson and 
Grant, 2003). This overlapping activity confirms that these enzymes are suitable 
for the detoxification of a wider range of xenobiotics.  
Three yeast GST with sequence similarities to the human omega class 
were identified in S. cerevisiae, Gto1, Gto2 and Gto3 (Garcera et al., 2006). 
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Recombinant analysis confirmed all three had activity as glutaredoxins, 
dehydroascorbate reductases and dimethylarsinic acid reductases, yet no activity 
against the GST substrate CDNB was detected (Garcera et al., 2006). 
In S. pombe three GST were identified, Gst1, Gst2 and Gst3 (Veal et al., 
2002). Comparative sequence analysis revealed that Gst3 shared significant 
sequence homology to S. cerevisiae GTT1. Gst1 and Gst2 were identified as 
potential homologues of human GST theta class and they were thought to be 
closely related to S. cerevisiae Ure2 (Veal et al., 2002). All three GST exhibited 
activity against CDNB (Veal et al., 2002) and expression of the three GST 
(gst1, gst2, gst3) was induced by peroxide (Veal et al., 2002). Mutational 
analysis of these genes identified a significantly reduced cellular response to 
peroxide stress and these authors showed that the three GST mutants (!gst1, 
!gst2, !gst3) exhibited more sensitivity to the anti-fungal agent fluconazole – 
implicating the three GST in anti-fungal drug detoxification (Veal et al., 2002).  
Sequence analysis of the C. albicans genome using the S. cerevisiae Gto1 
sequence identified one open reading frame (ORF) in the genome, which was 
annotated as CaGto1 while sequence analysis with S. cerevisiae Gtt1 identified 
four ORFs in the genome and were annotated CaGtt1 – 4 (Garcera et al., 2010). 
However, only CaGto1 and CaGtt1 were expresses significantly under oxidative 
stress with activity analysis confirming that CaGtt1 displays GSH-conjugating 
activity with CDNB. CaGto1 exhibited thiol oxidoreductase activity and both 
recombinantly expressed enzymes exhibited GSH-dependent peroxidase activity 
(Garcera et al., 2010).  
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Analysis of an A. nidulans GST performed using a deletion strain (A. 
nidulans !gstA), revealed a theta class GST (Fraser et al., 2002) and this protein 
was subsequently classed as Ure2p like (Morel et al., 2009). Functional analysis 
showed that GstA contributed to metal detoxification as the enzyme exhibited 
sensitivity to selenium, silver and nickel. Increased expression of A. nidulans 
gstA upon exposure to CDNB and H2O2 was also apparent (Fraser et al., 2002). 
Also, a fungal-specific GST (gstB) in a glutathione reductase deletion strain 
(!glrA ) has been identified in A. nidulans (Sato et al., 2009). 
Similarity searches of the A. fumigatus genome using A. nidulans gstA  
(Fraser et al., 2002) and S. pombe gst1 and gst2 (Veal et al., 2002) identified 
three GST, A. fumigatus gstA , gstB and gstC (Burns et al., 2005). Expression of 
all three GST was induced by CDNB. Strong expression of A. fumigatus gstA  
was noted upon exposure to H2O2 with a weaker induction of A. fumigatus gstC 
observed (Burns et al., 2005). No expression of A. fumigatus gstB was observed 
in the presence of H2O2 (Burns et al., 2005) and the absence of expression of A. 
fumigatus gstB in response to H2O2 contrasted with the observed expression of 
the homologue S. pombe gst1 (Burns et al., 2005). This difference correlated to 
the greater sequence divergence between these two homologues (Burns et al., 
2005). Identification of an elongation factor 1B protein from A. fumigatus, 
termed ElfA (CADRE identification number; AFUA_1G17120) exhibited GST 
activity with CDNB (Carberry et al., 2006).  
The identification of new fungal GST classes which have no similarity to 
the mainstream GST class indicates the highly divergent evolution amongst 
fungal GST (McGoldrick et al., 2005) and sequences obtained from both 
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Alternaria alternata and Pichia augusta showed almost no similarity to any 
previously defined GST class (McGoldrick et al., 2005). The A. alternata GST, 
shared 59 % sequence identity to a GST (sirG) from the L. maculans genome 
(McGoldrick et al., 2005). Interestingly, sirG forms part of the predicted 
biosynthetic gene cluster of sirodesmin, an ETP produced by L. maculans 
(Gardiner et al., 2004). The sirG paralogue, gliG, part of the gliotoxin cluster 
was also predicted to be a GST, using comparative genomics on the gliotoxin 
biosynthetic gene cluster (Gardiner and Howlett, 2005). It is believed that GST 
which form part of SM clusters (e.g., ETP) and that do not group with other 
known GST classes, are involved in self-protection or biosynthesis of the toxin 
produced (McGoldrick et al., 2005). A summary of some of the fungal GST, 
which have been previously characterised is described in Table 1.2. 
GST have also been implicated in the allergic response to A. fumigatus 
(Bowyer and Denning, 2007). These authors proposed that the GST, GliG 
(Carberry, 2008), which they define as Asp f GST, is a fungal allergen based on 
in silico analysis. The incidence of cross-reactivity of antibodies towards GST 
from different fungal sources, including A. fumigatus, has been demonstrated 
(Shankar et al., 2005). These authors also identified a rGST allergen from A. 
alternata (Alt a GST), which shares significant sequence homology to Asp f 
GST (94.8 %) (Shankar et al., 2006; Bowyer and Denning, 2007). 
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Table 1.2. Some fungal GST which have been functionally characterised. 
Fungal spp  Gene Name Class GST  Other Activity References 
S. cerevisiae  Gtt1  Gtt1 !  (Choi et al., 1998) 
S. cerevisiae Gtt2 Gtt2 !  (Choi et al., 1998; Ma et al., 
2009) 
S. cerevisiae Gto1 Omega !  (Garcera et al., 2006) 
S. cerevisiae Gto2 Omega !  (Garcera et al., 2006) 
S. cerevisiae Gto3 Omega !  (Garcera et al., 2006) 
S. cerevisiae Grx1  ! !Glutathione peroxidase (Collinson et al., 2002) 
S. cerevisiae Grx2  ! !Glutathione peroxidase (Collinson and Grant, 2003) 
S. pombe  Gst1  Human theta !  (Veal et al., 2002) 
S. pombe Gst2  Human theta !  (Veal et al., 2002) 
S. pombe Gst3  Human theta ! !Glutathione peroxidase (Veal et al., 2002) 
C. albicans CaGto1 Omega ! !Glutaredoxin (Garcera et al., 2010) 
C. albicans CaGtt11 Gtt1 ! !Glutathione peroxidase (Garcera et al., 2010) 
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A. nidulans GstA Human theta !  (Fraser et al., 2002) 
A. nidulans GstB    (Sato et al., 2009) 
A. fumigatus  GstA  !  (Burns et al., 2005) 
A. fumigatus  GstB  !  (Burns et al., 2005) 
A. fumigatus  GstC  !  (Burns et al., 2005) 
A. fumigatus  GliG  ! !Glutathione reductase  (Carberry et al., 2006) 
A. fumigatus  elfA  EF1! !  (Carberry et al., 2006) 
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1.8.6 A. fumigatus GST 
The genome of A. fumigatus is predicted to contain 23 GST (Morel et al., 
2009). This compares to the prediction that A. clavatus and A. nidulans both 
contain 18 GST (Table 1.3) (Morel et al., 2009). To date, only four A. fumigatus 
GST have been fully characterised (Burns et al., 2005; Carberry et al., 2006). 
GST play a significant role in detoxification and considering the pathogenicity 
of A. fumigatus and the obvious GST divergence and evolution in fungi 
(McGoldrick et al., 2005), it is surprising that the presence of 23 putative GST 
in this pathogenic fungi has warranted little attention. A. fumigatus gliG forms 
part of the co-regulated gliotoxin gene cluster. This GST has showed little 
phylogenetic comparison to A. fumigatus gstA, gstB and gstC (Burns et al., 
2005). The presence of a GST in the gliotoxin cluster suggests a possible role 
for this GST against the toxicity of gliotoxin or in the biosynthesis of this ETP 
(McGoldrick et al., 2005). The potential role of gliG in the biosynthesis of 
gliotoxin as opposed to the detoxification or self-protection of this compound 
would represent a novel role for a GST, and therefore it would constitute a 
significant advance in our understanding of the function of GST both in fungi, 
and in general.  
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Table 1.3. Comparative analysis of GST genes in A. clavatus, A. nidulans and A. fumigatus (Morel et al., 2009).  
 Genome (Mb) Gene Models GTT1 GTT2 URE2p Omega EFB!  MAK16 GTE Others Total 
A. clavatus  27.9 9,121 2 1 4 5 3 1 2 0 18 
A. nidulans  30.1 10,701 1 0 3 5 5 1 3 0 18 
A. fumigatus  29.4 9,887 4 1 4 5 3 1 2 3 23 
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1.9 Fungal transformation systems  
The investigation of gene function in fungi involves gene deletion or gene 
disruption, whereby the mutant strain differs from the parental strain by the 
missing gene of interest and different transformation systems are available for 
the genetic manipulation of fungi (Brakhage and Langfelder, 2002). Several 
advances in this area have facilitated more efficient genetic manipulation. 
Specifically, techniques used for the generation of DNA constructs for gene 
deletion/disruption have improved (Nielsen et al., 2006) and the generation of 
strains deficient in non-homologous end joining (NHEJ) have also had 
significant impact on fungal transformation (Ninomiya et al., 2004; da Silva 
Ferreira et al., 2006; Krappmann et al., 2006). Overall these improvements have 
assisted with successful genetic manipulation of filamentous fungi (Kuck and 
Hoff, 2010) and details of these tools for genetic manipulation will be discussed 
in this section. 
Various transformation systems are available for the genetic manipulation 
of A. fumigatus including (i) protoplast transformation, (ii) Agrobacterium-
tumefaciens mediated transformation and (iii) electroporation transformation 
(Brakhage and Langfelder, 2002). This Section will focus on the transformation 
strategies, which are relevant to the work described in this Thesis. Protoplast 
transformation involves the degradation of the fungal cell wall of young 
mycelium by using a mixture of lytic enzymes and the protoplasts are then 
osmotically stabilised before DNA uptake, which occurs in the presence of 
calcium ions and polyethylene glycol (PEG). Once DNA uptake has been 
completed, the transformed protoplasts require regeneration on osmotically-
buffered medium that facilitates the growth of potential transformants (Ruiz-
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Diez, 2002). Although there are several different A. fumigatus transformation 
methods available, the protoplast-based system is used more frequently. This 
system is more common for the deletion of genes involved in secondary 
metabolite pathways such as the gliotoxin, siderophore and ergot alkaloid 
biosynthetic pathways in A. fumigatus (Bok et al., 2006; Cramer et al., 2006; 
Kupfahl et al., 2006; Schrettl et al., 2007; Sugui et al., 2007; Spikes et al., 2008; 
Coyle et al., 2010; Scharf et al., 2010; Schrettl et al., 2010).  
Preparation of the transformation constructs can be performed by various 
methods such as (i) plasmid integrations (Kubodera et al., 2002), (ii) linear 
constructs (Kuwayama et al., 2002), (iii) double-joint PCR method (Yu et al., 
2004) and (iv) the bipartite method (Nielsen et al., 2006). An important 
consideration in the generation of the deletion construct is the selectable marker. 
A. fumigatus is sensitive to antibiotics such as phleomycin and hygromycin B 
and bacterial genes that confer resistance to these antibiotics can be used as 
dominant selectable markers for gene deletion and complementation (Spikes et 
al., 2008). Targeted gene deletion is facilitated by homologous recombination 
(HR) whereby the homologous flanking regions recombine in vivo and the 
selectable marker replaces the gene of interest producing a mutant strain (Figure 
1.10).  
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Figure 1.10. Schematic illustration of gene replacement by homologous 
recombination (HR). The gene replacement construct contains 5’and 3’ flanking 
regions that are homologous to the target locus. HR facilitates the integration of 
the selection marker in place of the gene of interest and generates a mutant 
strain, which lacks the target gene.  
Target locus 
Gene replacement 
construct 
Mutant locus 
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Molecular approaches to construct generation initially involved several 
Escherichia coli cloning steps which were both time consuming and tedious 
(Nielsen et al., 2006). A new PCR-based strategy for construct generation has 
been described in A. nidulans (Nielsen et al., 2006) which employs the 
generation of two constructs each containing either the 5’ or 3’ flanking region 
fused to a partial region of the selection marker. Reconstitution of the marker 
occurs in vivo by HR, forming the deletion construct. The homologous flanking 
regions align the deletion construct to the target locus and facilitate the 
replacement of the gene of interest with the selectable marker (Figure 1.11). 
Three HR events are required before a successful gene-targeting event will take 
place, however, DNA recombination in A. nidulans occurs primarily through 
NHEJ rather than HR, which makes the HR events seem unfavourable (Nielsen 
et al., 2006). These HR events are believed to force the DNA recombination 
machinery into HR rather than NHEJ and produce directed gene deletions rather 
than ectopic integrations. Nielsen et al. (2006) state that targeted gene deletion 
with the bipartite construct method is three-fold higher when compared to a 
continuous construct. However, these authors point out that the overall 
transformation efficiency is reduced when bipartite constructs are used instead 
of the continuous construct method and this is believed to happen as less ectopic 
integration occurs using bipartite constructs. Transformation is only successful 
upon integration of the reconstituted construct, as this will contain the full 
selectable marker (Nielsen et al., 2006). The bipartite construct approach has 
been used successfully in A. fumigatus and it has been used in the deletion of 
gliT from the gliotoxin cluster (Schrettl et al., 2010).  
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Figure 1.11. Schematic illustration of gene replacement facilitated by bipartite 
constructs. Two constructs containing partial regions to the selection marker 
reconstitute in vivo. HR of the 5’ and 3’ flanking region occurs facilitating the 
integration of the selection marker in place of the gene of interest, thereby 
producing a mutant strain.  
Target locus 
Bipartite replacement 
construct 
Mutant locus 
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Selection of transformants against a wild-type non-transformed 
background depends on the expression of genes conferring resistance to 
additives such as antibiotics. In A. fumigatus, there are three main selection 
marker options (i) antibiotic resistance, (ii) nutritional deficiency or (iii) 
compound toxicity resistance (Brakhage and Langfelder, 2002) and these 
resistance genes form part of the construct, which replaces the gene of interest 
in the mutant strain. 
In A. oryzae, resistance to pyrithiamine (PT) was conferred by ptrA  and 
PT is a potent antagonist of thiamine that functions by reducing thiamine 
transport and inhibiting the activity of thiamine pyrophosphokinase (TPK). TPK 
is an essential enzyme for the synthesis of thiamine pyrophosphate (TPP) from 
thiamine. TPP is an essential co-factor for several critical enzymes and lack of 
production is lethal (Kubodera et al., 2000). In Aspergilli the use of ptrA  as a 
resistance marker to PT was successful in A. nidulans (Kubodera et al., 2000). It 
was later used successfully in other filamentous fungi such as A. fumigatus, A . 
kawachii, and T. reesei (Kubodera et al., 2002) and PT selection has also been 
used for the deletion of gliT in A. fumigatus (Scharf et al., 2010; Schrettl et al., 
2010). 
Although construct generation is extremely important for successful 
transformation, targeted gene replacement in A. fumigatus is extremely low, 
with targeted integration reported as low as 5 % (da Silva Ferreira et al., 2006). 
In filamentous fungi, the integration of transforming DNA is carried out by the 
cellular machinery responsible for DNA repair and recombination (Krappmann 
et al., 2006). In eukaryotes, double-strand breaks (DSB) have two main 
pathways to repair this type of DNA damage (i) homologous recombination and 
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(ii) nonhomologous end-joining (NHEJ) (da Silva Ferreira et al., 2006). HR 
involves the recombination of sequences that are homologous to one another, 
while NHEJ involves the direct ligation of strand ends and does not require a 
region of homology. Non-targeted integration (ectopic integration) of constructs 
is frequently observed and a contributing factor to this high frequency in fungi 
is the NHEJ pathway of DNA recombination (Kuck and Hoff, 2010). 
Integration of DNA via NHEJ is mediated by the Ku70/Ku80 heterodimer and 
the DNA ligase IV-XRCC4 complex (Critchlow and Jackson, 1998; Walker et 
al., 2001; Krappmann et al., 2006). Homologues to the human Ku70 and Ku80 
genes were identified in Neurospora crassa and deleted to generate two mutant 
strains termed mus-51 and mus-52 (Ninomiya et al., 2004). These authors state 
that transformations using these strains resulted in 93 – 100 % homologous 
integration compared to 9 – 21 % in the wild-type when a 0.5 – 1 kb long 
flanking region was used for transformation. This indicates that the suppression 
of genes associated with NHEJ increased the frequency of HR (Ninomiya et al., 
2004) and led to the development of several strains deficient in NHEJ in other 
filamentous fungi such as A. nidulans (Nayak et al., 2006), and A. fumigatus (da 
Silva Ferreira et al., 2006; Krappmann et al., 2006). In A. fumigatus, a strain 
deficient in Ku80 termed !akuA exhibited 96 % HR when using flanking 
regions of 1 kb and 1.5 kb in length and HR increased to 95 % when flanking 
regions of 2 kb in length were used. Interestingly, 84 and 75 % HR was reported 
for a shorter flanking region of 500 and 100 bp respectively (Krappmann et al., 
2006) and the rate of HR in the Ku70 deficient strain, !akuB, was as much as 
80 % when using a flanking region between 1.5 - 2 kb in length (da Silva 
Ferreira et al., 2006). These HR events contrasted drastically to those observed 
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in wild-type strains, where only 3-5 % HR was observed with the intact Ku80 
and Ku70 (da Silva Ferreira et al., 2006). Since the breakthrough of NHEJ 
deficient strains, successful transformations using !akuB have been reported in 
A. fumigatus for the deletion of genes from the gliotoxin cluster, such as gliP 
and gliT (Kupfahl et al., 2006; Scharf et al., 2010). Overall, the low frequency 
of HR observed when transforming A. fumigatus means that the use of a mutant 
strain like !akuB should increase the percentage of successful transformants. 
Also a more efficient DNA transformation methodology, such as the bipartite 
strategy increases the likelihood of a successful targeted gene deletion.  
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1.10 Objectives of this thesis 
Biosynthesis of gliotoxin is directed by the multi-gene (gli) cluster in the 
opportunistic fungal pathogen, Aspergillus fumigatus (Gardiner and Howlett, 
2005). Apart from gliP, gliZ and gliT minimal functional cluster annotation is 
available (Cramer et al., 2006; Kupfahl et al., 2006; Sugui et al., 2007; Spikes et 
al., 2008; Scharf et al., 2010; Schrettl et al., 2010). The gene gliG, located in the 
gli cluster, is classified as a glutathione s-transferase by in silico analysis and 
recombinant GliG exhibits GST and glutathione reductase activity (Carberry, 
2008). Speculation as to a role for gliG within the gene cluster has indicated it 
may play a role in self-protection against gliotoxin or that it may have a role in 
gliotoxin biosynthesis (Gardiner et al., 2005b; Howlett, 2008). This plausible 
speculation warrants functional characterisation to determine the role of A. 
fumigatus within the gliotoxin gene cluster.  
Therefore, the overall work objectives presented in this thesis are as follows; 
(i) The targeted deletion of A. fumigatus gliG in AF293 and !akuB strains. 
(ii) Phenotypical characterisation of A. fumigatus !gliG in response to various 
stresses and the abolition of identified phenotype through restoration of gene 
functionality via complementation of A. fumigatus !gliG.  
(iii) Characterisation of putative on or off-pathway gliotoxin biosynthetic 
intermediates identified using various structural elucidation protocols, such as 
mass spectrometry, NMR and elemental analysis.  
(iv) Development of an analytical method to functionally detect gliotoxin with 
respect to, (a) the detection of thiol groups following reduction with various 
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reagents and subsequent alkylation, (b) the application of reduction and 
alkylation of gliotoxin in a novel diagnostic method to detect native gliotoxin 
secreted into culture supernatant of A. fumigatus.  
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2. Chapter 2 Materials and Methods 
2.1 Materials 
All chemicals were purchased from Sigma-Aldrich Chemical Co. Ltd. 
(U.K.), unless otherwise stated. 
2.1.1 Aspergillus Media and Agar 
2.1.1.1 Sabouraud Dextrose Broth 
Sabouraud-dextrose broth (30 g) (Oxoid, Cambridge, UK) was added to 1 
L distilled water, and dissolved. The solution was autoclaved and stored at 4 
o
C. 
2.1.1.2 Sabouraud Agar 
Sabouraud agar (65 g) (Oxoid, Cambridge, UK) was added to 1 L distilled 
water and dissolved. The solution was autoclaved, and allowed to cool to ~50 
o
C. Agar (25 ml) was subsequently poured into 90 mm petri dishes, under sterile 
conditions. The plates were allowed to set and stored at 4 
o
C. 
2.1.1.3  Malt Extract Agar 
Malt extract agar (50 g) (Difco, Maryland, USA) was added to 1 L 
distilled water, and dissolved. The solution was autoclaved, and allowed to cool 
to ~50 
o
C. Agar (25 ml) was then poured into 90 mm petri dishes, under sterile 
conditions. The plates were allowed to set and stored at 4 
o
C.  
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2.1.1.4 Aspergillus Minimal Media 
2.1.1.4.1  50 X Salt Solution 
KCl (26 g), MgSO4.7H2O (26 g), and KH2PO4 (76 g) was dissolved in 1 L 
distilled water and autoclaved. The solution was stored at 4 
o
C. 
2.1.1.4.2 100 X Ammonium Tartrate 
Ammonium Tartrate (92 g) was dissolved in 1 L distilled water. The 
solution was autoclaved and stored at room temperature. 
2.1.1.4.3 0.3 M L-Glutamine 
L-glutamine (43.8 g) was dissolved in 800 ml distilled water. One or two 
drops of conc. HCl was added to aid dissolution. The pH was adjusted to pH 6.5 
and the final volume was brought up to 1 L. The solution was filter sterilised 
and stored at room temperature. 
2.1.1.4.4 Trace Elements 
Na2B4O7.7H2O (40 mg), CuSO4.5H2O (400 mg), FeSO4.7H2O (800 mg), 
Na2MoO.2H2O (800 mg), and ZnSO4.7H2O (8 g) were dissolved in order, in 
800 ml distilled water allowing each to dissolve completely before addition of 
the next component. A few drops of conc. HCl was added to maintain the 
solution. The solution was then brought up to 1 L with distilled water, and filter 
sterilised.  
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2.1.1.5 Aspergillus Minimal Media Liquid 
2.1.1.5.1  AMM with Ammonium Tartrate 
Salt solution (50 X, 20 ml), Ammonium Tartrate (100 X, 10 ml), and 
Glucose (10 g) were added to 800 ml distilled water. Trace elements containing 
iron (1 ml) (Section 2.1.1.4.4) was added and the pH of the solution was 
adjusted to pH 6.8. The solution was brought to 1 L distilled water, mixed, 
autoclaved at 105 
o
C for 30 min and stored at room temperature. 
2.1.1.5.2 AMM with L-glutamine 
Salt solution (50 X, 20 ml), glucose (10 g) and trace elements containing 
iron (1 ml) (Section 2.1.1.4.4) were added to 800 ml distilled water and 
dissolved. The pH of the solution was adjusted to pH 6.5 and made up to 1 L 
distilled water. The solution was autoclaved at 105 
o
C for 30 min. Filter 
sterilised L-glutamine (0.3 M, 66.3 ml) (Section 2.1.1.4.3) was added to the 
solution. The solution was stored at room temperature.  
2.1.1.6 Aspergillus Minimal Media Agar 
2.1.1.6.1 AMM Agar with Ammonium Tartrate 
Agar (18 g) was added to 1 L of AMM liquid medium with ammonium 
tartrate (Section 2.1.1.4.2). The solution was autoclaved and allowed to cool to 
about 50 
o
C and the agar mixture (25 ml) was poured into 90 mm petri dishes 
under sterile conditions and stored at 4 
o
C. 
2.1.1.6.2 AMM Agar with L-glutamine 
Agar (20 g) was added to 1 L of AMM liquid medium without added L-
glutamine (Section 2.1.1.4.3). The solution was autoclaved and allowed to cool 
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to about 50 
o
C. L-glutamine (0.3 M; 66.3 ml) was mixed into the cooling agar 
solution and the agar mixture (25 ml) was poured into 90 mm petri dishes under 
sterile conditions and stored at 4 
o
C. 
2.1.1.7 Regeneration Agar 
2.1.1.7.1 1.8 % (w/v) Regeneration Agar 
Aspergillus salt solution (50 X; 20 ml), Ammonium Tartrate (100 X; 10 
ml), and Trace elements (1 ml) (Section 2.1.1.4) were added to 800 ml distilled 
water and dissolved. The solution was adjusted to pH 6.8. Sucrose (342 g) was 
added and the solution was made up to 1 L distilled water. Agar (18 g) was 
added to the solution. The solution was autoclaved and kept at 65 
o
C until 
required. 
2.1.1.7.2 0.7% (w/v) Regeneration Agar 
Aspergillus salt solution (50 X; 20 ml), Ammonium Tartrate (100 X; 10 
ml), and Trace elements (1 ml) (Section 2.1.1.4) were added to 800 ml distilled 
water and dissolved. The pH of the solution was adjusted to pH 6.8. Sucrose 
(342 g) was added and the solution was made up to 1 L distilled water. Agar (7 
g) was added to the solution. The solution was autoclaved and kept at 65 
o
C 
until required. 
2.1.2 Solutions for pH Adjustment 
2.1.2.1 5 M Hydrochloric Acid (HCl) 
Deionised water (40 ml) and hydrochloric acid (43.64 ml) were added 
slowly to a graduated cylinder (glass). The final volume was adjusted to 100 ml. 
The solution was stored at room temperature. 
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2.1.2.2 5 M Sodium Hydroxide (NaOH) 
NaOH pellets (20 g) were added to deionised water (80 ml) and dissolved 
using a magnetic stirrer. The final volume was adjusted to 100 ml. The solution 
was stored at room temperature. 
2.1.3 Phosphate Buffer Saline 
One PBS tablet (Oxoid, Cambridge, UK) was added to 200 ml of distilled 
water, and dissolved by stirring. The solution was autoclaved and stored at room 
temperature. 
2.1.4 Phosphate Buffer Saline-Tween 20 (PBST) 
Tween-20 (0.5 ml) was added to 1 L PBS (Section 2.1.3). The solution 
was stored at room temperature. 
2.1.5 Phosphate Buffer Saline-Tween 80 (PBST-80) 
Tween-80 (0.5 ml) was added to 1 L PBS (Section 2.1.3). The solution 
was stored at room temperature. 
2.1.6 Antibiotics and Supplements 
All antibiotics and supplements were prepared as stock solutions in water 
or methanol and filter sterilised. All were stored at – 20 °C. Further information 
is provided in Table 2.1. 
 
  
61 
Table 2.1. Additives and antibiobics used during this study. 
Condition Tested Reagent Used Stock Concentration Tested Concentration 
Sensitivity to Oxidative Stress H2O2  1 M (prepared in H2O) diluted 
from stock bottle (concentration 
11.6 M) 
1 mM, 2 mM  
Anti-fungals Sensitivity Voriconazole (Vfend; Pfizer) 
Amphotericin B 
0.5 mg/ml (prepared in H2O) 
250 µg/ml (prepared in H2O)  
0.15 µg/ml, 0.25 µg/ml  
1 µg/ml, 2 µg/ml, 5 µg/ml 
Gliotoxin Sensitivity Gliotoxin  1 mg/ml (prepared in methanol) 10 µg/ml, 30 µg/ml, 50 µg/ml 
Pyrithiamine Resistance Pyrithiamine  Hydrochloride 0.1 mg/ml (prepared in H2O)  0.1 µg/ml 
Phleomycin Resistance Phleomycin 25 mg/ml (prepared in H2O)  40 µg/ml 
Ampicillin Resistance Ampicillin 100 mg/ml (prepared in H2O)  0.1 µg/ml 
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2.1.7 Luria-Bertani Broth 
LB Broth (25 g) (Difco, Maryland, USA) was dissolved in 1 L distilled 
water and dissolved. The solution was autoclaved and stored at 4 
o
C. 
2.1.8 Luria-Bertani Agar 
LB Agar (40 g) (Difco, Maryland, USA) was dissolved in 1 L distilled 
water.  The solution was autoclaved, and allowed to cool to ~50 
o
C. Agar (25 
ml) was then poured into 90 mm petri dishes, under sterile conditions and 
allowed to set. They were stored at 4 
o
C. 
2.1.9 80 % (v/v) Glycerol 
Glycerol (80 ml) was added to 20 ml deionised water. The solution was 
autoclaved and stored at 4 
o
C. 
2.1.10 Molecular Biology Reagents 
2.1.10.1 Agarose Gel Electrophoresis Reagents 
2.1.10.1.1  0.5 M Ethylenediaminetetraacetic acid (EDTA) 
Ethylenediaminetetraacetic acid disodium salt dihydrate (186.12 g) was 
dissolved in 800 ml distilled water. The pH was adjusted to pH 8.0 using 5 M 
NaOH (Section 2.1.2.2) and the final volume was brought up to 1 L. 
2.1.10.1.2 50 X Tris-Acetate Buffer (TAE) 
Trizma base (242 g) was added to 57.1 ml glacial acetic acid and 100 ml 
of 0.5 M EDTA, pH 8.0 (Section 2.1.10.1.1). The volume was adjusted to 1 L 
with distilled water. The solution was stored at room temperature. 
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2.1.10.1.3 1 X Tris-Acetate Buffer (TAE) 
50 X TAE (20 ml) (Section 2.1.10.1.2) was added to distilled water (980 
ml). The solution was stored at room temperature. 
2.1.10.1.4 Ethidium Bromide 
Ethidium bromide was supplied at 1 mg/ml of which 7 µl was used per 
100 ml agarose gel. 
2.1.10.1.5 SYBR!  Safe DNA Gel Stain 
A 10,000 X concentrate solution of SYBR! Safe was diluted into 1 % 
(w/v) agarose gel at a 1 X concentration.  
2.1.10.1.6 6 X DNA Loading Dye 
Loading dye (Promega, Southampton, UK) was used at the concentration 
supplied. 
2.1.10.1.7 1 % (w/v) Agarose Gel 
Agarose powder (1 g) was dissolved into 100 ml 1 X TAE (Section 
2.1.10.1.3). This mixture was heated in a microwave oven until the agarose had 
dissolved and the mixture was molten. Ethidium Bromide solution (Section 
2.1.10.1.4), or 10 !l SYBR® Safe gel stain (Section 2.1.10.1.5) was added. The 
gel was left to set for at least 30 minutes. 
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2.1.10.1.8 Molecular Weight Markers 
2.1.10.1.8.1 Roche Molecular Weight Marker vii  
Image of the Roche molecular weight marker vii.  
 
2.1.10.1.8.2 Directload"  Step Ladder, 50 bp, Sigma 
Image of the Directload
TM 
Step Ladder, 50 bp.  
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2.1.10.2 DNA Reagents 
2.1.10.2.1 100 % (v/v) Ice-cold Ethanol  
Molecular biology grade ethanol (100 % (v/v)) was aliquotted into a 
sterile tube and stored at – 20 °C.  
2.1.10.2.2 70 % (v/v) Ice-cold Ethanol 
Molecular biology grade ethanol (70 ml) was added to molecular biology 
grade sterile water (30 ml) and stored in a sterile tube at – 20 °C. 
2.1.10.2.3 3 M Sodium Acetate 
Sodium acetate (12.3 g) was dissolved in molecular biology grade sterile 
water (50 ml). The pH was adjusted to 5.2 and the solution was stored at room 
temperature.  
2.1.11 Aspergillus Transformation Reagents 
2.1.11.1 0.7 M Potassium Chloride 
KCl (26.1 g) was dissolved in 500 ml distilled water. The solution was 
autoclaved and stored at room temperature. 
2.1.11.2 25 mM Potassium Phosphate Monobasic 
KH2PO4 (1.7 g) was dissolved in 500 ml distilled water. 
2.1.11.3 25 mM Potassium Phosphate dibasic 
K2HPO4 (0.87 g) was dissolved in 200 ml distilled water. 
2.1.11.4 Lysis Buffer and Lytic Enyzmes 
2.1.11.4.1 Lysis Buffer 
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KCl (26.1 g) was dissolved in 25 mM KH2PO4 (350 ml) (Section 
2.1.11.2). The pH was adjusted to pH 5.8 with 25 mM K2HPO4 (Section 
2.1.11.3). The solution was brought to 500 ml with distilled water. 
 
2.1.11.4.2 Lytic Enzymes solution for protoplast generation 
Lytic enzymes from Trichoderma harzianum (0.45 g) were added to 15 ml 
lysis buffer (Section 2.1.11.4.1) and filter sterilised with a 0.45 µm filter, 
changing the filter after every 10 ml. 
2.1.11.5 Buffer L6 
Sorbitol (1 M), Tris-HCl (10 mM), and CaCl2 anhydrous (10 mM) was 
prepared by dissolving sorbitol (72.88 g), Tris-HCl (0.484 g), and CaCl2 (0.444 
g) in distilled water. The pH was adjusted to pH 7.5 before the final volume was 
adjusted to 400 ml with distilled water. The solution was autoclaved and stored 
at room temperature. 
2.1.11.6 Buffer L7 
PEG 6000 (60 g) was dissolved in distilled water (40 ml). Tris-HCl (0.157 
g) and CaCl2 anhydrous (0.444 g) was added and the solution was heated gently 
whilst covered with tin foil until completely dissolved. After dissolution the 
solution was placed on a cool plate. To adjust the pH, concentrated HCl was 
added dropwise. This was done over a time period of 1 – 2 hr until the pH was 
7.5. The solution was autoclaved and stored at room temperature. The solution 
was discarded once precipitation was observed as particulate matter may burst 
protoplasts during transformation.  
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2.1.12 Southern and Northen Blotting reagents 
2.1.12.1 Southern Transfer buffer 
Sodium hydroxide (0.6 M; 16 g) and Sodium chloride (0.4 M; 35.07 g) 
were dissolved in 800 ml distilled water. The volume was adjusted to 1 L with 
distilled water.  
2.1.12.2 20 X SSC 
Sodium chloride (175.3 g) and sodium citrate (88.2 g) were added to 
distilled water (800 ml). The pH was adjusted to pH 7 and the volume brought 
up to 1 L distilled water. The solution was autoclaved and stored at room 
temperature.  
2.1.12.3 10 X SSC (Northern transfer buffer) 
20 X SSC (500 ml) (Section 2.1.12.2) was added to distilled water (500 
ml) and mixed. The solution was stored at room temperature.  
2.1.12.4 2 X SSC 
SSC (100 ml, 20 X) (Section 2.1.12.2) was added to 900 ml distilled water 
and stored at room temperature. 
2.1.12.5 10 % SDS (w/v) 
SDS (10 g) was dissolved into I L distilled water. The solution was stored 
at room temperature.  
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2.1.12.6 0.1 % (w/v) SDS / 1 X SSC 
20 X SSC (50 ml) (Section 2.1.12.2) and 10 ml of SDS 10 % (w/v) 
(Section 2.1.12.5) were dissolved in 1 L distilled water. The solution was stored 
at room temperature. 
2.1.12.7 Digoxigenin (DIG) Detection Buffers 
2.1.12.7.1 10 % (w/v) Lauroylsarcosine 
Lauroylsarcosine (1 g) was dissolved in 10 ml distilled water. 
2.1.12.7.2 Membrane Pre-hybridisation Buffer 
SDS (35 g), formamide (250 ml), 100 ml 10 % Blocking reagent (Roche 
Applied Science, Mannheim, Germany), 5 ml 10 % (w/v) laurylosarcosine were 
dissolved in 500 ml distilled water. The solution was prepared under sterile 
conditions and stirred well before storage at 4 °C. Before use the solution was 
pre-heated at 65 
o
C for 15 minutes. 
2.1.12.7.3 DIG Buffer 1 (1 X) 
Maleic Acid (2.32 g) (0.1 M) and NaCl (1.75 g) (0.15 M) were added to 
180 ml distilled water. The pH was adjusted to pH 7.5 before the final volume 
was adjusted to 200 ml with distilled water. The solution was filter sterilised and 
stored at room temperature for up to one month. 
2.1.12.7.4 Antibody Blocking Reagent 
Blocking reagent (0.4 g) (Roche Applied Science, Mannheim, Germany) 
was dissolved in 40 ml of DIG buffer 1 (Section 2.1.12.7.3) at 50 °C. The 
solution was prepared fresh on the day.  
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2.1.12.7.5 DIG Buffer 3 
Tris-HCl (1.575 g) (0.1 M), NaCl (0.584 g) (0.1 M) and MgCl2.6H20 
(1.02 g) (50 mM) were dissolved in distilled water (80 ml). The pH was 
adjusted to pH 9.5 and the final volume brought up to 100 ml. The solution was 
filtered sterilised and then stored at room temperature for up to one month. 
2.1.12.7.6 DIG Wash Buffer  
Tween 20 (0.15 g) was dissolved in DIG Buffer 1 (50 ml) (Section 
2.1.12.7.3). The solution was mixed and filter sterilised before being stored at 
room temperature. 
2.1.12.7.7 Anti-Digoxigenin-Alkaline Phosphatase (AP), Fab fragment 
conjugate 
Anti-Digoxigenin- AP, Fab fragments (Roche, Mannheim, Germany) (1 
µl) was added to 10 ml antibody blocking reagent (Section 2.1.12.7.4). 
2.1.12.7.8 Chemiluminescent substrate phosphatase detection (CSPD) 
Substrate 
CSPD (50 µl) (Roche, Mannheim, Germany) was added to DIG Buffer 3 
(4.95 ml) (Section 2.1.12.7.5). 
2.1.12.7.9 DIG-labelled deoxynucleotide Triphosphates (dNTP’s) 
Pre-mixed DIG-labelled dNTPs were purchased from Roche and used 
according to the manufacturers guidelines for the generation of DIG-labelled 
probes for Southern and Northern detection probes.  
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2.1.12.8 Chemicals for developing Southern and Northern blots 
2.1.12.8.1 Developer Solution 
Developer (Kodak) was diluted 1/4 in distilled water and stored in a tinfoil 
covered Duran in a dark room. 
2.1.12.8.2 Fixer Solution 
The fixer solution (Kodak) was diluted 1/5 in distilled water and stored in 
a tinfoil covered Duran in a dark room. 
2.1.12.9 RNA Electrophoresis Reagents 
2.1.12.9.1 RNA Glassware 
All glassware, microcentrifuge tubes and general disposable material used 
for RNA reagent preparation and RNA extraction was double autoclaved before 
use.  
2.1.12.10 10 X Formaldehyde Agarose (FA) Gel Buffer 
MOPS (41.9 g) (0.2 M), sodium acetate (6.8 g) (82 mM) and 0.5 M 
EDTA pH 8 (20 ml) were dissolved in 800 ml double-autoclaved water. The pH 
of the solution was adjusted to pH 7.0 and the final volume brought up to 1 L 
with double-autoclaved water. The solution was autoclaved and stored at room 
temperature.  
2.1.12.11 1 X Formaldehyde Agarose (FA) Running Buffer 
FA gel buffer (10 X, 100 ml) (Section 2.1.12.10), 37 % (v/v) (12.3 M) 
formaldehyde (20 ml) and  double-autoclaved water (880 ml) were added to a 
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double-autoclaved 1 L Duran bottle. The solution was stored at room 
temperature. 
2.1.12.12 RNA Master Mix (20 X) 
FA gel buffer (10 X, 50 µl) (Section 2.1.12.10), 37 % (v/v) (12.3 M) 
formaldehyde (80 µl), formamide (240 µl) and ethidium-bromide (1 mg/ml) (2 
µl) (Section 2.1.10.1.4) were added together. The master mix was aliquotted 
(18.5 µl) before RNA was added. Samples were heated at 60 °C for 15 min, 
before loading dye (Section 2.1.10.1.6) was added prior to electrophoresis.  
2.1.12.13 RNA Agarose Gel (1.2 %) 
Low-melt agarose (Carl Roth, Germany) (1.8 g) was heated and dissolved 
in 135 ml double-autoclaved water. FA gel buffer (10X, 15 ml) (Section 
2.1.12.10) was added in a fume hood and mixed before casting.  
2.1.13 Reverse-Phase High Performance Liquid Chromatography (RP-
HPLC) Solvents 
2.1.13.1 RP-HPLC Mobile Phase Solvents 
2.1.13.1.1 Solvent A: 0.1 % (v/v) Trifluoroacetic acid (TFA) in HPLC grade 
water 
TFA (1 ml) was added to HPLC Grade Water (1 L) in a darkened Duran. 
2.1.13.1.2 Solvent B: 0.1 % (v/v) Trifluoroacetic acid (TFA) in HPLC grade 
Acetonitrile 
TFA (1 ml) was added to HPLC Grade Acetonitrile (1 L) in a darkened 
Duran. 
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2.1.14 Carbonate Dialysis Buffer 
Sodium carbonate (2.65 g) was dissolved into 300 ml deionised water, the 
pH adjusted to pH 9.4 with 5M HCL. The final volume was made up to 500 ml 
with deionised water, and stored at 4 °C.  
2.1.15 Enzyme Activity Assay Reagents 
2.1.15.1 1M Potassium Phosphate Monobasic 
KH2PO4 (68.05 g) was dissolved in 500 ml distilled water. 
2.1.15.2 1M Potassium Phosphate dibasic 
K2HPO4 (87.08 g) was dissolved in 500 ml distilled water. 
2.1.15.3 Potassium Phosphate Buffer (PPB) 
KH2PO4 (12.38 ml) (1M) and K2PO4 (7.62 ml) (1M) were added to 80 ml 
deionised water to a final pH of 6.6. 
2.1.15.4 1-Chloro-2, 4-dinitrobenzene (CDNB) Assay 
CDNB (0.10 g) was added to 10 ml Ethanol (100 %). Reduced glutathione 
(0.078 g) was added to 10 ml PPB (Section 2.1.15.3).  
2.1.15.5 1, 2- Epoxy- (3- (4- nitrophenoxy) propane (EPNP) Assay  
EPNP (97.5 mg) (Acros Scientific) (50 mM) dissolved in 10 ml Ethanol 
(100 %). Reduced glutathione (0.1536 g) dissolved in 10 ml PPB (Section 
2.1.15.3). 
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2.1.16 Reduction and Alkylation Assay 
2.1.16.1 Gliotoxin (1 mg/ml) 
Gliotoxin (25 mg) was dissolved in 25 ml Methanol (HPLC grade).  
2.1.16.2 Gliotoxin (100 µg/ml) 
Gliotoxin (1 ml; 1 mg/ml) was added to Methanol (HPLC Grade) (9 ml).  
2.1.16.3 1M Sodium Phosphate Monobasic 
Sodium phosphate monobasic (NaH2PO4) (29.99 g) was dissolved in 
water (250 ml).  
2.1.16.4 1M Sodium Phosphate Dibasic 
Sodium phosphate monobasic (Na2HPO4) (35.49 g) was dissolved in 
water (250 ml).  
2.1.16.5 1M Sodium Phosphate pH 8.0 
Sodium phosphate dibasic (93.2 ml) (1 M) and sodium phosphate 
monobasic (6.8 ml) (1 M) were mixed together. The pH was checked brought to 
pH 8.0.  
2.1.16.6 50 mM Sodium Borohydride 
Sodium borohydride (18.9 mg) was dissolved in water (HPLC Grade) (10 
ml).  
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2.1.16.7 500 mM Sodium Borohydride 
Sodium borohydride (189 mg) was dissolved in water (HPLC Grade) (10 
ml).  
2.1.16.8 50 mM TCEP  
TCEP.HCl (14.3 mg) was dissolved in deionised water (1 ml). The pH 
was adjusted to pH 7.6 with 5M NaOH (Section 2.1.2.2). 
2.1.16.9 1 M DTT 
DTT (154 mg) was dissolved in distilled water (1 ml).  
2.1.16.10 10 mM DTT 
DTT (1 M) (1 ml) (Section 2.1.16.9) was added to distilled water (99 ml). 
2.1.16.11 20 mM 5’ Iodoacetamidofluorescein (5’-IAF) 
5’-IAF (10 mg) was dissolved in DMSO (1ml). The solution was wrapped 
in tinfoil and stored at -20 °C.  
2.1.16.12 6 mM 5’ Iodoacetamidofluorescein (5’-IAF) 
5’-IAF (3 mg) was dissolved in DMSO (1ml). The solution was wrapped 
in tinfoil and stored at -20 °C.  
2.1.17 MALDI-ToF Reagents 
2.1.17.1 Matrix (!-cyano-4-hydroxycinnamic acid) (4-HCCA) Preparation 
Aqueous trifluoroacetic acid (TFA) (0.1% (v/v)) (500 !l) was added to an 
equal volume of acetonitrile. To 200 µl of this solution 4-HCCA (5 mg) was 
added. The mixture was vortexed for 2 min and allowed to stand at room 
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temperature for 15 min. The mixture was vortexed for 30 sec and centrifuged at 
12,000 x g for 1 min. The supernatant was retained as the matrix sample.  
2.1.18 TLC Reagents 
2.1.18.1 Dichloromethane : Methanol (90 : 10: 0.5 % (v/v) acetic acid) 
Dichloromethane (90 ml) was mixed with methanol (10 ml), acetic acid 
(0.5 ml). The solution was prepared in a fume hood and stored in a Duran bottle 
until use.  
2.1.18.2 Dichloromethane : Methanol (97 : 3: 0.5 % (v/v) acetic acid) 
Dichloromethane (97 ml) was mixed with methanol (3 ml), acetic acid 
(0.5 ml). The solution was prepared in a fume hood and stored in a Duran bottle 
until use.  
2.1.19 
13
C L-Phenylalanine (C6H5
13
CH2CH(NH2)CO2H) 
13
C L-Phenylalanine (20 mg) was dissolved in sterile molecular grade 
water (1 ml). The sample was filter sterilised before use.  
 
13
C 
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2.2 Methods 
2.2.1 Microbiological Methods – Strain Storage and Growth 
Fungal and bacterial strains used in this study are listed in Table 2.2 and 
Table 2.3, respectively. 
2.2.1.1 A. fumigatus Growth, Maintenance and Storage 
A. fumigatus strains were maintained on AMM agar (Section 2.1.1.6.1). A 
loop of spores from a stock spore solution was streaked onto a plate and 
incubated at 37 
o
C in a static incubator for 5-7 days with periodic checking. 
Once grown, conidia were harvested from the plate by adding sterile PBST (10 
ml) (Section 2.1.4) to the conidia and rubbing the surface with a sterile 
inoculation loop to dislodge the spores. The spore solution was centrifuged at 
2000 x g for 5 min. The supernatant was removed and the spore pellet was 
resuspended in sterile PBS (5 ml) (Section 2.1.3). This was repeated. The spores 
were counted using a haemocytometer to determine the spore density 
(spores/ml). The spores solution was stored at 4 
o
C, until required. 
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Table 2.2. Aspergillus fumigatus fungal strains, including antibiotics and supplements used. 
Strain Genotype Antibiotics/Supplements Reference 
A. fumigatus AF293 Wild-type  N/A (Nierman et al., 2005) 
A. fumigatus CEA17 !akuB Hygromycin (250 µg/ml) (da Silva Ferreira et al., 
2006) 
A. fumigatus !gliG
!akuB 
 !gliG::ptrA  Pyrithiamine (100 ng/ml) This Thesis 
A. fumigatus !gliG
AF293 
!gliG::ptrA  Pyrithiamine (100 ng/ml) This Thesis 
A. fumigatus gliG
C
 15.1 !gliG
AF293
::(p)topogliGPhleo
 
Phleomycin (80 µg/ml)  This Thesis 
A. fumigatus gliG
C
 15.4 !gliG
AF293
::(p)topogliGPhleo
 
Phleomycin (80 µg/ml)  This Thesis 
A. fumigatus gliG
C
 17.1  !gliG
AF293
::(p)topogliGPhleo Phleomycin (80 µg/ml)  This Thesis 
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Table 2.3. Bacterial strains, including antibiotics and supplements used. 
Species Strain Antibiotics/Supplements 
E. coli TOP 10 Ampicillin (100 !g/ml) 
E.coli pSK275 Pyrithiamine (100 ng/ml) 
E. coli pPhleo Phleomycin (40 µg/ml) 
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2.2.1.2 E. coli Growth, Maintenance and Storage 
E. coli strains were grown on Luria-Bertani agar (Section 2.1.8) overnight 
at 37 
o
C or in Luria-Bertani broth (Section 2.1.7) at 37 
o
C overnight, shaking at 
200 rpm. Where appropriate, media was supplemented with suitable antibiotics.  
2.2.2 Molecular Biological Methods 
2.2.2.1 Isolation of Genomic DNA from A.fumigatus  
A. fumigatus conidia were harvested from five day old plates as described 
in Section 2.2.1.1. An aliquot of the resulting conidial suspension (100 µl) was 
used to inoculate 100 ml cultures of AMM (Section 2.1.1.5.2). The cultures 
were incubated at 37 
o
C for 24 hr with constant agitation. The cultures were 
then filtered through autoclaved miracloth and the mycelia collected. The 
mycelia mass was flash frozen in liquid Nitrogen and ground to a fine powder 
using a pestle and mortar. The DNA extractions were carried out using the ZR 
Fungal/Bacterial DNA Kit! supplied by Zymo Research (California, U.S.A). 
All buffers and reagents were supplied with the kit. For each sample, mycelia (1 
g) was added to 750 µl DNA buffer in the ZR Bead Bashing tube. DNA 
extraction was carried out according to the manufacturers instructions. DNA 
was eluted in sterile molecular grade water (100 µl). 
2.2.2.2 Precipitation of A. fumigatus Genomic DNA 
Sterile molecular grade water was added to the DNA sample until the 
final volume was 100 µl. Sodium acetate (10 µl) (Section 2.1.10.2.3) and 250 µl 
of ice-cold ethanol (100 % (v/v)) (Section 2.1.10.2.1) was added and the 
samples were mixed by gentle inversion. Samples were incubated at – 20 °C for 
at least 1 hr. Samples were then centrifuged at 13,000 x g for 10 min at 4 °C. 
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Supernatants were discarded and the DNA pellet was washed with ice-cold 
ethanol (70 % (v/v) (Section 2.1.10.2.2). At this point, care was taken not to mix 
the solution as this would disturb the DNA pellet. Subsequently, samples were 
centrifuged at 13,000 x g for 10 min at 4 °C. The supernatant was discarded. A 
quick spin on the microfuge was carried out (approximately 10,000 x g, 15 sec). 
Any ethanol droplets on the inside of the tube was removed carefully using a 
sterile pipette tip. The pellet was let to air dry and finally resuspended in 16 µl 
of sterile molecular grade water.  
2.2.2.3 Polymerase Chain Reaction (PCR) 
Polymerase chain Reaction (PCR) was used to amplify fragments of DNA 
for cloning, transformation constructs, DIG-labelled probes, confirmation of A. 
fumigatus gene deletion and complementation and to test E. coli for 
recombinant plasmid presence. PCR was carried out using either AccuTaq LA 
polymerase (Sigma-Aldrich) or Expand Long Template PCR system (Roche). 
Annealing temperatures were estimated as ca. 4 
o
C below the melting 
temperature (Tm) of the primers used. Extension times used were ca. 1 min/kb of 
DNA to be synthesised. Reactions were carried out using either the Eppendorf 
PCR or G-Storm PCR (Roche) Systems.  
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The general reaction constitutes for both polymerases used was as follows: 
AccuTaq LA polymerase 
10X reaction buffer  2 µl 
dNTP mix (10 µM)  2 µl 
Primer 1 (100 pmol/µl) 1 µl 
Primer 2 (100 pmol/µl) 1 µl 
DMSO    0.8 µl 
DNA template   10 – 100 ng 
AccuTaq   0.2 µl 
Sterile water   to a total of 20 µl 
 
Expand Long Template PCR system 
10X Reaction Buffer  5 µl 
dNTP mix (5 µM)  5 µl 
Primer 1 (100 pmol/µl) 2 µl 
Primer 2 (100 pmol/µl) 2 µl 
DNA template   up to 500 ng 
ExpandTaq   1 µl 
Sterile water   to a total of 50 µl 
 
The following reaction cycle was used unless otherwise stated: 
95 
o
C (denaturing) 5 min 
95 
o
C (denaturing) 1 min 
55 
o
C (annealing) 1 min 30 sec             x 30 – 40 cycles 
72 
o
C (extending) 1 min 
72 
o
C (extending) 10 min 
 
When AccuTaq was used, extension temperature was reduced to 68 
o
C as per 
manufacturers guidelines. 
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2.2.2.4 DNA Gel Electrophoresis  
2.2.2.4.1 Preparation of Agarose Gel 
Agarose gel electrophoresis was used to visualise restriction digest 
reactions, to separate DNA for Southern analysis, to separate differently sized 
DNA fragments prior to purification and for estimation of DNA yield. Agarose 
gels were cast and run using Bio-Rad electrophoresis equipment. Agarose gels 
of between 0.7 – 2 % (w/v) in 1X TAE buffer (Section 2.1.10.1.3) were used, 
although for the majority of applications a 1 % (w/v) agarose content was 
suitable. Powdered agarose was added to the appropriate volume of 1X TAE 
buffer (Section 2.1.10.1.3) in a 200 ml flask with loose stopper. This was then 
gently heated in a microwave, with frequent mixing, until the agarose had 
dissolved. While allowing the gel to cool, a mould was prepared by inserting the 
casting unit in a casting holder and sealed. A gel comb was inserted. After 
allowing the gel to cool to 40 – 50 
o
C, ethidium bromide (Section 2.1.10.1.4) or 
SYBR-Safe was used (Section 2.1.10.1.5). The molten gel was then poured into 
casting unit, and allowed to set on a level surface. Once set, the gel comb was 
removed gently, and the gel casting unit containing the set gel was placed into 
the gel tank, with the wells nearer the negative (black) electrode. 1 X TAE 
buffer (Section 2.1.10.1.3) was then poured into the gel tank to fully submerge 
the gel. 
2.2.2.4.2 Loading and Running Samples 
DNA samples were prepared for loading by adding 5 volumes of DNA 
sample to 1 volume of 6 X loading dye (Section 2.1.10.1.6). DNA fragment size 
was estimated by running molecular weight markers alongside the unknown 
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samples. Two different molecular weight markers were used throughout this 
study; marker VII (Roche) and 50 bp ladder (Roche). Gels were electrophoresed 
at 50 – 100 volts for 30 – 90 min. 
2.2.2.4.3 DNA Gel Extraction 
DNA gel extraction was carried out using the QIA quick gel extraction kit 
(Qiagen, UK). All reagents and columns were supplied with the kit and the 
procedure was carried out according to the manufacturer’s instructions. DNA 
was eluted in 30 µl of sterile molecular grade water. 
2.2.2.5 Restriction Enzyme Digest 
Restriction enzymes, 10 X reaction buffers, and bovine serium albumin 
(BSA) were obtained from either Promega or New England Biolabs. Reactions 
were carried out according to the manufacturer’s instructions as follows; 
DNA  1- 5 µg 
Enzyme  1 µl 
10 X buffer 2.5/5 µl  
10 B BSA 2.5/5 µl  
Sterile water to a total of 25/50 µl  
 
2.2.2.6 Ligation of DNA Fragments 
Ligation of DNA fragments was required for the generation of gene 
disruption constructs. DNA was digested (Section 2.2.2.5) to produce 
compatible fragments. These fragments were then separated by DNA gel 
electrophoresis (Section 2.2.2.4). Ligation of DNA fragments was carried out 
using the Ligafast! Rapid DNA Ligation System (Promega) which employs T4 
 84 
DNA ligase. Ligations were carried out as per manufacturer’s instructions. 
Restriction digests either produce a DNA fragment with an overhang of single-
stranded DNA at either end of the double-stranded section, called a cohesive 
end or where no overhangs exist, called a blunt end. For cohesive ended 
ligation, the preferred molecular ration of insert to backbone is 3 : 1. This was 
estimated based off the sixe of the DNA fragment using the following formula; 
 
 
 
Ligations were carried out using 50 – 200 ng of vector DNA. T4 DNA 
ligase (1 µl), and 2X Rapid ligation buffer. For ligations where inserts were 
ligated to vectors, a control ligation was also carried out where the insert DNA 
was omitted from the reaction. For the generation of complementation 
constructs a ratio of insert to backbone of 3 : 1 and 2 : 1 was used. This was 
estimated based on the above formula. All reactions were carried out in a 
thermal cycler to ensure the ligation temperature was constant.  
 
2.2.2.7 Transformation of DNA into Competent DH5! Cells 
LB agar plates (Section 2.1.8) containing Ampicillin (Section 2.1.6) were 
pre-heated to 37 
o
C for at least one hr. For DH5! transformation, competent 
cells (50 µl) were removed from -70 
o
C freezer and were defrosted on ice for 2 
min. DNA (1-10 ng) was added to the DH5! cells. The mixture was incubated 
(ng of vector) * (kb of insert)             3 (molar ratio of insert/vector) 
kb size of vector   1 
 
 
= ng of insert 
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on ice for 5 min. The mixture was spread onto the agar plates as quickly as 
possible and the plates were incubated at 37 
o
C overnight.  
2.2.2.8 TOPO TA Cloning 
One step cloning of PCR products were carried out using the TOPO TA 
Cloning kit from Invitrogen, according to the manufacturer’s instructions. The 
principle behind one step Cloning is based on the non-template dependant 
activity of Taq polymerase that results in the addition of a single 
deoxyadenosine (A) to the 3’ ends of the PCR products. The linearised cloning 
vector has single 3’ deoxythymidine (T) residues therefore facilitating PCR 
inserts to ligate efficiently with the vector. The TOPO TA Cloning vector map 
is presented in Figure 2.1. The TOPO TA Cloning kit contains TOP 10 One 
Shot competent E. coli cells, Super Optimal Catabolite repression (SOC) media, 
TOPO vector and salt solution. Prior to cloning, TOP10 cells were thawed on 
ice and LB agar plates (Section 2.1.8) containing 100 µg/ml Ampicillin (Section 
2.1.6) pre- warmed in a 37
 o
C incubator. Genomic DNA PCR product (4 µl), 
Salt solution (1 µl) and TOPO vector (1 µl) were added to a sterile 0.5 ml tube 
and left at room temperature for 30 min. A 2 µl aliquot of this reaction mixture 
was added to a vial of TOP10 E. coli cells and placed on ice for 30 min. Cells 
were heat shocked at 42
 o
C for 30 s in a water bath and pre-warmed SOC media 
(200 µl) was added to the vial. The cell suspension was transferred to a 15 ml 
tube and incubated at 37 
o
C for 1 hr with constant agitation (200 rpm). During 
this incubation period, 32 µl of 5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside (X-gal) (Promega) (Southampton, UK) (40 mg/ml) was 
spread over the pre-warmed agar plates using a sterile glass spreader and the 
plates were returned to the incubator. This reagent facilitates blue/white colony 
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screening which greatly aids in the identification of desired clones. A 50 µl 
aliquot of the cell suspension was spread on the selection plates using a sterile 
disposable spreader and the plates were incubated overnight at 37 
o
C. White 
colonies were selected and sub-cultured on to LB agar plates (Section 2.1.8) 
with Ampicillin (100 µg/ml) (Section 2.1.6). Restriction digest (Section 2.2.2.5) 
was carried out to verify the presence and orientation of the desired insert in the 
vector of the sample clones. 
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Figure 2.1. Vector map of the TOPO® TA Cloning® vector (Invitrogen, The 
Netherlands). 
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2.2.2.9 Small Scale Plasmid Purification 
Plasmid purification was carried out according to the Qiagen Plasmid 
purification manual using the QIA prep Mini-prep kit. All buffers and columns 
were supplied with the kit and details of buffer constituents are outlined in the 
Qiagen Plasmid Purification Handbook. An isolated colony was picked 
aseptically and used to inoculate LB broth (Section 2.1.7) (3 ml) containing 100 
µg/ml Ampicillin (Section 2.1.6). Cultures was grown overnight at 37 °C and 
the cells harvested by centrifugation at 13,000 x g for 10 min at 4 °C. 
Procedures were then carried out according to the manufacturer’s guidelines. 
Purified plasmids were subsequently analysed by restriction digestion followed 
by DNA gel electrophoresis (Section 2.2.2.4 and 2.2.2.5).  
2.2.3 Generation of A. fumigatus "gliG Mutant Strains 
2.2.3.1 Generation of Constructs for A. fumigatus gliG Gene Deletion 
The bipartite gene disruption strategy was employed for the generation of 
A. fumigatus mutant strains in this study. This method involved the generation 
of gene deletion constructs by PCR and a ligation (Nielsen et al., 2006). Briefly, 
this strategy involved the generation of two constructs which each contain a 
partial fragment to the pyrithiamine (PT) resistance gene (ptrA ) from A. oryzae 
(Kubodera et al., 2000) which is ligated to respective 5’ and 3’ flanking regions 
of A. fumigatus  gliG. This facilitates overlapping of the two constructs and 
reconstitution of the deletion cassette in vivo. The ptrA  gene was excised from a 
plasmid vector pSK275 (a kind gift from Prof. Sven Krappmann, Göttingen, 
Germany), using two restriction enzymes. Both the 5’ and 3’ flanking regions of 
A. fumigatus gliG were amplified from A. fumigatus genomic DNA by PCR 
 89 
(Section 2.2.2.3), where a SpeI and XhoI restriction sites were incorporated to 
the PCR products. This facilitates cloning of the PCR products to ptrA . About 
1.0 – 1.2 kb of the flanking region were amplified. The resulting PCR products 
were digested with the same enzymes (SpeI and XhoI) as ptrA  to make the ends 
compatible for ligation (Section 2.2.2.6). The ligation products were used as 
template for a subsequent second round of PCR, where nested primers amplified 
the majority of the flanking region and only a partial section of ptrA . Schematic 
representation of the bipartite gene deletion strategy is illustrated in (Chapter 3, 
Figure 3.4). All primers used in this study are listed in Table 2.4.  
Both first and second round PCR were performed with the Expand Long 
Range Template PCR System (Roche). PCR products were extracted from 1 % 
(w/v) agarose gels and purified using a Qiagen gel extraction kit (Section 
2.2.2.4.1 and 2.2.2.4.3). Successful transformation of A. fumigatus protoplasts 
generated potential A. fumigatus transformants which had the ability to grow on 
pyrithiamine (PT) selection plates. This ability only occurred with the 
successful integration of a fully reconstituted ptrA . These transformants were 
then screened by Southern blot analysis where a single homologous integration 
of ptrA  in place of A. fumigatus gliG was desired.  
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Table 2.4. Oligonucleotide primers used for the creation of constructs for the 
transformation of gliG. Engineered restriction sites are underlined for XhoI and 
SpeI in ogliG-3 and ogliG-4 respectively.  
 
Primer Identity Sequence (5’-3’) 
ogliG-1  CACGGTTGTTGCTGTAGGTGT 
ogliG-2  CTTCGTCCTTCCATACGCACG 
ogliG-3  CTCTCGAGTACAAGATCGGAG 
ogliG-4  AAACTAGTAAAGCTGCAGGAG 
ogliG-5  AGGCGAAGATGCCATTGC 
ogliG-6  CTCTCCACGCTGCAATAC 
ogliG-7  GACCCTCCGATCTTGTAG 
ogliG-8  TTCTCGCCATGGCCAAAC 
ogliG-9 AACAGGTTGGTGCTTTTCGTGG  
ogliG-10 ATTGCACCGTAATGTTGCTGCG 
optrA-1 GAGGACCTGGACAAGTAC 
optrA-2 CATCGTGACCAGTGGTAC 
ogliM-1 GTCCAGTTCGAGCAAGCCA 
ogliM-2 AACAGGTATGCAATCCTAGAC 
ogliK-1 TGGGGGAATCTGGTACTTTG 
ogliK-2 ATTTAGACGCTGGCTGCTGT 
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2.2.3.2 Constructs for Complementation Transformations 
To restore A. fumigatus gliG back into the genome of A. fumigatus "gliG, 
a construct containing a new selectable marker gene and the full gliG sequence 
with the respective 5’and 3’ flanking regions was generated. The primers used 
for the complemented construct are listed in Table 2.4. The gliG coding 
sequence was PCR amplified from wild-type genomic DNA with ogliG-5 and 
ogliG-6. The PCR products were cloned into the TOPO vector. The orientation 
of the inserted DNA was verified, by performing a diagnostic restriction digest 
(Section 2.2.2.5) with PstI. For the selection marker, the phleomycin resistance 
plasmid, Bphleo was used where the phleomycin resistance gene was excised 
using XbaI and KpnI. This was then cloned into the topogliG plasmid via KpnI 
and SpeI sites. A diagnostic restriction digest (Section 2.2.2.5) was performed 
using SmaI to confirm the correct orientation of ble. This vector, topogliGphleo, 
was then linearised using a restriction enzyme that had a unique site in the 
sequence. In this case, HpaI was chosen. The linearised plasmid was then 
transformed into protoplast of A. fumigatus "gliG
AF293
.  
2.2.3.3 A. fumigatus Protoplast Preparation 
A. fumigatus conidia were harvested from 5 day old plates grown on 
AMM agar (Section 2.2.1.1). An aliquot of the spore suspension was diluted 
(1/10 dilution) and counted on a haemocytometer. A 500 ml conical flask 
containing AMM medium (200 ml) (Section 2.2.1.1) was inoculated with A. 
fumigatus conidia. The culture was incubated overnight at 37 
o
C, whilst shaking 
at 200 rpm. The mycelia were harvested by filtering through sterile miracloth 
and washed with sterile distilled water. Excess water was removed by gentle 
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blotting. Mycelia (1.5 g) was weighed out in duplicate, and each was added to 
15 ml Lysis buffer (Section 2.1.11.4.1) containing lytic enzymes (Section 
2.1.11.4.2), and then incubated with the tubes laying down flat at 30 
o
C while 
shaking at 100 rpm. After 5 min incubation the tubes were removed from the 
incubator, using a P1000 the mycelial solution was pipetted to break up clumps 
of mycelia. After 5 min, a 200 µl pipette tip was placed on top of a fresh 1000 µl 
tip and the mycelial solution was pipetted to further break up the mycelia. The 
mycelia solution was placed back in the incubator and incubated until the total 
time of mycelial lysis was 3 hr. The samples were placed on ice for 5 min to 
inhibit the lytic enzymes therefore terminating the lysis. The mycelial solution 
was centrifuged at 132 x g for 18 min with the brake off. The supernatant was 
filtered through sterile filter paper and brought up to 40 ml with 0.7 M KCl 
(Section 2.1.11.1). The solution was centrifuged at 1769 x g for 12 min with the 
brake off. The supernatant was poured off and discarded. The pellet was 
resuspended in 10 ml 0.7 M KCl (Section 2.1.11.1). The solution was 
centrifuged at 1769 x g for 12 min with the brake off. The supernatant was 
poured off and discarded. The tubes were then left upside down on sterile tissue 
for 1 min. The pellet was resuspended in 70 µl of Buffer L6 (Section 2.1.11.5) 
by gentle pipetting and swirling the resuspended pellet. The samples were 
centrifuged at 58 x g for 1 min with the brake off to gather the entire protoplast 
suspension in the bottom of the tube. Duplicate protoplast solutions were pooled 
at this point. Finally, the protoplasts were viewed on a haemocytometer to 
ensure adequate yield and viability was assessed prior to the transformation. 
The protoplasts were stored on ice for up to 1 hr before use in transformation 
experiments. 
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2.2.3.4 A. fumigatus Protoplast Transformation 
For each transformation event approximately 5 µg of"5’ and 3’ constructs 
were mixed together in a 50 ml sterile tube and the final volume was brought up 
to 50 µl with Buffer L6 (Section 2.1.11.5). A. fumigatus protoplasts (150 µl), of 
at least 1 x 10
7 
/ ml were added to the constructs. Buffer L7 (50 µl) (Section 
2.1.11.6) was added to the protoplast / DNA mixture. This was mixed by gentle 
swirling (not pipetting) and placed on ice for 20 min. Once on ice it was 
important that the protoplast / DNA solution was not moved. Buffer L7 (1 ml) 
(Section 2.1.11.6) was added to the mixture and left at room temperature for 5 
min, to allow for recovery of protoplasts. Buffer L6 (5 ml) (Section 2.1.11.5) 
was added, and the mixture was left on ice until required for plating. This 
incubation time on ice did not exceed 30 min. Simultaneously, control plates 
were set up where Buffer L6 (185 µl) was added to A. fumigatus protoplasts (15 
µl). The tube was swirled gently before the addition of Buffer L7 (50 µl).  
2.2.3.5 Plating of Transformation Protoplasts 
Regeneration agar (1.8% (w/v), 25 ml) (Section 2.1.1.7.1) containing PT 
(0.1 µg/ml) or phleomycin (40 µg/ml) (Section 2.1.6) was poured into 90 mm 
petri dishes on the transformation day. These plates were stored at room 
temperature until required for use. For each transformation, six plates 
containing the selective reagent were prepared and two plates without this 
reagent were prepared. The two plates without the selective reagent were used 
for the protoplast viability check. For the negative control, protoplasts (1.25 ml) 
were added to a sterile tube, which was brought to 6 ml with the 0.7 % (w/v) 
regeneration agar (Section 2.1.1.7.2). This was then poured onto one of the 
transformation plates that contained the selective agent. For the protoplast 
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viability control plate dilutions of the protoplasts were plated for a viable 
titration. To do this two protoplast dilutions were prepared in fresh 50 ml tubes. 
One of these contained 1.25 ml of the A. fumigatus protoplast suspension and 
the other contained 1.25 µl of the A. fumigatus protoplast suspension. 
Independently, the protoplast dilutions were brought to 6 ml with the 0.7 % 
(w/v) regeneration agar (Section 2.1.1.7.2). These were then separately poured 
onto transformation plates that contained no selective agent. Finally, 
transformed A. fumigatus protoplasts were topped up to 30 ml with the 0.7 % 
(w/v) regeneration agar (Section 2.1.1.7.2). This was mixed by inversion once 
and then 5 ml was poured onto each of the five transformation plates that 
contained the selective agent. All the plates were left upright at room 
temperature overnight (as long as the room temperature did not drop below 20 
°C).  
2.2.3.6 Overlaying of Transformation Plates 
0.7 % (w/v) regeneration agar (50 ml) (Section 2.1.1.7.2) containing 
pyrithiamine (0.1 µg/ml) or phleomycin (40 µg/ml) (Section 2.1.6) was mixed 
and 6 ml was poured over the 5 transformation plates, and the negative control 
plate. For the positive control plates, 6 ml of 0.7 % (w/v) regeneration agar 
(Section 2.1.1.7.2) without pyrithiamine or phleomycin was added to each of the 
plates. Once the agar had set, all the plates were incubated upside down in a 37 
o
C static incubator for approximately 5 – 7 days or until colonies were observed 
through the top of the overlay layer. The appearance of colonies on the 
protoplast viability plates after 2 – 3 days confirmed viable protoplasts had been 
generated.  
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2.2.3.7 Isolation of A. fumigatus Transformants After Transformation 
Potential transformants exhibited the ability to grow on the transformation 
plates, which contained the selective agent. Approximately 20 – 40 colonies 
were usually identified per transformation event. Spores from the transformants 
were picked aseptically from the transformation plates and point inoculated onto 
fresh selective plates (Section 2.1.1.7.1) which contained the selective agent 
(Section 2.1.6). No more than 10 colonies were point inoculated onto a single 
fresh plate at a time. The plates were then incubated at 37 °C in a static 
incubator until colonies were observed. The individual potential transformant 
colonies were aseptically excised from the plates by plugging with the base of a 
blue pipette tip. The plug was transferred to an Eppendorf tube containing PBST 
(750 µl) (Section 2.1.4). The tubes were then vortexed vigorously to release the 
conidia from the agar and into the solution. The conidial suspensions were 
stored at 4 
o
C until required. Putative transformant conidial suspensions (500 µl) 
were inoculated into Sabouraud Dextrose Broth (100 ml) (2.1.1.1) in a 500 ml 
conical flask. The cultures were incubated overnight at 37 
o
C, whilst shaking at 
200 rpm. The cultures were then harvested and DNA extraction (Section 
2.2.2.1) was performed for Southern blot analysis (Section 2.2.5). 
 
2.2.3.8 Single Spore Isolation of Transformant Colonies 
Following a first round of Southern blot analysis, transformants which 
showed the correct signal on the Southern blot were selected for single spore 
isolation. This was to ensure that a transformant contained a homogenous single 
nucleus and that it was not a heterokaryon. Potential transformants were diluted 
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by serial dilutions ranging from 10
-2
 to 10
-6
 in filter sterilised PBST (Section 
2.1.4). One-hundred µl of the dilutions were spread onto AMM plates (Section 
2.1.1.6) containing pyrithiamine (0.1 µg/ml) or phleomycin (40 µg/ml) (Section 
2.1.6) and incubated at 37 
o
C in a static incubator until conidiation of colonies 
were observed. The individual colonies were numbered and isolated in PBST 
(Section 2.1.4) as described in Section 2.2.3.7 and were then subjected to a 
second round of Southern blot analysis (Section 2.2.5).  
2.2.4 Synthesis of DIG-labelled Probes 
The probes used in the Southern and Northern analysis (Table 2.5) were 
generated by PCR (Section 2.2.2.3) with the incorporation of DIG-labelled 
dNTP’s. PCR products were resolved on a 1 % agarose gel and excised as 
previously described (Section 2.2.2.4). DNA was denatured by heating at 95 °C 
for 10 min on a heating block. The DNA was centrifuged for 1 min under a 
quick spin before it was placed on ice. The DNA (400 ng) was added to 
membrane pre-hybridisation buffer (10 ml) (Section 2.1.12.7.2) which had been 
pre-heated to 65 °C for at least 30 min. The probe was stored at – 20 °C  and 
always heated at 65 °C for at least 30 min before use in Southern or Northern 
blot analysis.  
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Table 2.5. Primers used to generate the DIG-labelled probes used for Southern 
and Northern analysis. For primer sequences please refer to Table 2.4.  
Probe Name Primers Used Probe Size Probe Use 
5’ Probe ogliG-4 and ogliG-5 1200 bp Southern 
3’ Probe ogliG-3 and ogliG-6 1002 bp  Southern 
gliG cds Probe ogliG-7 and ogliG-8 794 bp Southern/Northern 
ptrA  Probe optrA-1 and optrA-2 559 bp Southern 
gliM Probe ogliM-1 and ogliM-2 1452 bp Northern 
gliK Probe ogliK-1 and ogliK-2 1331 bp Northern 
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2.2.5 Southern Blot Analysis 
2.2.5.1 Southern Blot Analysis – DNA Transfer 
Southern blot analysis was performed to determine whether the gene of 
interest has been deleted of replaced. Genomic DNA was isolated from the 
potential transformants (Section 2.2.2.1) and a restriction digest was performed 
using a suitable enzyme (Section 2.2.2.5). The choice of enzyme depended on 
the sequence of the A. fumigatus wild-type and transformed strain. The enzyme 
of choice would cut upstream to the 5’ or 3’ flanking region and once within the 
gene of interest for the wild-type loci and it would also cut once within the 
replacement gene for the mutant loci. This digestion would generate one signal 
on the blot of different sizes in the wild-type and mutant strain. The digested 
DNA was resolved on 0.7 % (w/v) agarose gels (Section 2.2.2.4.1). After the 
digested DNA had resolved sufficiently. The gel was placed on a UV cross-
linking machine (Strategene, La Jolla, CA) and pulsed at 800 µJ to nick the 
DNA which aids transfer to the nylon membrane. Following the DNA nicking 
the Southern tower was set up (Figure 2.2). A Biorad electrophoresis tank was 
used for this procedure where the two reservoirs on each side of the tank were 
filled with Southern transfer buffer (Section 2.1.12.1). Two large sheets of 
Whatman filter paper were draped from reservoir to reservoir across the tank 
and left until they were soaked in the transfer buffer. On top of these, the DNA 
gel was placed with the loaded side face down. A piece of nylon membrane (H
+
 
Bond Nylon Membrane, GE Electric) cut to the exact size of the gel was placed 
on top of the gel. Once contact was made with the gel, the membrane was not 
moved. Three pieces of filter paper cut to gel size were placed on top, followed 
by three stacks of pocket-sized tissue. A glass plate was placed on top of the 
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stack and a duran bottle containing approximately 400 ml of water was used to 
balance the tower. The Southern blot was left overnight at room temperature (as 
long as room temperature was consistent and did not drop below 20 °C).   
 
 
 
 
Figure 2.2. Schematic illustration of a Southern / Northern transfer tower.  
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2.2.5.2 Disassembly of the Southern Tower 
The Southern Blot tower (Section 2.2.5.1) was taken apart and the 
membrane and gel were removed together and placed on a clean glass plate. The 
position of the wells was marked onto the corresponding place on the 
membrane, and the gel was peeled away from the membrane. The membrane 
was then washed in SSC buffer (2 X, 40 ml) (Section 2.1.12.4), and rocked 
gently for 10 min. The membrane was removed and placed on clean tissue paper 
to remove excess buffer. The membrane was then placed in a UV crosslinker 
(Strategene, La Jolla, CA) and crosslinked at 1200 µJ for 20 – 50 sec in order to 
fix the DNA onto the membrane. 
2.2.5.3 Pre-hybridisation of the Nylon Membrane  
After UV crosslinking the membrane was placed in a Hybaid tube (which 
had been heated to 42 °C) with the DNA side facing inwards. Pre-hybridisation 
buffer (20 ml) (Section 2.1.12.7.2), which had been heated to 65 °C was poured 
into the tube. The tubes were incubated at 42 °C in a Hybaid oven whilst 
rotating for 4 – 5 hr to block the membrane.  
2.2.5.4 Addition of DIG-labelled Probe to Southern Blots 
After pre-hybridisation of Southern blots (Section 2.2.5.3), the pre-
hybridisation buffer was removed. The DIG-labelled probe which had been 
heated to 65 °C was then poured into the tube. The tubes were then incubated 
overnight at 42 °C whilst rotating in a Hybaid oven to allow the probe to 
hybridise to regions of homology on the membrane. After probing the probe 
was removed from the tube and stored at – 20 °C.  
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2.2.5.5 DIG detection  
The membrane was removed from the Hybaid tube and washed with 0.1 
% (w/v) SDS / 1 X SSC solution (Section 2.1.12.6) for 5 min. The Buffer was 
discarded and replaced again and the wash was repeated for another 5 min. The 
blot was placed in a clean Hybaid tube (which had been heated to 65 °C) and 
half filled with 0.1 % (w/v) SDS / 1 X SSC solution (Section 2.1.12.6). The 
membrane was rotated in the Hybaid oven for 15 min at 65 
o
C. The solution was 
discarded and replaced and the membrane was rotated for 15 min at 65 
o
C. 
Between each wash step the tubes were allowed to drip dry on clean tissue 
paper. The solution was poured off from the tube and DIG Wash Buffer (10 ml) 
(Section 2.1.12.7.6) was poured in with the membrane. The membrane was 
rotated for 5 min in the Hybaid oven at 25 
o
C. The buffer was poured off from 
the tube and the blots were blocked with Antibody Blocking buffer (Section 
2.1.12.7.4) whilst rotating for 30 min at 25 
o
C. The Buffer was poured off from 
the tube and the Anti-Digoxigenin-Fab AP conjugate (10 ml) (Section 
2.1.12.7.7) was added. The membrane was rotated for 30 min at 25 
o
C. The 
solution was poured off from the tube and DIG wash buffer (10 ml) (Section 
2.1.12.7.6) was added to the tube. The membrane was rotated for 15 min at 25 
o
C. The wash step was repeated. The buffer was poured off from the tube and 
DIG Buffer 3 (10 ml) (Section 2.1.12.7.5) was added and the membrane was 
rotated at 25 
o
C for 5 min. The buffer was poured off from the tube and CSPD 
Substrate (5 ml) (Section 2.1.12.7.8) was added. The membrane was rotated at 
25 
o
C for 5 min. The CSPD Substrate was collected from the tube covered in 
tinfoil and kept at 4 °C to be reused within one week. The membrane was 
removed from the Hybaid tube and placed on a clean tissue briefly. The 
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membrane was carefully wrapped in a single layer of cling film and incubated at 
37 
o
 C for 15 min. This incubation step was performed to enhance the signal on 
the Southern blot.  
2.2.5.6 Developing the Southern Blot membrane 
The cling film wrapped membrane was taped into a photo developer case 
and an in the dark an X-ray film was placed over the membrane. Exposure time 
usually ranged between 1 – 3 hr initially and an overnight exposure was usually 
performed also. After this, the X-ray film was removed from the case in 
complete darkness and placed into developer solution (Section 2.1.12.8.1) for a 
couple of seconds or until signals began to appear. The film was rinsed with 
water and then placed into Fixer Solution (Section 2.1.12.8.2). The film was 
then thoroughly rinsed with water and left to dry. 
2.2.6 RNA Analysis 
2.2.6.1 RNA Isolation 
A. fumigatus liquid cultures which were incubated at the required 
temperature and time were filtered through autoclaved miracloth and the 
mycelia collected. Mycelia were then flash frozen in liquid Nitrogen and ground 
to a fine powder in a mortar by pestle. The RNA was isolated using the RNeasy  
plant mini kit supplied by Qiagen, according to the manufacturer’s instructions. 
All buffers and columns were supplied with the kit, details of which are outlined 
in the kit handbook. "-mercaptoethanol (10 µl) was added to Buffer RLC (1 ml) 
before RNA extraction. For each sample, mycelia (100 mg) was placed in sterile 
microcentrifuge tubes. The procedure was then carried out as per 
manufacturer’s guidelines. RNase-free water (50 µl) was added to the columns 
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and the RNA was eluted by centrifuging the column at 10,000 x g for 1 min. To 
increase RNA concentration, the eluent was passed through the RNeasy spin 
column for a second time and centrifuged at 10,000 x g for 1 min. The RNA 
samples were stored at – 20 
o
C up to 6 months and at – 70 
o
C long term. 
2.2.6.2 RNA Gel Electrophoresis 
2.2.6.2.1 RNA Gel Preparation 
Low melt agarose gels (1.2 % (w/v)) were prepared by adding agarose 
(1.2 g) to double-autoclaved water (80 ml). The agarose was melted in a 
microwave and allowed to cool. 10 X Formaldehyde Agarose (FA) gel buffer 
(10 ml) (Section 2.1.12.10) was added to the agarose in a fume hood and the 
final volume was adjusted to 100 ml with double-autoclaved water. The gel was 
poured into a casting tray and allowed to set.  
2.2.6.2.2 RNA Gel Running Buffer 
Ten X FA buffer (100 ml) (Section 2.1.12.10) was mixed with 
Formaldehyde (37 % (v/v)) (20 ml) in a fume hood and adjusted to 1 L with 
double-autoclaved water. This solution was used in a hood at all times. The 
RNA gel (Section 2.2.6.2.1) was allowed to equilibrate in the running buffer for 
30 min prior to use.  
2.2.6.2.3 RNA Gel 
A master mix (Section 2.1.12.12) was prepared depending on the number 
of RNA samples. RNA (5 – 20 µg) was added to a 1 X master mix. The samples 
were incubated at 60 
o
C for 15 min, followed by a quick spin in the microfuge 
and allowed to chill on ice. Samples were loaded onto the gel and 
 104 
electrophoresed at 120 V for ~1 hr in a rig in the fume hood. The RNA gels 
were then visualised on the DigiDoc RT system (Alpha Innotech). 
2.2.6.3 Northern Blotting 
2.2.6.3.1 Northern Blotting – Nucleic Acid Transfer 
The RNA samples were separated on a 1.2 % (w/v) low melt agarose gels 
(Section 2.2.6.2). Once the gels had run to completion, they were washed in 10 
X SSC (Section 2.1.12.3) for 20 min. This wash step was repeated. The 
Northern tower (Figure 2.2) was assembled by filling the reservoir tanks on 
either side of the transfer tray with 500 ml Northern Transfer Buffer (Section 
2.1.12.3). Two sheets of Whatman filter paper were cut to fit across the transfer 
tray and into the reservoir on each side and with the exact width of the gels. The 
gels were then placed on top of the filter paper loaded side face down, with the 
wells of the gels closest to the reservoirs. The Amersham N+ Hybond 
membrane (GE Healthcare, Buckingham shire, U.K) was then cut to the exact 
size of the individual gels and placed directly on top of the gel, ensuring that no 
air bubbles were trapped between the gel and the membrane. Three pieces of 
Whatman filter paper the exact size of the gel were placed on top. Three packets 
of pocket tissues were stacked on top of the membrane. A glass plate covered all 
the stacks placed on the tray and a 500 g weight, usually in the form of a 
partially filled duran bottle, was placed on top of the stacks. Towers were left 
for the RNA to transfer from the gel to the membrane overnight at room 
temperature (as long as it did not drop below 20 °C). Generally only a 
maximum of 2 gels were placed in the same tower to ensure complete transfer 
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of RNA from the gels to the membranes. To ensure complete transfer room 
temperature must be kept constant.  
2.2.6.3.2 Disassembly of Northern Blots Following Nucleic Acid Transfer 
The Northern Blot tower (Section 2.2.6.3.1) was taken apart and the 
membrane and gel were removed together and placed on clean tissue paper, gel 
facing upwards. The position of the wells was carefully marked with a pencil 
onto the corresponding place on the membrane, and the gel was peeled away 
from the membrane. The membrane was washed in SSC buffer (2X, 40 ml) 
(Section 2.1.12.4) for 2 X 5 min with gentle rocking. The membrane was 
removed and placed on clean tissue paper. The membrane was placed in a UV 
crosslinker (Strategene, La Jolla, CA) and crosslinked at 12,000 µjoules for 20 – 
50 sec (autocrosslink). The membrane was then viewed on a UV box where the 
rRNA subunits (26S, 18S and 5s) were carefully marked at the edge of the blot. 
The membrane was placed in a Hybaid tube with the nucleic acid side facing 
inwards and pre-heated pre-hybridisation buffer (15 ml) (Section 2.1.12.7.2) 
was added. The membrane was rotated in a Hybaid oven at 42 
o
C for 
approximately 4 – 5 hr.  
2.2.7 Digioxigenin (DIG) – Detection of RNA on Northern Blot 
2.2.7.1 Generation of DIG-labelled Probes 
DIG-labelled probes were generated as perviously described in Section 
2.2.4 and Table 2.5. Probes were handled in the same way as all other probes 
previously described.  
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2.2.7.2 Pre-Hybridisation oy Nylon Membrane Following UV Crosslinking 
Pre-hybridisation was performed exactly as described previously for 
Southern Blot Analysis (Section 2.2.5.3)  
2.2.7.3 Addition of DIG-labelled Probe to Northern Blots 
This was performed exactly as described previously for Southern blot 
Analysis (Section 2.2.5.4). 
2.2.7.4 DIG Detection 
This was performed exactly as described previously for Southern Blot 
analysis (Section 2.2.5.5). 
2.2.7.5 Developing the Northern Blot Membrane 
This was performed exactly as described previously for Southern Blot 
analysis (Section 2.2.5.6).  
2.2.8 Dialysis of recombinant protein. 
Purified recombinant gliG (4 ml; 9 mg/ml) was acquired in 4M urea 
(Carberry, 2008). An aliquot (5 ml; 250 µg/ml) was pipetted into dialysis tubing 
which was tied at one end. The recombinant GliG was dialysed into 50 mM  
sodium carbonate buffer pH 9.4 twice for 3 hr (Section 2.1.14). Following 
dialysis, GliG was removed from the dialysis tubing, aliquoted and stored at – 
20 °C until required for analysis. 
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2.2.9 Recombinant Protein GST Activity Assays 
2.2.9.1 1-Chloro-2, 4-dinitrobenzene (CDNB) Assay 
PPB, GSH and CDNB (Section 2.1.15) were added to a 1.5 ml Eppendorf 
and 900 #l  incubated at 30 ºC for exactly 10 min. Tube contents were 
transferred to a UV suitable cuvette. For either the blank or protein sample, 100 
#l of dialysate buffer or 100 # l of dialysed protein sample were added to the 
cuvette, mixed by inversion and blanked immediately at A340nm (Table 2.6). The 
change in absorbance at A340nm was then recorded every 15 sec for 3 min. For 
each the blank and sample the reaction was repeated 3 times. The extinction co-
efficient of CDNB at A340nm is 9.6 x 10
3
 M
-1
.cm
-1
 and activity was measured as 
Units/mg protein. 
 
Table 2.6. Components of the CDNB Activity assay. 
Buffer Test (µ l) Blank (µ l) 
100 mM PPB 790 790 
25 mM GSH 100 100 
50 mM CDNB 10  10 
Dialysate __ 100 
GliG 100 __ 
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2.2.9.2 1, 2- Epoxy- (3- (4- nitrophenoxy) propane  
PPB, GSH and EPNP (900 # l) (Section 2.1.15) were added to a 1.5 ml 
Eppendorf and incubated at 30 ºC for exactly 10 min. Tube contents were 
transferred to a UV suitable cuvette For either the blank or protein sample 100 
#l of dialysate buffer or 100 # l of dialysed protein sample were added to the 
cuvette, mixed by inversion and immediately blanked at A360nm (Table 2.7). The 
change in absorbance at A360nm was then recorded every 15 sec for 3 min. For 
each the blank and sample the reaction was repeated 3 times. The extinction co-
efficient of EPNP at A360nm is 0.5 mM
-1
.cm
-1
 and activity was measured as 
Units/mg protein. 
 
Table 2.7. Components of the EPNP Activity assay. 
Buffer Test (µ l) Blank (µ l) 
100 mM PPB 790 790 
25 mM GSH 100 100 
0.5 mM EPNP 10  10 
Dialysate __  100 
GliG 100 __ 
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2.2.10 A. fumigatus Plate Assays 
A. fumigatus wild-type and mutant strains were grown on AMM agar for 5 
days at 37 °C after which conidia were harvested (Section 2.2.1.1). Conidia was 
serially diluted to 10 
-2
 and 10 
-4
 in PBS. Aliquots (5 µl) of each dilution was 
spotted onto agar plates containing various additives (Section 2.2.1.1 and Table 
2.1). Plates were incubated at 37 °C and growth was monitored at specific time 
intervals by measuring the diameter of radial growth (cm) of each colony. Two-
way ANOVA analysis was performed to determine the statistical significance 
between strains on the various additives.  
2.2.11 Small Scale Organic Extraction of A. fumigatus Culture 
Supernatants  
A. fumigatus culture supernatants (20 ml) were added to chloroform (20 
ml) in 50 ml Falcon tubes which were sealed with parafilm. The mixtures were 
then placed on a rotating wheel overnight. The mixtures were removed and 
centrifuged for 10 min at 650 x g. The top aqueous layers were removed and 
discarded and the bottom organic layers were stored at -20 
o
C until required. 
2.2.12 Large Scale Organic Extraction of A. fumigatus Culture 
Supernatants  
A. fumigatus cultures (1 L) were grown in AMM (Section 2.1.1.5.2) in a 
conical flask (5 L) for 48 hr. Mycelia was harvested, and the culture supernatant 
was collected in a clean sterile duran. To the supernatant, an equal volume of 
chloroform (CHCl3) was added in a 2 L separating funnel. The mixture was 
shaken vigorously, with intermittent gas release, for 5 min. The funnel was 
clamped securely to a retort stand and allowed to separate. Once two defined 
 110 
phases resolved the lower chlorform layer was dispensed into a clean 1 L duran 
and stored at 4 °C until required for rota-evaporation. The procedure was 
repeated a second time on the same batch of supernatant for a double extraction. 
(Experimental note: If subsequent NMR analysis was to be performed on a 
metabolite of interest, no plastic was used throughout this entire procedure i.e., 
from culturing, to organic extraction to purification). 
2.2.13 Rotary evaporation of Organic Extraction Samples 
Organic extracts (Section 2.2.11 or 2.2.12) were placed in an evaporation 
bulb and the bulb was evaporated under vacuum whilst sitting in a water bath 
set to 37 
o
C (Heidolph Laborata 4001 efficient, Vacuubrand CVC 2000 II). The 
chloroform evaporated leaving the dried organic extract in the bulb. The extracts 
were resuspended in HPLC grade methanol in sequential washes (200 – 500 µl) 
until all the dried material was fully resuspended. The resuspended extract was 
then transferred to clean glass vial and stored at – 20 
o
C. 
2.2.14 Comparative Metabolite Profile Analysis by Reverse Phase – High 
Performance Liquid Chromatography (RP – HPLC)  
2.2.14.1 RP – HPLC Analysis 
Organic extracts from supernatants (Section 2.2.11 or 2.2.12) were 
analysed by RP – HPLC with UV detection (Agilent 1200 system), using a C18 
RP – HPLC column (Agilent Zorbax Eclipse XDB-C18; 5 mm particle size; 4.6 
x 15 mm) at a flow rate of 1 ml/min. A mobile phase of water (Section 
2.1.13.1.1) and acetonitrile (Section 2.1.13.1.2) with TFA, was used under 
various gradient conditions (Table 2.8, Table 2.9 and Table 2.10). Injection 
volume was either 20 or 100 µl.  
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Table 2.8. RP – HPLC Gradient 1. 
 Time (min) % B % B / min 
1 0 5  
2 5 5 95 % " B / 20 min 
3 25 100 4.75 % " B / min 
4 28 100  
5 30 5  
 
Table 2.9. RP – HPLC Gradient 2.  
 Time (min) % B % B / min 
1 0 5  
2 5 5  
3 16 60 5 % " B / min 
4 19 100 13 % " B / min 
5 21 5  
 
Table 2.10. RP – HPLC Gradient 3.  
 Time (min) % B % B / min 
1 0 5  
2 5 5 95 % " B / 24 min 
3 29 100 4 % " B / min 
4 32 100  
5 34 5  
6 44 5  
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2.2.15 Reduction and Alkylation of Pure Gliotoxin  
2.2.15.1 Sodium Borohydride (NaBH4) Mediated Reduction of Gliotoxin 
and Subsequent Alkylation Under Organic Conditions 
Gliotoxin (100 µl; 100 µg/ml methanol; 30.6 nmol gliotoxin) (Section 
2.1.16.2) was reduced following the addition of NaBH4 (2.5 µl; 50 mM; 120 
nmol) (Section 2.1.16.6), followed by gentle mixing by vortexing and 
incubation for 60 min at room temperature. A negative control sample where no 
NaBH4 was added was also prepared. Alkylation of reduced gliotoxin was 
performed using the alkylation agent iodoacetamidofluorescein (5’-IAF). 5’-
IAF (20 µl 10 mg/ml; 400 nmol) (Section 2.1.16.12) was added to the reduced 
or unreduced gliotoxin preparations, followed by vortexing of the resultant 
mixtures briefly. Samples were wrapped in tinfoil and incubated for 40 min in 
the dark at room temperature prior to HPLC analysis using gradient 1 (Table 
2.8) and subsequent and MALDI-ToF analysis (Section 2.2.16.1).  
2.2.15.2 Dithiothreitol (DTT) Mediated Reduction of Gliotoxin and 
Subsequent Alkylation Under Organic Conditions 
Gliotoxin (100 µl; 100 µg/ml methanol; 30.6 nmol gliotoxin) (Section 
2.1.16.2) was reduced following the addition of DTT (6 µl; 10 mM) (Section 
2.1.16.9), followed by gentle mixing by vortexing and incubation for 60 min at 
room temperature. A negative control sample where no DTT was added was 
also prepared. Alkylation of reduced gliotoxin was performed using the 
alkylation agent iodoacetamidofluorescein (5’-IAF). 5’-IAF (20 µl 10 mg/ml; 
400 nmol) was added to the reduced or unreduced gliotoxin preparations, 
followed by vortexing of the resultant mixtures briefly. Samples were wrapped 
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in tinfoil and incubated for 40 min in the dark at room temperature prior to 
HPLC analysis using gradient 1 (Table 2.8). 
2.2.15.3 Tris(2-carboxyethyl)phosphine (TCEP) Mediated Reduction of 
Gliotoxin and Subsequent Alkylation Under Organic Conditions 
Gliotoxin (100 µl; 100 µg/ml methanol; 30.6 nmol gliotoxin) (Section 
2.1.16.2) was reduced following the addition of TCEP (2.5 µl; 50 mM) (Section 
2.1.16.9), followed by vortexing and incubation for 60 min at room temperature. 
A negative control sample where no TCEP was added was also prepared. 
Alkylation of reduced gliotoxin was performed using the alkylation agent 
iodoacetamidofluorescein (5’-IAF). 5’-IAF (20 µl 10 mg/ml; 400 nmol) was 
added to the reduced or unreduced gliotoxin preparations, followed by vortexing 
of the resultant mixtures briefly. Samples were wrapped in tinfoil and incubated 
for 40 min in the dark at room temperature prior to HPLC analysis using 
gradient 1 (Table 2.8). 
2.2.16 MALDI-ToF Analysis 
2.2.16.1 MALDI-ToF Detection of Labelled Gliotoxin  
Mass Spectrometry was carried out using an Ettan! MALDI-ToF mass 
spectrometer (Amersham Biosciences (Europe) GmbH, Freiburg, Germany). 
Samples (1 µl) for mass determination were mixed with #-cyano-4-
hydroxycinnaminic acid (4-HCCA) (Section 2.1.17.1) and deposited onto mass 
spectrometry slides and allowed to dry prior analysis. All samples were 
subjected to delayed extraction reflectron MALDI-ToF analysis with a nitrogen 
laser (337 nm) at 20 kV. Internal calibrants, Angiotensis III and ACTH 
fragment 18-39, were used to calibrate spectra.  
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2.2.17 Thin Layer Chromatography (TLC) 
TLC analysis used Merck silica gel 60-F254 TLC plates (aluminium 
backed). Solvent systems of dichloromethane : methanol were used as mobile 
phase (Section 2.1.18.1 or 2.1.18.2). Samples (1 µl) were applied using a 
capillary tube and allowed to dry fully before it was subjected to the mobile 
phase. The plates were viewed under a UV box (254 nm). Images were obtained 
using a Fluorescence Scanner (Typhoon Variable Mode Imager; GE Healthcare) 
at 488/520 nm excitation and emission respectively (Sensitivity setting: 600 V; 
50 µm pixel size).  
2.2.18 Preparative Thin Layer Chromatography (pTLC)  
Samples were spotted along a straight line approximately 2 cm from the 
bottom of the TLC plate, using a capillary, tube and allowed to dry (Silica gel, 
UV 254 nm, 20 x 20 cm, 50 µm, Analtech, Newark, Delaware). A second 
application of the sample was spotted directly on top of the first sample after it 
had dried. TLC was run in a mobile phase of dichloromethane: methanol (97:3 
0.5 % (v/v) acetic acid). The chromatography was stopped 1 cm from the top 
and the plates were allowed to dry completely. Once dry, the TLC plate was 
subjected to a second round of chromatography in the same mobile phase. This 
was performed to obtain better resolution of the band of interest. Plates were 
viewed under a UV box (254 nm) and bands of interest were etched out using a 
glass pasteur pipette. The band of interest was excised carefully and the excised 
silica was placed in a clean 50 ml glass conical. The excised silica was washed 
in acetone (20 ml), and passed through filter paper to remove the silica and keep 
the flow through, the silica was washed with a 1 ml aliquot of acetone. This was 
repeated 5 times. The acetone flow though was then rota-evaporated to complete 
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dryness (Section 2.2.13). (Note: If the extracted material was needed for NMR 
analysis no plastic apparatus was used during this process).  
2.2.19 Time Course Monitoring of NaBH4 mediated reduction of Gliotoxin  
Gliotoxin (100 µl; 100 µg/ml methanol; 30.6 nmol gliotoxin)  (Section 
2.1.16.2) was reduced following the addition of NaBH4 (2.5 µl; 50 mM; 120 
nmol) (Section 2.1.16.6), followed by vortexing. Samples were incubated at 
specific time intervals of 0, 15, 30, 60 and 120 min, respectively before they 
were subjected to HPLC analysis using gradient 2 (Section 2.2.14.1 and Table 
2.9). 
2.2.20 Reduction and Alkylation of Native Gliotoxin Produced by A. 
fumigatus  
2.2.20.1 Reduction and Alkylation of Native Gliotoxin produced by A. 
fumigatus – Method 1 
A. fumigatus liquid cultures (AF293; 48 hr; 37 °C) were filtered through 
autoclaved miracloth and the supernatant was kept. Organic extracts (Section 
2.2.11) of A. fumigatus supernatants were generated. The extracts (100 µl) were 
reduced with NaBH4 (2.5 µl) (Section 2.1.16.6), vortexed and allowed to 
incubate at room temperature for 60 min. The sample was then labelled with 5’-
IAF (20 µl 10 mg/ml; 400 nmol) (Section 2.1.16.11), wrapped in tinfoil, 
vortexed and allowed to incubate in the dark at room temperature for 40 min. 
This was followed by HPLC analysis under gradient 1 (Table 2.8).  
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2.2.20.2 Reduction and Alkylation of Native Gliotoxin produced by A. 
fumigatus – Method 2 
A. fumigatus liquid cultures (AF293; 48 hr; 37 °C) were filtered through 
autoclaved miracloth and the supernatant was retained. Organic extracts 
(Section 2.2.11) of A. fumigatus supernatants were generated. The extracts (100 
µl) were reduced with NaBH4 (2.5 µl) (Section 2.1.16.6), vortexed and allowed 
to incubate at room temperature for 60 min. The sample was labelled with 5’-
IAF (20 µl 10 mg/ml; 400 nmol) (Section 2.1.16.11), wrapped in tinfoil, 
vortexed and allowed to incubate in the dark at room temperature for 40 min. 
This was followed by HPLC analysis under gradient 3 (Table 2.10).  
2.2.20.3 Reduction and Alkylation of Native Gliotoxin Produced by A. 
fumigatus – Method 3 
A. fumigatus liquid cultures (AF293; 48 hr; 37 °C) were filtered through 
autoclaved miracloth and the supernatant was kept. Organic extracts (Section 
2.2.11) of A. fumigatus supernatants were generated. The extracts (100 µl) were 
reduced with NaBH4 (2.5 µl) (Section 2.1.16.6), vortexed and allowed to 
incubate at room temperature for 60 min. The sample was labelled with 5’-IAF 
(20 µl 3 mg/ml; 120 nmol) (Section 2.1.16.12), wrapped in tinfoil, vortexed and 
allowed to incubate in the dark at room temperature for 40 min. This was 
followed by HPLC analysis under gradient 3 (Table 2.10). 
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2.2.21 Reduction and Alkylation of Gliotoxin Spiked Supernatant Without 
Prior Organic Extraction 
2.2.21.1 Reduction (50 mM NaBH4) and Alkylation of Culture 
Supernatants Spiked With Gliotoxin Without Prior Organic 
Extraction 
A. fumigatus liquid cultures (AF293; 48 hr; 37 °C) were filtered through 
autoclaved miracloth and the supernatant was kept. The pH of the supernatant 
was adjusted from pH 3.29 to pH 7.5 with 1M sodium phosphate (Section 
2.1.16.5). The pH adjusted supernatant (50 µl) was spiked with gliotoxin to a 
final concentration of gliotoxin of 327 µg/ml and DMSO (50 µl) was added. The 
gliotoxin spiked supernatant sample was reduced with NaBH4 (50 mM) (3.3 µl) 
(Section 2.1.16.6), vortexed and incubated at room temperature for 60 min. The 
sample was labelled with 5’-IAF (20 µl 10 mg/ml; 400 nmol) (Section 
2.1.16.11), wrapped in tinfoil, vortexed and allowed to incubate in the dark at 
room temperature for 40 min followed by HPLC analysis under gradient 3 
(Table 2.10).  
2.2.21.2 Reduction (500 mM NaBH4) and Alkylation of Culture 
Supernatants Spiked With Gliotoxin Without Prior Organic 
Extraction 
A. fumigatus liquid cultures (AF293; 48 hr; 37 °C) were filtered through 
autoclaved miracloth and the supernatant was kept. The pH of the supernatant 
was adjusted from pH 3.29 to pH 7.5 with 1M sodium phosphate (Section 
2.1.16.5). The pH adjusted supernatant (50 µl) was spiked with gliotoxin to a 
final concentration of gliotoxin 327 µg/ml and DMSO (50 µl) was added. The 
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spiked supernatant sample was reduced with NaBH4 (500 mM) (3.3 µl) (Section 
2.1.16.7, vortexed and incubated at room temperature for 60 min. The sample 
was labelled with 5’-IAF (20 µl 10 mg/ml; 400 nmol) (Section 2.1.16.11), 
wrapped in tinfoil, vortexed and allowed to incubate in the dark at room 
temperature for 40 min followed by HPLC analysis under gradient 3 (Table 
2.10).  
2.2.22 Reduction With 500 mM NaBH4 and Alkylation of Native Gliotoxin 
Produced by A. fumigatus Without Prior Organic Extraction 
A. fumigatus liquid cultures (AF293; 48 hr; 37 °C) were filtered through 
autoclaved miracloth and the supernatant was kept. The pH of the supernatant 
was adjusted from pH 3.29 to pH 7.5 with 1M sodium phosphate (Section 
2.1.16.5). Supernatant (100 µl) was reduced with NaBH4 (500 mM) (2.5 µl) 
(Section 2.1.16.7), vortexed and incubated at room temperature for 60 min. The 
sample was then labelled with 5’-IAF (20 µl 3 mg/ml; 120 nmol) (Section 
2.1.16.12), wrapped in tinfoil, vortexed and allowed to incubate in the dark at 
room temperature for 40 min followed by HPLC analysis under gradient 3 
(Table 2.10).  
2.2.23 NMR 
Structural elucidation of a gliotoxin-related metabolite was undertaken 
using NMR analysis. Ultra pure and concentrated samples (6 – 10 mg) were 
generated by multiple large-scale organic extractions (Section 2.2.12) and pTLC 
(Section 2.2.18). All 
1
H, 
13
C, DEPT, COSY, HSQC and HMBC nuclear 
magnetic resonance spectra were recorded in CD3CN or CDCl3, on either a 
Bruker Avance spectrometer (25 °C) operating at 300 MHz for the 1H nucleus 
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and 75 MHz for the 
13
C nucleus or a Bruker Avance III spectrometer operating 
at 500 MHz for the 
1
H nucleus and 125 MHz for the 
13
C nucleus. Chemical 
shifts ($) are reported in ppm and referenced from the standard 
tetramethylsilane (TMS). All NMR was performed in collaboration with the 
Chemistry Department, NUI Maynooth or at Teagasc Ashtown Food Research 
Centre, Dublin.  
2.2.23.1 LC ToF Analysis 
LC-ToF analysis of organic extracts of A. fumigatus supernatant was 
performed on an Agilent HPLC 1200 series and injected (injection volume: 1 
µl) using electrospray ionisation inputted into a time of flight chamber 
(Agilent). The LC separation was done on a XDB C18 column (4.6 x 150 mm) 
using a water/acetonitrile (both containing 0.1 % (v/v) formic acid) gradient at a 
flow rate of 0.5 mL/min. The gradient was started at 50 % (v/v) acetonitrile, 
which was increased to 100 % acetonitrile in 10 min; 100 % acetonitrile was 
maintained for 5 min before the gradient was returned to starting conditions. 
Spectra were collected at 0.99 spectra per second. All LC-ToF was performed in 
collaboration with the Chemistry Department, NUI Maynooth. 
2.2.24 Feeding Experiments 
2.2.24.1 Feeding Experiment Using Cultures 
A. fumigatus AF293 was cultured in AMM media (10 ml) (Section 
2.1.1.5.2) at 37 
o
C, for 24 hr. At 24 hr the gliotoxin related metabolite was 
added to the cultures, and a 1 ml aliquot of the supernatant was removed. 
Cultures were incubated for a further 15, 60 and 180 min and an aliquot (1 ml) 
of the supernatant was removed at each time point. A control sample was 
 120 
treated the same except nothing was spiked into the culture. The 1 ml aliquots of 
supernatant from each time point were subjected to organic extraction (Section 
2.2.11) at a 1:1 ratio of chloroform. The organic extracts were dried overnight in 
a fume hood until all chloroform had evaporated. The dried extract was 
resuspended in HPLC grade methanol (50 µl). Extracts (20 !l) were then 
analysed by HPLC (Section 2.2.14.1) to determine whether the gliotoxin related 
metabolite had been taken up by A. fumigatus.  
2.2.24.2 Feeding Experiment Using Protoplasts 
Protoplasts of A. fumigatus AF293 were generated (Section 2.2.3.3) and 
counted. An aliquot of the protoplast suspension (100 !l) was added to Buffer 
L6 (900 µl) (Section 2.1.11.5). The gliotoxin related metabolite was added to 
the samples. A control sample was also set up where HPLC grade methanol was 
added to the cultures. Immediately after this addition, a 100 µl aliquot of the 
suspension was removed from each sample. Cultures were incubated at 25 °C, 
100 rpm for a further 1, 3 and 24 hr and an aliquot (100 µl) of the supension was 
removed at each time point. The aliquots were centrifuged at 1769 x g for 12 
min to pellet the protoplasts. The supernatant was removed carefully and added 
to a fresh tube. The protoplast pellet was resuspended in buffer L6 (100 µl) 
(Section 2.1.11.5). Separately, the supernatant (100 µl) and the resuspended 
protoplast pellet (100 µl) were subjected to organic extraction with HPLC grade 
chloroform (500 µl). The samples were mixed for 1 hr followed by 
centrifugation at 10,000 x g (10 min). The upper aqueous layer was discarded 
and the lower organic layere was dried completely. The samples were 
resuspended in HPLC grade methanol (50 !l) and then analysed by HPLC 
(Section 2.2.14.1) using gradient 1 (Table 2.8).  
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2.2.24.3 Feeding Experiments using Cultures and 
13
C L-Phenylalanine   
A. fumigatus "gliG liquid cultures where incubated in AMM (100 ml) 
(Section 2.1.1.5.2) at 37 °C for 24 hr. After 24 hr, 
13
C L-phenylalanine
 
(10mg) 
(Section 2.1.19) was added to the cultures and they were incubated for a further 
24 hr. The cultures were harvested using miracloth and the supernatant was 
retained in a clean sterile Duran bottle. The supernatant was pooled and 
subjected to organic extraction (Section 2.2.12). The gliotoxin related 
metabolite was purified by pTLC (Section 2.2.18). Confirmation of the structure 
of the compound was performed using LC-ToF (Section 2.2.23.1) and NMR 
(Section 2.2.23) analysis.  
2.2.25 Galleria mellonella Virulence Testing 
Virulence testing using G. mellonella larvae was carried according to 
Reeves et al. (2004). Briefly, sixth instar larvae of G. mellonella  (Lepidoptera: 
Pyralidae, the Greater Wax Moth) (Mealworm Company, Sheffield, England) 
were stored in wood shavings in the dark at 15 °C. Larvae weighing between 
0.2 and 0.4 g were used for testing. Conidial suspensions of A. fumigatus  
strains were prepared in PBS (Section 2.2.1.1). G. mellonella larvae were 
divided into groups of ten and placed in 90 mm petri dishes that contained a 
single sheet of filter paper. All were weighed and size matched. The larvae (n = 
10) were inoculated through the last proleg on the left with a fungal load of 1 x 
10
7 
conidia per inoculum (20 µl). As a control, larvae were inoculated with 
sterile PBS (20 µl) (Section 2.1.3). The larvae were incubated in a static 
incubator at 30 
o
C in the dark. Mortality rates were recorded over 72 hr. No 
response to stimulation and the lack of movement indicated larval death. The 
degree of melanisation was recorded with photographic images.  
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2.2.26 Statistical Analysis 
All data was analysed using built-in GraphPad prism version 5.01 
functions, as specified. The level of significance was set at P < 0.05 (*), P < 
0.001 (**), and P < 0.0001 (***), unless otherwise stated. Post-hoc comparisons 
between groups were performed using the Bonferroni multiple comparisons test, 
unless otherwise stated. 
2.2.27 Software Graphing 
All graphs were compiled using Graphpad Prism version 5.01, unless 
otherwise stated. 
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3. Chapter 3 Deletion and complementation of glutathione s-transferase, 
gliG, from Aspergillus fumigatus. 
3.1 Introduction 
Functional genomics is an important tool for fungal biology, which 
provides information which helps characterise a gene of interest. It allows the 
study of the corresponding gene product and it identifies the role the gene 
product has in specific downstream biochemical processes (Meyer, 2008; Kuck 
and Hoff, 2010). Specifically, this method can be employed to uncover the 
complex biosynthesis of biologically active secondary metabolites, such as 
gliotoxin. As detailed in Chapter 1, gliotoxin is a member of ETP class of 
compounds. These compounds are characterised by a disulphide bridged 
diketopiperazine ring synthesised from two amino acids (Fox and Howlett, 
2008). As yet, the function of gliG, a putative GST within the gliotoxin gene 
cluster, is unknown. Advanced molecular techniques have confirmed the 
function of several genes in A. fumigatus: including some of the genes 
contained within the gliotoxin cluster, such as; gliP, gliZ, gliA  and gliT 
(Gardiner et al., 2005a; Balibar and Walsh, 2006; Bok et al., 2006; Cramer et 
al., 2006; Kupfahl et al., 2006; Sugui et al., 2007; Spikes et al., 2008; Scharf et 
al., 2010; Schrettl et al., 2010). A functional genomics approach for the study of 
gliG has been employed in the work described in this Chapter. This was 
facilitated by the generation of a gliG mutant strain with a view to studying the 
impact of gene deletion on gliotoxin biosynthesis and resistance, respectively.  
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Prior to the work described in this Chapter the A. fumigatus genome was 
predicted to contain 23 putative GST (Morel et al., 2009). One of these genes, 
A. fumigatus gliG (AFUA_6G09690), forms part of the gliotoxin biosynthetic 
cluster (Gardiner and Howlett, 2005). Phylogenetic analysis of various members 
of the ascomycete taxa identified 14 fungi with putative ETP clusters (Patron et 
al., 2007). From these, 11 contained paralogues of A. fumigatus gliG ((Patron et 
al., 2007)). Partial cluster duplication was apparent in three fungi, A. fumigatus, 
N. fischeri and A. terreus. Notably, both Gibberella zeae (anamorph; F. 
graminaerum) and Chaetomium globosum did not contain a GST within the 
ETP cluster (Patron et al., 2007).  
The presence of a GST within this secondary metabolite cluster warranted 
further investigation into the function of this gene. Speculation as to the 
function of the GST within ETP clusters has identified two potential functions 
for this gene, (i) a role in the self-protection mechanism for the fungus against 
the toxic effects of the metabolite or, (ii) a biosynthetic role (McGoldrick et al., 
2005). As mentioned in Chapter 1, GST are primarily detoxification enzymes. 
The A. nidulans SM sterigmatocystin cluster contains GST (Brown et al., 1996), 
however, this gene remains uncharacterised with respect to metabolite function 
and cellular GST activity is also associated with aflatoxin production in A. 
parasiticus (Allameh et al., 2002). Observed GST activity during toxin 
production and the presence of GST within SM clusters led to the speculation 
that these enzymes play a role in detoxification of the SM (McGoldrick et al., 
2005). However, it has been postulated that A. fumigatus gliG may encode an 
enzyme which can form or break carbon-sulphur bonds (Gardiner et al., 2005b; 
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Howlett, 2008) and therefore this GST may have a biosynthetic function in 
gliotoxin production.  
To determine the role of A. fumigatus gliG, a putative GST within the 
gliotoxin gene cluster, functional analysis was performed using a gliG mutant 
strain. Therefore, the overall objectives of the work presented in this Chapter 
were to (i) perform phylogenetic analysis of all GST within A. fumigatus, (ii) 
perform phylogenetic analysis of A. fumigatus gliG with other sequenced fungal 
genomes, (iii) create replacement constructs using the bipartite method for the 
targeted deletion of gliG, (iv) delete gliG in two A. fumigatus strains, AF293 
(Nierman et al., 2005) and "akuB (da Silva Ferreira et al., 2006) and (v) 
complement A. fumigatus "gliG by reintroducing gliG into the mutant genome. 
The generation A. fumigatus "gliG strain will allow for comparative phenotypic 
analysis in the identification of a role for gliG and this investigation will be 
detailed in Chapter 4.  
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3.2 Results 
3.2.1 Phylogenetic analysis of GST within the A. fumigatus genome 
To investigate the relationship of A. fumigatus gliG to the other GST 
within the A. fumigatus genome a phylogenetic tree was constructed (in 
collaboration with Dr David Fitzpatrick, NUI Maynooth) (Figure 3.1) A. 
fumigatus gliG grouped in a clade (gliG clade A) with 4 other genes. Three of 
these are putative GST with no confirmation of function (AFUA_4G01440, 
AFUA_4G14530, AFUA_7G05500). One member of the clade, A. fumigatus 
gstA  (AFUA_3G10830) has previously been confirmed as a GST (Burns et al., 
2005). This GST is a paralogue of A. nidulans gstA  (Fraser et al., 2002), 
however, A. nidulans does not contain a gliotoxin gene cluster (Nierman et al., 
2005).  
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Figure 3.1. Phylogenetic analysis of A. fumigatus gliG and the 25 other putative 
GST in A. fumigatus. A. fumigatus gliG (AFUA_6G09690) clusters with three 
putative GST in A. fumigatus (AFUA_4G01440, AFUA_4G14530, 
AFUA_7G05500) and one confirmed theta class GST, A. fumigatus gstA 
(AFUA_3G10830). Bootstrap values are marked out of 1000, the gliG 
containing clade (gliG clade A) has a bootstrap value of 770, confirming good 
alignment.  
gliG clade A 
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3.2.2 Phylogenetic Analysis of A. fumigatus gliG With Other Sequenced 
Fungi 
To further investigate the phylogenetic relationship of A. fumigatus gliG 
to other sequenced fungi (Dr David Fitzpatrick, NUI Maynooth), the A. 
fumigatus gliG clade A (Figure 3.1) was searched against a database of other 
sequenced fungi (104 sequenced fungi; Appendix I) (Figure 3.2 and Table 3.1). 
Homologs were retrived and aligned using the multiple sequence aligner Muscle 
v3.7 (Edgar, 2004) with the default settings. Optimum models of protein 
evolution were selected using Modelgenerator (Keane et al., 2004) and these 
were used to reconstruct maximum likelihood phylogenies in Phyml v3.0 
(Guindon and Gascuel, 2003). Bootstrap resampling was performed 100 times 
on each alignment and majority rule consensus (threshold of 70%) trees were 
reconstructed. 
A. fumigatus gliG did not cluster with the other GST from the A. 
fumigatus gliG clade A and instead it clustered with other ETP producing fungi 
(gliG clade B; Figure 3.2); A. fumigatus, N. fischeri, P. marneffei (Penicillium 
spp), A. clavatus, Trichoderma. reesei, Magnaporthe grisea, Trichoderma virens, 
A . terreus, A . flavus, A. oryzae, Fusarium verticillioides (Fusarium spp), 
Mycosphaerella graminicola, Microsporum gypseum, Trichophyton equinum, 
Trichophyton tonsurans and Trichophyton rubrum. The last five have not been 
identified in previous phylogenetic analyses to contain a putative ETP cluster 
(Table 3.1) (Patron et al., 2007). Additionally, A. oryzae does not contain a 
putative gliotoxin gene cluster (Nierman et al., 2005). However, the possibility 
of A. oryzae not producing another ETP cannot be ruled out (Seya et al., 1986; 
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Gardiner et al., 2005b). The other genes in the gliG clade A are highlighted in 
red with the corresponding CADRE identification numbers.  
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Figure 3.2. Phylogenetic tree of A. fumigatus gliG clade A against other 
sequenced fungi (104 in total). (A) A. fumigatus gliG (highlighted in blue and 
indicated by the blue arrow) clusters with GST from other fungi with putative 
ETP clusters (branch highlighted in red). The bootstrap values are marked out of 
100, with the gliG clade B scoring a value of 100. All the members of the gliG 
clade B are members of the Pezizomycotina. The four other genes from the gliG 
clade A are indicated in red with the corresponding CADRE identification 
numbers included. (B) Magnification of A. fumigatus gliG clade B.  
B 
gliG  
 
 132 
Table 3.1. Putative gliG paralogues. Fungi containing gliG paralogues 
identified in 2007 and those identified now in 2011.  
gliG paralogues (Patron et al., 2007) gliG paralogues (2011) 
L. maculans  na 
S. diversum  na 
A. fumigatus  A . fumigatus  
N. fischeri  N. fischeri   
P. lilacinoechinulatum P. marneffei (Penicillium spp) 
A. clavatus A. clavatus  
T. reesei  T. reesei  
M. grisea  M. grisea  
T. virens  T. virens  
A . terreus  A . terreus  
A . flavus  A . flavus  
A. oryzae  A. oryzae  
G. zeae (anamorph; F. graminaerum)  F. verticillioides (Fusarium spp) 
C. globosum  na 
 M. graminicola  
 M. gypseum  
 T. equinum  
 T. tonsurans  
 T. rubrum  
(na: sequence not available) 
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3.2.3 Generation of replacement constructs for the transformation of gliG. 
In order to determine the function of gliG, a gene deletion strategy was 
employed (Figure 3.3). Protoplast transformations were performed using two 
background strains on independent occasions, A. fumigatus AF293 and !akuB. 
Each A. fumigatus strain was co-transformed with two DNA constructs, each 
containing an incomplete fragment of the pyrithiamine (ptrA ) resistance gene 
which was excised from the plasmid pSK275. These fragments were fused to 
1.2 kb (5’) and 1.0 kb (3’) of gliG flanking sequences. These constructs were 
generated by PCR and transformed into the A. fumigatus strains. Southern 
analysis was used to determine targeted deletion of gliG. The constructs created 
for the deletion of gliG were generated from the flanking regions of wild-type 
target DNA (Figure 3.3). First round PCR amplified the 5’ flanking region of 
gliG, PCR1 (1047 bp), and the 3’ flanking region, PCR2 (1270 bp). The primers 
introduced a restriction site into the PCR amplified flanking region, SpeI for 
PCR1 and XhoI for PCR2. This facilitated targeted digestion and ligation of the 
5’ and 3’ flanking regions to the ptrA cassette individually. The PCR products 
were gel-purified to remove any non-specific PCR products (Figure 3.4) 
The pSK275 plasmid was independently linearised with SpeI and XhoI 
(Figure 3.3). PCR1 was digested with SpeI and PCR2 was digested with XhoI. 
The SpeI digested pSK275 plasmid was ligated to PCR1 that had also been 
digested with SpeI. The XhoI digested pSK275 plasmid was ligated to the XhoI 
digested PCR2. These ligation products were used as template for the final 
round of PCR. PCR3 used a nested primer (ogliG-5) and a second primer 
(optrA-2), which amplified a partial section of the ptrA gene creating the 5’ 
construct (2528 bp). PCR4 used a second nested primer (ogliG-6) and the 
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second primer (optrA-1), which amplified a partial section of the ptrA gene 
creating the 3’ construct (2305 bp). The PCR products were gel-purified to 
remove any non-specific products (Figure 3.5) and concentrated prior to 
protoplast transformation.  
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Figure 3.3. Schematic representation of the gene deletion strategy employed for 
the generation of A. fumigatus !gliG mutant strains.  
PCR and Southern analysis to 
confirm single homologous 
integration 
 
4910 bp 
2077 bp 
 136 
 
 
  
 
Figure 3.4. PCR products of the gel purified flanking regions of gliG. Lane M: 
Molecular weight marker (Roche VII) (Section 2.1.10.1.8.1), Lane 1: PCR 1 
(1047 bp) is the 5’ flanking region of gliG, Lane 2: PCR 2 (1270 bp) is the 3’ 
flanking region of gliG.  
 
 
M      1              M         2   
1270 bp 
1047 bp 
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Figure 3.5. PCR products of the gel purified PCR 3 and PCR 4 for the deletion 
of A. fumigatus gliG. Lane M: Molecular weight marker (Roche VII) (Section 
2.1.10.1.8.1), Lane 1: PCR 3 (2528 bp) which comprises the 5’ flanking region 
of gliG ligated to a partial section of ptrA , Lane 2: PCR 4 (2305 bp) which 
comprises the 3’ flanking region of gliG ligated to a partial section of ptrA .  
2528 bp 
2305 bp 
M      1        2   
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3.2.4 Generation of DIG-labelled probes by PCR for transformant 
identification. 
Two probes were prepared by PCR amplification for use in Southern blot 
analysis. The probes contained DIG-labelled nucleotides, which facilitated 
detection with Southern blot analysis, as described in Section 2.2.5. A 5’ probe 
was made using primers ogliG-4 and ogliG-5, which detected a region just 
upstream of gliG (data not shown). A 3’ probe was made using primers ogliG-3 
and ogliG-6, which detected a region just downstream of gliG (Figure 3.6).  
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Figure 3.6. Generation of a DIG- labelled 3’ probe by PCR. Lane M: Molecular 
weight marker (Roche VII) (Section 2.1.10.1.8.1), Lane 1: 3’ gliG probe PCR 
product (1201 bp).  
      M           1           
1201 bp 
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3.2.5 Protoplast transformation facilitated the deletion of gliG from 
Aspergillus fumigatus AF293 and !akuB  
The constructs from Section 3.2.1 were transformed into protoplasts of A. 
fumigatus AF293 and !akuB on independent occasions. Approximately 5 µg of 
each 5’ and 3’ construct was used per transformation event. The transformation 
procedure was carried out as described in Section 2.2.7. The resultant 
transformants were selected for on agar plates containing pyrithiamine (100 
µg/ml). The colonies that grew on the agar plates containing pyrithiamine were 
considered resistant and therefore predicted to have reconstituted ptrA  
incorporated into the genome.  
For the !akuB transformation event, 37 colonies were observed on 
pyrithiamine selection plates. Genomic DNA from nine colonies was digested 
with an EcoRV restriction enzyme (Figure 3.7). These were screened by 
Southern analysis using a 3’ probe (Figure 3.10). Comparison of the Southern 
blot against the DNA gel identified the band of interest based on the distance it 
appeared down the blot. The mutant band (!gliG; 3866 bp) appeared at 1.7 cm 
down the blot, this was confirmed with a ruler. Two colonies (colony 7 and 9) 
were selected for single spore isolation and it was believed that colony 9 
contained the wild-type signal, possibly due to the presence of a heterokaryon. 
Further single spore isolation could potentially eliminate this wild-type signal. 
Due to the presence of a non-specific band in EcoRV digested samples a 
different enzyme was used for the single spore isolated Southern blot. Single 
spore isolates of colonies 7 and 9 were digested with XbaI and a second round 
of Southern blot analysis using the 5’ probe was performed. Comparison of the 
Southern blot against the DNA gel identified the bands of interest based on the 
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distance they appeared down the gel. This identified a gliG mutant (lane 3) 
(!gliG; 1668 bp) and this strain was confirmed as !gliG!
akuB 
 (Figure 3.10). 
This mutant band appeared 2.7 cm down the blot, which was confirmed using a 
ruler on the Southern blot. The isolate from lane 4 was eliminated based on the 
presence of an unknown additional band and isolates from lane 5 and 6 were 
eliminated as they contained the wild-type signal. Isolates from lane 1 and 2 
were discounted, as only one !gliG strain was necessary.  
For the AF293 transformation, 45 colonies were observed on pyrithiamine 
selection plates. Genomic DNA from twenty colonies was digested individually 
with XbaI restriction enzyme (Figure 3.9). The colonies were screened by 
Southern analysis using a 5’ probe (Figure 3.11). Three colonies (colonies 14, 
15 and 20) were selected for single spore isolation. Single spore isolates of 
colonies 14, 15 and 20 were digested with XbaI. A second round of Southern 
blot analysis with the same probe identified a gliG mutant (!gliG; 1668 bp) and 
this strain was confirmed as !gliG (Figure 3.11). In !gliG an 828 bp internal 
section of the gliG coding region was replaced with a 2.0 kb region containing 
ptrA  from the pSK275 vector. 
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Figure 3.7. Illustration showing the Southern blot analysis of A. fumigatus wild-type and !gliG using an EcoRV restriction enzyme and a 3’ 
probe (1002 bp). In the wild-type a fragment of 1475 bp was identified using a 3’ probe. In the !gliG a fragment of 3866 bp was identified using 
a 3’ probe. 
Wild-type  
!gliG  
3’ Probe 
3’ Probe 
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Figure 3.8. Identification of A. fumigatus !gliG
!akuB
. First round Southern 
analysis of !gliG transformants in A. fumigatus !akuB. Here, a 3’ DIG-labelled 
probe was used to detect the predicted presence of 3.8 and 1.4 kb fragments in 
EcoRV digested genomic DNA from !gliG or wild-type, respectively. Lanes 1-
9: potential transformants. Putative transformants in lane 7 (colony 7) and 9 
(colony 9) were selected for single spore isolation. Isolate in lane 7 contained a 
non-specific band and the isolates in lane 9 contained both wild-type and mutant 
signal as well as an non-specific band.  
 
1       2       3       4       5       6        7        8       9    
3866 bp 
 
1475 bp 
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Figure 3.9. Illustration showing the Southern blot analysis of A. fumigatus wild-type and !gliG using an XbaI restriction enzyme and a 5’ probe 
(1200 bp). In the wild-type a fragment of 2124 bp was identified using a 5’ probe. In the !gliG a fragment of 1668 bp was identified using a 5’ 
probe.  
Wild-type  
!gliG  
5’ Probe 
5’ Probe 
1668 bp 
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Figure 3.10. Identification of A. fumigatus !gliG
!akuB
. Second round Southern 
analysis of single spore isolates of !gliG transformants in A. fumigatus !akuB. 
Here, the 5’ DIG-labelled probe was used to detect the predicted presence of 1.6 
and 2.1 kb fragments in XbaI digested genomic DNA. Lane 1-3: Single spore 
isolates of potential mutant strain from colony 7, Lane 4-6: Single spore isolates 
of potential mutant strain from colony 9. The presence of an unknown band 
from the isolate in lane 4 was evident, this isolated was eliminated from 
selection. Isolates in lanes 5 and 6 contained the wild-type bands so both were 
eliminated. The isolate from lane 3 was confirmed as the !gliG strain, 
!gliG!
akuB
. Isolates in lane 1 and 2 were not used as only one !gliG strain was 
necessary.  
2124 bp 
1668 bp 
1     2      3     4       5      6  
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Figure 3.11. Identification of A. fumigatus !gliG
AF293
. (A and B) First round 
Southern analysis of ! gliG transformants in A. fumigatus AF293. Here, a 5’ 
DIG-labelled probe was used to detect the predicted presence of 1.6 and 2.1 kb 
fragments in XbaI digested genomic DNA from !gliG and wild-type, 
respectively. Lane 1-20: potential transformants. Putative transformants in lane 
14 (colony 14), lane 15 (colony 15) and 20 (colony 20) were selected for single 
spore isolation. (C) Second round Southern analysis of single spore isolates of 
the putative transformants in A. fumigatus AF293. Here, the 5’ DIG-labelled 
probe was used to detect the predicted presence of 1.6 and 2.1 kb fragments in 
XbaI digested genomic DNA from !gliG and wild-type, respectively. Lane 1 
and 2: Single spore isolates of potential mutant strain from colony 14, Lane 3 
and 4: Single spore isolates of potential mutant strain from colony 20, Lane 5-
1       2      3     4       5      6      7      8      9     10     wt  !gliG 
2124 bp 
1668 bp 
2124 bp 
1668 bp 
    1     2      3     4      5      6     7      8     9    10   !gliG wt    
  11    12    13   14   15     16    17    18    19    20 !gliG wt  
2124 bp 
1668 bp 
C 
 
B 
A 
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10: Single spore isolates of potential mutant strain from colony 15. The isolate 
from lane 10 was confirmed as the !gliG strain, !gliG
AF293
.   
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3.2.6 Complementation of gliG into !gliG
AF293 
 
Once gliG had been successfully deleted from A. fumigatus AF293 and 
!akuB, it was necessary to reintroduce the gene into the genome of A. fumigatus 
!gliG::ptrA . This would ensure the phenotype observed could be solely 
attributed to the product of gliG. The complementation method for gliG 
reintroduction is described in Section 2.2.3.  
3.2.6.1 Generation of a Complementation Construct  
The full gliG coding sequence along with both 5’ and 3’ flanking regions 
were cloned into TOPO (Figure 3.12). A phleomycin resistance gene, ble, was 
digested from the BPhleo plasmid (Figure 3.12), and was then cloned into the 
topogliG vector producing a topogliGphleo vector (Figure 3.13). To confirm 
correct cloning of gliG and ble, a diagnostic digest was performed on potential 
plasmids (Figure 3.13). This confirmed two constructs were cloned correctly as 
the expected fragments of 2780 and 7519 bp were observed after digestion with 
SmaI. This vector was then used for gliG complementation. Before 
transformation the topogliGphleo vector was linearised with HpaI (Figure 3.14). 
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Figure 3.12. Plasmid maps of BPhleo and TopogliG. (A) BPhleo contains the 
ble gene that is indicated by the black arrow. Restriction sites, KpnI and XbaI, 
facilitated the removal of ble for cloning into TopogliG. (B) TopogliG contains 
the full gliG coding sequence and the respective 5’ and 3’ flanking regions. 
Restriction sites, KpnI and SpeI, are indicated; these sites were used to clone in 
the ble gene. 
BPhleo 
6381 bp 
TopogliG   
6822 bp 
gliG  
ble 
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Figure 3.13. Diagnostic digest of the complementation plasmid that contains  
topogliGPhleo with the full gliG coding sequence and 5’ and 3’ flanking 
regions. The selection marker ble, is also present on this plasmid. (A) Plasmid 
map showing ble, indicated by the black arrow, and gliG which indicated by the 
grey arrow. The diagnostic digest used the restriction site SmaI as indicated. (B) 
M    1      2      3      4     5      6     7      8      9    10    11    M 
7519 bp 
2780 bp 
TopogliGphleo 
10,299 bp 
gliG  
ble 
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Diagnostic digest of potential topogliGphleo plasmid. Digestion using SmaI 
would yield two fragments, 2780 and 7519 bp. Lanes 1-10: Plasmid 
topogliGphleo. Lane 11: Undigested plasmid. Lane M: Molecular weight 
marker (Roche VII) (Section 2.1.10.1.8.1). Lane 7 and 10: contains fragments 
2780 and 7519 bp. These expected fragments confirm that both of these 
plasmids were accurately cloned and suitable for complementation.  
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Figure 3.14. Plasmid map of topogliGphleo (10322 bp) linearised with the 
restriction enzyme HpaI which is indicated. Once linearised this plasmid was 
suitable for use in complementation of A. fumigatus !gliG
AF293
 .  
TopogliGPhleo 
10322 bp 
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3.2.6.2 Southern blot Analysis of Transformants from A. fumigatus gliG
C
 
Complementation 
Screening of the potential complemented transformants involved several 
rounds of Southern blot analysis. Figure 3.15 summarises the Southern strategy 
employed to confirm gliG
C
 complementation. Genomic DNA from all potential 
transformants was digested with EcoRV and probed with the 3’ probe. Southern 
blot analysis (Section 2.2.5) identified two putative complemented 
transformants, termed 15 and 17 (Figure 3.16). Both contained the predicted 
fragment sizes of 3.5 kb and 1.5 kb when analysed by Southern blot. These 
potential complemented transformants were single-spore isolated and genomic 
DNA of these isolates was digested with EcoRI. These digested isolates were 
probed with a gliG coding sequence probe to check for the presence of gliG. 
Three transformants were identified as complemented strains and were termed 
15.1, 15.4 and 17.1 (Figure 3.17). A third round of Southern blotting was 
performed and genomic DNA from these three complemented strains were 
digested with PstI. These strains (15.1, 15.4 and 17.1) were probed with a ptrA 
coding sequence probe to ensure the ptrA gene was present. The detection of 
ptrA  confirmed the three strains as gliG complemented strains, gliG
C 
15.1, gliG
C 
15.4 and gliG
C 
17.1 (Figure 3.18). Complementation was performed on 
!gliG!
akuB
, however no transformants were observed on selection plates. 
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Figure 3.15. Illustration showing the Southern blot strategy for gliG complementation. (A) An EcoRV restriction enzyme of gliG
C
 generated 
fragments of 3481 bp and 1475 bp which were identified using a 3’ probe (1002 bp). (B) An EcoRI restriction enzyme of gliG
C
 generated a 
fragment of 2447 bp which was identified using a gliG coding sequence-specific probe (794 bp). (C) A PstI restriction enzyme of gliG
C
 
generated a fragment of 3568 bp which was identified using a ptrA-specific probe (559 bp).  
.  
A 
B 
C 
3’ Probe  3’ Probe  
gliG cds Probe  
ptrA Probe  
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Figure 3.16. Southern blot analysis of potential gliG complemented strains in A. 
fumigatus !gliG::ptrA genome. Genomic DNA was digested with EcoRV and 
probed with the 3’ probe. Lanes 1-10: Potential transformants screened; Lane 
M: DIG-labelled molecular weight marker (Roche VII) (Section 2.1.10.1.8.1). 
In lanes 5 and 7, transformants termed 15 and 17 are identified as potential 
complemented strains. Lane 11: Wild-type DNA that contains the predicted 
fragment of 1.5 kb only. Lane 12: !gliG DNA that contains neither the 3.4 or 
1.5 kb fragments.   
 
 
 
1     2     3    4     5    6     7     8    9     10  11  12  M 
3481 bp 
 
1475 bp 
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Figure 3.17. Southern blot analysis of single-spore isolates of potential gliG 
complemented strains in A. fumigatus !gliG::ptrA genome. Genomic DNA of 
single-spore isolates was digested with EcoRI and probed with a gliG coding 
sequence probe. Lane M: DIG-labelled molecular weight marker (Roche VII) 
(Section 2.1.10.1.8.1). Lanes 1-10: Potential transformants screened with the 
expected fragment (2447 bp) indicated. In lanes 1, 4 and 6, transformants 
termed 15.1, 15.4 and 17.1 respectively, are identified as potential 
complemented strains.  
 
M     1      2       3       4      5      6      7       8       9     10  
2447 bp 
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Figure 3.18. Southern blot analysis of potential gliG complemented strains in A. 
fumigatus !gliG::ptrA genome. Genomic DNA was digested with PstI and 
probed with a ptrA -specific probe. Lane M: DIG-labelled molecular weight 
marker (Roche VII) (Section 2.1.10.1.8.1). Lanes 1-12: Potential transformants 
screened with the expected fragment (3568 bp) indicated. In lanes 1, 5 and 7 
transformants termed 15.1, 15.4 and 17.1 respectively, are identified as 
complemented strains.  
3568 bp 
M     1     2     3    4      5     6     7    8     9     10    11  12 
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3.2.6.3 PCR Analysis of Genomic DNA Extracted AF293 wild-type, !gliG 
and gliG
C
 15.1, 15.4 and 17.1.  
To further confirm successful complementation of A. fumigatus 
!gliG
AF293
, PCR analysis (Section 2.2.2.3) was performed (Table 3.2). Briefly, 
genomic DNA was extracted from the three A. fumigatus gliG
C
 complemented 
strains. PCR analysis using primers ogliG-9 and ogliG-10 (Table 2.4) was 
performed to confirm the presence of the gliG coding sequence. The expected 
fragment size of 539 bp was observed (Figure 3.19), confirming gliG DNA was 
successfully integrated into the gliG
C
 strains. PCR analysis using ogliG-5 and 
optrA-2 (Table 2.4) was performed to confirm the presence of the ptrA  coding 
sequence. The expected fragment size of 2528 bp was observed (Figure 3.19), 
confirming ptrA  DNA was successfully integrated into the gliG
C
 strains. 
Detection of both gliG and ptrA  confirmed complementation of A. fumigatus 
gliG.  
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Table 3.2. Expected PCR fragments of A. fumigatus gliG
C 
15.1, 15.4 and 17.1, 
respectively.  
Gene gliG
C
 15.1 gliG
C
 15.4 gliG
C
 17.1 
gliG  539 bp 539 bp 539 bp 
ptrA  2528 bp 2528 bp 2528 bp 
 
 A 
 
 
 
 
 B 
 
 
 
 
Figure 3.19. PCR of genomic DNA extracted from A. fumigatus gliG
C
 15.1, 
15.4 and 17.1, respectively. (A) Lane M1: Molecular weight marker 
DirectLoad™ Step Ladder, 50 bp (Sigma) (Section 2.1.10.1.8.2), Lane 1 – 3: 
PCR amplification of the gliG coding sequence using ogliG-9 and ogliG-10 
primers with genomic DNA from gliG
C
 15.1, 15.4 and 17.1, respectively. 
M1  1        2         3     
  
539 bp 
 
 M2    4          5          6       
         3       4 
2528 bp 
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Expected fragment size 539 bp. (B) Lane M2: Molecular weight marker (Roche 
VII) (Section 2.1.10.1.8.1), Lane 4 – 6 : PCR amplification of the ptrA gene 
using ogliG-5 and optrA-2 with genomic DNA from gliG
C
 15.1, 15.4 and 17.1, 
respectively. Expected fragment size 2528 bp.  
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3.3 Discussion 
Phylogenetic analysis of A. fumigatus gliG with 104 other fungal genomes 
identified that this GST clustered with other putative ETP producing fungi and 
not with other putative GST from A. fumigatus. The work presented in this 
Chapter describes the deletion of a putative glutathione s-transferase gene, gliG, 
which is a component of the gliotoxin gene cluster in A. fumigatus (Gardiner 
and Howlett, 2005). This gene was deleted in two separate strains, A. fumigatus 
AF293 and !akuB. Transformation constructs were generated using the 
bipartite method (Nielsen et al., 2006), where two constructs were produced 
containing partial regions of the PT resistance gene, ptrA . Southern analysis was 
used to screen nine colonies. An EcoRV digest generated the expected fragment 
size of 3.8 kb and confirmed the deletion of gliG in the NHEJ-deficient parent 
strain !akuB (da Silva Ferreira et al., 2006), resulting in A. fumigatus 
!gliG!
akuB
. A second round of Southern analysis with XbaI digested DNA of 
single-spore isolates confirmed the expected fragment size of 1.6 kb in 
!gliG!
akuB
. On an independent occasion, Southern analysis was used to screen 
twenty transformed colonies. An XbaI digest generated the expected fragment 
size of 1.6 kb and confirmed the deletion of gliG in the wild-type AF293 
(Nierman et al., 2005) parent strain, resulting in !gliG
AF293
. A complementation 
transformation construct containing gliG coding sequence and a new marker 
gene, ble, was generated. Southern analysis was used to screen ten 
transformants and an EcoRV digest generated the expected fragment sizes of 3.5 
and 1.5 kb in two gliG complemented strains, gliG
C
. Two further Southern blots 
on single-spore isolates using EcoRI and PstI identified expected fragments of 
2.4 and 3.6 kb, respectively. PCR analysis identified both gliG and ptrA in the 
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three complemented strains. This confirmed the complemented strains contained 
both ptrA and gliG.  
The advances in genetic manipulation tools for functional analysis of 
genes in A. fumigatus has increased the success rate of fungal transformation 
(Kuck and Hoff, 2010) and the bipartite method (Nielsen et al., 2006) for 
generation of DNA-transforming constructs was used for the deletion of gliG in 
A. fumigatus. The two deletion constructs each contained partial sections of the 
ptrA  gene, the 5’ construct contained 1.2 kb flanking region and the 3’ construct 
contained 1.0 kb flanking region. This method was favoured over other linear- 
and PCR-based constructs as only two rounds of PCR are necessary. Generation 
of constructs that use more PCR steps (double-joint method) has the potential to 
introduce mutations into the replacement cassette and this may have the 
undesired effect of disrupting neighbouring genes due to the high gene density 
in filamentous fungi (Yu et al., 2004). Reconstitution of the constructs in vivo 
restores the ptrA  gene. This event drives DNA recombination into HR due to 
the long flanking regions HR facilitates targeted gene replacement with the 
marker gene. Transformants are only obtained in the presence of a reconstituted 
ptrA  gene, so ectopic integration of either the 5’ or the 3’ construct would not 
confer the resistance to PT.  
The deletion of gliG in A. fumigatus was originally performed in !akuB 
using the protoplast-mediated transformation system. Transformation resulted in 
thirty-seven transformants on the selection plates. Southern analysis was 
performed on nine transformants to screen for the targeted deletion of gliG and 
one transformant was confirmed as !gliG!
akuB
. The use of !akuB as a parent 
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strain for gene deletion increases the likelihood of targeted gene deletion in A. 
fumigatus (Krappmann et al., 2006) who reported a success rate of 80 % when 
the NHEJ-deficient strain was used to delete a calcineurin A gene (calA ) and a 
polyketide synthase pksP (alb1) gene. This compared to a success rate of 
between 3 – 5 % when the wild-type strain was used. The success rate of gliG 
deletion in !akuB was 11 %, which was lower than previously reported by da 
Silva Ferreira et al. (2006), however, only nine transformants were screened out 
of the thirty-seven generated in transformation, leaving 75 % unscreened. The 
low percentage of transformants screened means that the transformation 
efficiency reported here using !akuB could have been higher. Using A. 
fumigatus !akuB has one known drawback; the loss of Ku70 may have an effect 
on fungal growth and development, yet Krappman et al. (2006) reported no 
phenotype associated with growth, sporulation, pigmentation and nutritional 
requirement for the !akuA  strain. However, mild sensitivity to DNA damaging 
agents like methyl methanesulphonate (MMS) and UV light has been observed 
(Ninomiya et al., 2004; da Silva Ferreira et al., 2006; Nayak et al., 2006). These 
observed phenotypes would be expected in a strain deficient in a gene 
associated with DNA damage and so, ideally, the complementation of the Ku70 
deficiency in the mutant strain should be carried out before full phenotype 
analysis is performed (Nielsen et al., 2008). This strain has provided the 
background for successful disruption of gliT from the A. fumigatus gliotoxin 
cluster (Scharf et al., 2010). 
The deletion of gliG was also performed in the wild-type strain AF293. 
This strategy was identical to the strategy used in !akuB except the parent strain 
has no previous gene deletions in the genome. Transformation with bipartite 
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constructs yielded forty-five transformants on selection plates and southern 
analysis of twenty transformants was used to screen for gliG mutants. One 
transformant with a single homologous integration was confirmed as A. 
fumigatus !gliG
AF293
 and this transformation efficiency of 5 % correlates to the 
success rate of 3 – 5 % for wild-type strains (da Silva Ferreira et al., 2006).  
Complementation of gliG into the A. fumigatus !gliG genome was only 
successful in !gliG
AF293
, here a linear construct containing the gliG coding 
sequence with corresponding flanking regions and a new marker gene, ble, was 
transformed into !gliG
AF293
. Twelve transformants selected on the basis of 
phleomycin resistance were screened by Southern analysis and two were 
identified as potential complemented strains. Single spore isolates of these 
putative complemented strains were screened by Southern analysis and PCR 
analysis identified both gliG and ptrA  in the three complemented strains. This 
confirmed both ptrA  and gliG genes were present and three strains were 
confirmed to have gliG restoration into the mutant strain (gliG
C
 15.1, 15.4 and 
17.1). Transformation in !gliG!
akuB
 resulted in no observed transformants. As 
complementation usually occurs ectopically, the NHEJ-deficient strain lacks the 
DNA recombination mechanism to facilitate this integration (Carvalho et al., 
2010) which is a plausible explanation as to why gliG complementation was 
never observed in the NHEJ-deficient !gliG strain.  
In summary, the work described here confirms for the first time the 
successful deletion and complementation of gliG in A. fumigatus. This is the 
first reported deletion of a GST in A. fumigatus and this was performed in the 
NHEJ-deficient strain !akuB and in the wild-type strain, AF293. However, 
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restoration of gliG into !gliG was only successful in the AF293 background. 
Functional analysis relies on the generation of strains which (i) have targeted 
gene deletion and (ii) complementation of the gene of interest into the mutant 
strain. To investigate the significance of the phylogenetic clustering described in 
this Chapter, comparative phenotypic analysis to identify a role for gliG in A. 
fumigatus was initially performed using both !gliG strains but later performed 
solely on the strains in the AF293 background, and this work will be described 
in Chapter 4. 
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4. Chapter 4 Functional Characterisation of gliG – a Component of the 
Gliotoxin Biosynthetic gene Cluster in Aspergillus fumigatus 
4.1  Introduction 
A. fumigatus gliG has been identified as a glutathione transferase (GST; 
EC 2.5.1.18) and as a gene within the gliotoxin cluster (Gardiner and Howlett, 
2005; Carberry, 2008). GST are phase II detoxification enzymes that conjugate 
toxic xenobiotics facilitating their cellular elimination (Sheehan et al., 2001). 
Very little information is available regarding the role of GST in fungi (Morel et 
al., 2009) and in particular their role in A. fumigatus. The A. fumigatus genome 
contains 26 predicted GST (Chapter 3), only three of which have been 
characterised within A. fumigatus through the use of recombinant functional 
studies (Burns et al., 2005). The previous Chapter detailed the deletion of gliG 
from A. fumigatus, and so comparative phenotypic analysis between wild-type 
and !gliG should aid the identification of the specific role of gliG within the 
gliotoxin biosynthetic cluster (Gardiner and Howlett, 2005). Characterisation of 
the gliG null mutant will determine whether this enzyme plays a role in 
gliotoxin self-protection or biosynthesis. This characterisation will involve 
subjecting the mutant and corresponding wild-type strain to, (i) H2O2 to 
determine whether it plays a role in peroxide-induced oxidative stress, (ii) anti-
fungal agents voriconazole and AmpB to determine whether it is involved in the 
detoxification of these compounds, (iii) exposing mutant and wild-type strains 
to various concentrations of gliotoxin to determine whether it plays a role in 
gliotoxin self-protection (Schrettl et al., 2010) and finally, (iv) performing 
comparative HPLC analysis to determine whether the mutant strain produces 
gliotoxin or any potential intermediates associated with gliotoxin biosynthesis. 
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The presence of a GST within this gene cluster suggests a possible 
detoxification role, however, the possibility of A. fumigatus gliG performing a 
biosynthetic function cannot be eliminated and it has been suggested that gliG 
may be involved in sulphur incorporation into gliotoxin (Howlett, 2008) and the 
availability of A. fumigatus !gliG allows this issue to be addressed.  
As discussed in Chapter 1, GST are known to play a role in mediating 
drug detoxification (Hayes et al., 2005). In S. pombe, three GST mutants; !gst1, 
!gst2 and !gst3 all exhibited sensitivity to the anti-fungal agent fluconazole. 
Which shows a role for fungal GST in mediating anti-fungal drug resistance 
(Veal et al., 2002). This activity may also be evident against other members of 
the azole anti-fungal agents, such as voriconazole. Transcriptomic analysis of A. 
fumigatus AF293 treated with amphotericin B (AmpB) (MIC50 = 0.125 µg/ml) 
revealed a 3.2-fold increase in expression (microarray hybridisation) of a 
putative GST (CADRE identification; AFUA_3G07930) (Gautam et al., 2008). 
This increase in GST expression suggests a role for this A. fumigatus GST in 
AmpB detoxification. Surprisingly, expression analysis of A. fumigatus gliG 
upon exposure to AmpB (final concentration 0.32 µg/ml) detected elevated 
expression 1 hr post-induction however, after 2 and 4 hr gliG expression was 
absent (Figure 4.1) (Reeves; unpublished). This suggests that A. fumigatus gliG 
may not be directly involved in mediating an anti-fungal response against 
AmpB and that gliG may have another role in A. fumigatus.  
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Figure 4.1. Expression analysis of gliotoxin gene cluster (+ / – AmpB; 0.32 
µg/ml) by RT-PCR. AmpB up-regulated expression of both gliP and gliG after 1 
hr exposure. Inhibition of expression in both genes was observed after 2 and 4 
hr exposure. Calmodulin (calm) is a house-keeping gene (Dr Emer Reeves, 
unpublished). 
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As mentioned in Chapter 1, the characterisation of three GST (gstA , gstB 
and gstC) from A. fumigatus through recombinant functional analysis 
confirmed that all three exhibited GST activity (Burns et al., 2005) and a fourth 
A. fumigatus GST (A. fumigatus elfA ) was confirmed to have GST activity, 
after the native enzyme was purified from fungal lysate (Carberry et al., 2006). 
Expression analysis of A. fumigatus gstA  and gstC indicated an up-regulation in 
response to oxidative stress caused by H2O2 and expression of all three GST 
(gstA , gstB and gstC) was induced by CDNB (Burns et al., 2005). Orthologues 
of A. fumigatus gstB and gstC in the yeast S. pombe (gst1 and gst2, 
respectively) (Veal et al., 2002) revealed that both were induced in the presence 
of H2O2. However only gstC was induced by H2O2 in A. fumigatus (Burns et al., 
2005). Phylogenetic analysis of A. fumigatus gstB/gstC with S. pombe gst1/gst2 
revealed greater divergence of the A. fumigatus gstB/gstC from the S. pombe 
orthologues (Burns et al., 2005). This indicates diverging roles for GST within 
fungi as the A. fumigatus and S. pombe homologues (gstB and gst1, 
respectively) show differential induction patterns in response to oxidative stress. 
The location of A. fumigatus gliG within the gliotoxin gene cluster suggests a 
possible metabolic role for this GST (Burns et al., 2005). 
The genes responsible for gliotoxin production are co-regulated within a 
cluster in the A. fumigatus genome (Gardiner and Howlett, 2005). Expression 
analysis of the gliP mutant (ARC2) demonstrated that the transcription of genes 
in the gliotoxin cluster was dramatically reduced (Cramer et al., 2006) which 
was directly related to the absence of gliP. Upon exposure to exogenous 
gliotoxin (24 hr; 20 µg/ml) up-regulation of eleven genes from the cluster was 
observed in ARC2, with the exception of gliP which had been deleted and gliH 
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which had not been assigned to the gliotoxin cluster at that time (Cramer et al., 
2006; Schrettl et al., 2010). In particular, the expression of gliG increased three-
fold (3.18 ± 0.62) upon exposure to exogenous gliotoxin (20 µg/ml) (Cramer et 
al., 2006). Expression of gliG was also induced in A. fumigatus ATCC46646 
and !gliT
46645
 upon exposure to exogenous gliotoxin (5 µg/ml) (Schrettl et al., 
2010) which confirmed that gliotoxin positively regulates the expression of A. 
fumigatus gliG.  
Among the pathogenic Aspergilli, A. fumigatus is the most prolific 
producer of gliotoxin (Lewis et al., 2005b). Culturing conditions for gliotoxin 
production show it is optimally secreted on a minimal medium where carbon 
and nitrogen sources are limiting (Frisvad et al., 2009). Only low gliotoxin 
levels have been detected on complete media such as Czapeks yeast autolysate 
(CYA) and yeast extract sucrose (YES) (Frisvad et al., 2009). HPLC is the 
method of choice for fungal secondary metabolite profiling (Frisvad, 1987) and 
this method is well-established for the identification of novel metabolites 
produced by the Aspergilli (Chiang et al., 2008), and was used by others for the 
detection of gliotoxin in A. fumigatus culture supernatants (Bok et al., 2006; 
Cramer et al., 2006; Kupfahl et al., 2006; Sugui et al., 2007; Kupfahl et al., 
2008; Spikes et al., 2008; Scharf et al., 2010; Schrettl et al., 2010).  
To date, no secreted gliotoxin biosynthetic intermediate has been 
identified in A. fumigatus with much of the emphasis focusing on whether the 
gli (gliP; gliZ) mutant strains exhibit attenuated virulence (Bok et al., 2006; 
Kupfahl et al., 2006; Spikes et al., 2008). Comparative HPLC profiles of A. 
fumigatus wild-type (B-5233) and A. fumigatus gliP
C
 (reconstituted gliP strain) 
identified two unknown metabolites along with gliotoxin (Sugui et al., 2007) 
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and the disappearance of these two metabolites in A. fumigatus !gliP led to 
speculation that they may be gliotoxin biosynthetic intermediates (Sugui et al., 
2007). However, the identity of these metabolites remains unknown. More 
recently, A. fumigatus gliT has been identified as a gliotoxin oxido-reductase 
(Scharf et al., 2010; Schrettl et al., 2010). Comparative HPLC analysis of A. 
fumigatus wild-type (CEA!akuB) and !gliT
CEA!akuB identified no additional 
metabolites in the mutant (Scharf et al., 2010). However, comparative HPLC of 
A. fumigatus !gliT
ATCC26933 
identified a metabolite (RT = 11.7 min) that was 
absent in A. fumigatus ATCC26933 (wild-type). HRMS (LC-ToF) of the 
purified metabolite (RT = 11.7 min) confirmed a mass of 279.0796 m/z and 
predicted a molecular formula of C13H15N2O3S (Schrettl et al., 2010). These 
authors speculate that the metabolite could be a monothiol form of gliotoxin 
secreted by A. fumigatus !gliT
ATCC26933
. However, the precise nature of the 
metabolite and other possible gliotoxin biosynthetic intermediates can only be 
confirmed through structural elucidation.  
The overall objectives of the work presented in this Chapter were (i) to 
perform expression analyses of A. fumigatus gliG in wild-type, !gliG and gliG
C
 
(15.1, 15.4 and 17.1), (ii) to observe any phenotype associated with A. 
fumigatus !gliG in comparison to the corresponding wild-type under various 
conditions of oxidative stress, anti-fungal drug exposure or gliotoxin resistance 
through a series of phenotypic assays where wild-type and !gliG strains were 
subjected to these various stresses, (iii) to perform comparative metabolite 
profile analysis of wild-type, !gliG and complemented strains to identify 
possible gliotoxin intermediates and (iv) test the difference in virulence of the 
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wild-type and !gliG strains using G. mellonella  larvae. Together data should 
aid the elucidation of the role of gliG in A. fumigatus.  
4.2 Results 
4.2.1 Expression Analysis of gliG. 
The deletion of A. fumigatus gliG from !akuB and AF293 and subsequent 
complementation of !gliG
AF293
 was confirmed by Southern analysis, as shown 
in Chapter 3. Northern analysis was employed to confirm that the deletion of 
gliG resulted in the abolition of gliG expression in both A. fumigatus !gliG 
strains and the restoration of gliG expression was evident in gliG
C
. Expression 
analysis is detailed in the following sections.  
4.2.1.1 Northern Analysis of gliG expression in A. fumigatus !akuB and 
!gliG following exposure to exogenous gliotoxin.  
Northern analysis was performed on A. fumigatus !akuB wild-type and 
A. fumigatus !gliG!
akuB
. Both wild-type and mutant strains were cultured in 
AMM and incubated at 37 °C for 21 hr, followed by the addition of gliotoxin 
(final concentration 5 µg/ml) for 3 hr. Gliotoxin was added to the cultures as it 
has been previously demonstrated to induce the expression of genes within the 
gliotoxin cluster (Cramer et al., 2006). Total RNA was extracted (20 µg) and 
subjected to gel electrophoresis (Section 2.2.4.2) and Northern blotting (Section 
2.2.4.3) where a DIG-labelled gliG coding sequence specific probe was used to 
detect the gliG transcript. Expression of gliG was evident in A. fumigatus 
!akuB (Figure 4.2), where a single band was detected on the Northern blot after 
probing with a DIG-labelled gliG coding sequence probe (black arrow). Only 
one band was present on the blot between the 18 S and 5 S rRNA subunits, 
 173 
confirming it as the gliG transcript. Absence gliG expression was evident in A. 
fumigatus !gliG!
akuB
 (Figure 4.2). As a positive control for the Northern 
blotting technique, total RNA from A. fumigatus ATCC46645 under identical 
culturing conditions was analysed where gliG expression was confirmed (Figure 
4.2) (Schrettl et al., 2010).  
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Figure 4.2. Northern analysis of gliG expression. (A) RNA gel, (B) exposure 
after 5 hr and, (C) exposure after 16 hr using chemiluminescent detection. Lane 
1: RNA isolated from A. fumigatus !akuB grown in AMM for 21 hr and shifted 
to gliotoxin for 3 hr, Lane 2: RNA isolated from A. fumigatus !gliG
akuB
 grown 
in AMM for 21 hr and shifted to gliotoxin for 3 hr, Lane 3: RNA isolated from 
A. fumigatus ATCC46645 wild-type grown in AMM for 21 hr and shifted to 
gliotoxin for 3 hr. Expression of gliG was confirmed in A. fumigatus !akuB 
evident after a 16 hr exposure (Lane 1), no gliG expression was observed in A. 
fumigatus !gliG (Lane 2). Expression of gliG was confirmed in A. fumigatus 
ATCC46645 (Lane 3). 
     1      2      3           1      2        3            1      2      3  
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          5 hr           16 hr 
 
26 S (3.5 kb) 
18 S (1.8 kb) gliG  
A            B   C 
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4.2.1.2 Northern Analysis of gliG expression in A. fumigatus AF293, 
!gliG
AF293
 and gliG
C
 15.1, 15.4 and 17.1.  
Expression analysis of gliG in the A. fumigatus AF293 strain was 
performed by Northern blotting. All strains were cultured in AMM and 
incubated at 37 °C for 48 hr (n = 2; biological duplicate). Total RNA was 
extracted (5 µg) (Section 2.2.4.1) and subjected to gel electrophoresis and 
blotting (Section 2.2.4.2 and 2.2.4.3). Expression of gliG was evident in A. 
fumigatus AF293 (Figure 4.2, Lane 9 and 10) where a single band was detected 
on the Northern blot after probing with a DIG-labelled gliG coding sequence 
probe (black arrow). Only one band was present on the blot between the 18 S 
and 5 S rRNA subunits, confirming it as the gliG transcript. Absence of gliG 
expression in A. fumigatus !gliG
AF293
 was confirmed (Figure 4.3, Lane 7 and 8). 
Expression of gliG was restored in the three A. fumigatus gliG
C
 complemented 
strains, where a single band was detected on the Northern blot after probing 
with a gliG coding sequence this was comparable to wild-type expression of 
gliG (Figure 4.3, Lane 1-6).  
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Figure 4.3. Northern analysis of the expression of gliG in A. fumigatus gliG
C
 
15.1, gliG
C
 15.4, gliG
C
 17.1, !gliG
AF293
, AF293 (wild-type). Total RNA (n = 2; 
biological duplicate) was extracted from AMM cultures at a 48 hr time point 
and probed using a specific gliG coding sequence probe (Table 2.4). Lanes 1 
and 2: RNA isolated from gliG
C
 15.1, Lanes 3 and 4: RNA isolated from gliG
C
 
15.4, Lanes 5 and 6: RNA isolated from gliG
C
 17.1, Lanes 7 and 8: RNA 
isolated from !gliG, Lanes 9 and 10: RNA isolated from AF293 wild-type. 
Expression of gliG was confirmed in A. fumigatus AF293 (Lanes 9 and 10), no 
gliG expression was observed in A. fumigatus !gliG
AF293
 (Lanes 7 and 8). 
Expression of gliG was confirmed in A. fumigatus gliG
C
 15.1 (Lanes 1 and 2). 
Expression of gliG was confirmed in A. fumigatus gliG
C
 15.4 (Lanes 3 and 4). 
Expression of gliG was confirmed in A. fumigatus gliG
C
 17.1 (Lanes 5 and 6).  
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4.2.1.3  Northern Analysis of the neighbouring gliG genes gliM and gliK.  
Once it was confirmed that gliG was deleted successfully and that this 
coincided with the loss of gliG expression, it was important to ensure that the 
neighbouring genes to gliG within the cluster were not disrupted. Northern 
analysis was performed on RNA (5 µg) extracted from AF293 wild-type, !gliG
 
and the three complemented strains (Section 2.2.4). The Northern blots were 
probed separately using DIG-labelled probes, specific for the gliM and gliK 
coding sequences. A single band was evident on the Northern blot, located just 
below the 18 S rRNA subinit, this confirmed gliM expression. Expression of 
gliM was evident in all five strains (Figure 4.4; Lanes 1-5). A single band was 
evident on the Northern blot located below the 18 S rRNA sbunit, this 
confirmed gliK expression. Expression of gliK was also evident in all five 
strains (Figure 4.4; Lanes 6-10). This confirmed the expression of the 
neighbouring gliG genes in A. fumigatus AF293, A. fumigatus !gliG
AF293
 and in 
the three A. fumigatus gliG
C
 strains. Noticably, both gliM and gliK appear to 
exhibit a higher degree of expression in the A. fumigatus !gliG, gliG
C
 15.4 and 
gliG
C
 17.1 strains. A plausible explanation for this will be discussed in Section 
4.3.  
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Figure 4.4. Northern blot analysis of gliM and gliK expression in A. fumigatus 
AF293 wild-type, !gliG and gliG
C
 15.1, gliG
C
 15.4 and gliG
C
 17.1. Total RNA 
was extracted at a 48 hr. The 26 S and 18 S rRNA subunits are indicated by the 
asterix (A) gliM expression analysis (indicated by the arrow); Lane 1: RNA 
isolated from A. fumigatus AF293. Lane 2: RNA isolated from A. fumigatus 
!gliG
AF293
. Lane 3 – 5: RNA isolated from A. fumigatus gliG
C
 15.1, 15.4 and 
17.1, respectively. Expression of gliM in all strains (Lanes 1 – 5) was confirmed 
using a gliM-specific probe. Expression of gliM was evident in A. fumigatus 
!gliG
AF293
. (B) gliK expression analysis (indicated by the arrow); Lane 6: RNA 
isolated from A. fumigatus AF293. Lane 7: RNA isolated from A. fumigatus 
!gliG
AF293
. Lane 8 – 10: RNA isolated from A. fumigatus gliG
C
 15.1, 15.4 and 
17.1, respectively. Expression of gliK in all strains (Lanes 6 – 10) was 
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confirmed using a gliK-specific probe. Expression of gliK was evident in A. 
fumigatus !gliG
AF29.
.
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4.2.2 Recombinant Protein Activity Analysis of GliG  
Analysis performed by Dr Stephen Carberry prior to the work presented in 
this thesis confirmed that GliG was a GST, which was enabled by the 
generation of recombinant GliG. Briefly, gliG was PCR amplified from A. 
fumigatus ATCC26933 cDNA before cloning into the pProEX™ Htb 
expression vector. The expression vector was then transformed into competent 
E. coli DH5" cells and sequenced to ensure the insertion of gliG was correct 
and in frame (Carberry, 2008). Enzymatic activity assays confirmed GliG 
exhibited GST activity against substrates 1-chloro-2,4-dinitrobenzene (CDNB) 
(specific activity (SA) = 0.21 U/mg) and 3,4-dichloro-nitrobenzene (DCNB) 
(SA = 0.09 U/mg). GliG also exhibited low but reproducible glutathione 
reductase activity (SA = 0.01 U/mg) and no glutathione peroxidase activity was 
observed (Carberry, 2008). In the present work, enzymatic activity of GliG was 
performed against the GST substrates CDNB and 1,2-epoxy-3-(4-
nitrophenoxy)-propane (EPNP) and data obtained during the activity analyses 
are presented Section 4.2.2.1.  
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4.2.2.1 Recombinant GliG and A. fumigatus Protein Lysate GST Activity 
analysis against CDNB and EPNP 
The GST activity of rGliG and protein lysates (A. fumigatus !gliG and 
wild-type) was analysed against GST substrates CDNB and EPNP. The activity 
of rGliG against CDNB was calculated; SA = 0.2 ± 0.1 U/mg. Activity of rGliG 
against EPNP was also analysed and SA calculated; SA = 2.3 ± 0.122 U/mg 
(Table 4.1). The SA of rGliG using EPNP was 12-fold higher than CDNB 
meaning that rGliG had higher epoxide conjugating s-transferase activity. 
Enzymatic activity using total protein lysates generated from A. fumigatus 
!gliG mycelia exhibited 17 % less activity towards EPNP than those from A. 
fumigatus AF293 (wild-type) (SA = 0.12 ± 0.02 versus 0.145 ± 0.011 U/mg, 
respectively) (Table 4.1), indicating that GliG plays a role in the GST activity 
towards this substrate, however there are predicted to be 25 other GST in the A. 
fumigatus  genome which may also exhibit activity against EPNP.  
Table 4.1. Activity of rGliG and A. fumigatus protein lysates towards GST 
substrates CDNB and EPNP. The s-transferase activity of rGliG toward EPNP 
was 12-fold higher in comparison to CDNB. Lysates from A. fumigatus !gliG 
exhibited 17 % less EPNP-conjugating activity than lysates from A. fumigatus 
AF293 (wild-type).  
 CDNB EPNP 
rGliG 0.2 ± 0.1 U/mg 2.3 ± 0.122 U/mg 
A. fumigatus !gliG lysate ___ 0.12 ± 0.02 U/mg 
A. fumigatus  AF293 lysate ___ 0.145 ± 0.011 U/mg 
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4.2.3 Phenotypic Analysis of A. fumigatus !gliG  
To assess a possible role for GliG in protection against oxidative stress, 
anti-fungal drug detoxification or gliotoxin sensitivity, comparative phenotypic 
analysis of A. fumigatus !gliG and wild-type was performed under these 
conditions (described in Section 2.2.10 and Table 4.2) which would identify any 
altered phenotype observed in the mutant strain and help identify a role for gliG. 
To first assess whether the loss of gliG affected growth rate of A. fumigatus 
!gliG the strain was grown with the wild-type on AMM only (Figure 4.5) and 
no difference in growth rate between the two strains was observed. No 
significant difference in the growth rate of A. fumigatus !gliG was observed for 
the majority of conditions tested. 
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Table 4.2. Summary of phenotypic assays performed on A. fumigatus wild-type and !gliG. The observed difference between wild-type and 
mutant is noted. 
 
 
 
 
 
 
 
 
 
 
 
Compound Tested Concentration Phenotype Observation (Growth of !gliG in 
comparison to wild-type  
Hydrogen Peroxide 
(H2O2) 
(Figure 4.6) 
1 mM 
2  mM cdscdscds 
5 mM 
Oxidative Stress No difference 
Slight difference at 67 hr (ns)   
Neither strain grew 
Voriconazole 
(Figure 4.7) 
0.15 µg/ml 
0.25 µg /ml 
Anti-fungal sensitivity No difference 
No difference 
Amphotericin B 
(AmpB) 
(Figure 4.7) 
1 µg /ml 
2 µg/ml 
5 µg/ml 
Anti-fungal sensitivity Neither strain grew 
 for all concentrations  
tested 
Gliotoxin 
(Figure 4.8) 
10 µg/ml 
30 µg/ml 
50 µg/ml 
Gliotoxin sensitivity No difference 
ns: not significant  
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Figure 4.5. Growth rate of A. fumigatus !gliG and wild-type. A. fumigatus 
AF293 and !gliG were incubated on AMM agar only plates. Radial growth 
(mean ± standard deviation) is shown at 67 hr. No statistically significant 
difference in growth rate was observed between the two strains. The data were 
generated using two-way ANOVA analysis on three biological replicates (n = 
3).  
Incubation Period (hr) 
Wild-type  
!gliG  
!   
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4.2.3.1 Phenotypic Analysis of A. fumigatus !gliG in Response to H2O2 
Induced Oxidative Stress 
Plate assays were performed to determine the response of gliG to 
peroxide-induced oxidative stress by using the oxidising agent H2O2. Both wild-
type and !gliG were grown on AMM agar plates with a range of H2O2 
concentrations (1, 2 and 5 mM) (Section 2.2.10 and Table 4.2). Radial growth 
was observed at 24 hr time points (Figure 4.6). The data were analysed, as 
previously mentioned, on three biological replicates (n = 3). A. fumigatus !gliG 
exhibited a decrease in growth when exposed to 2 mM H2O2 after 67 hr (P < 
0.01; ±0.09). No significant difference in growth was observed between the two 
strains for the remaining time intervals and no statistically significant difference 
was observed in the presence of 1 mM H2O2. No growth was observed for the 5 
mM H2O2 concentration for either strain, indicating that this concentration was 
inhibitory.  
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A 
 
 
 
 
 
 
B 
 
 
 
 
 
Figure 4.6. Effect of peroxide-induced oxidative stress on A. fumigatus !gliG 
and wild-type when exposed to H2O2. (A) Growth of A. fumigatus !gliG and 
AF293 upon exposure to 1 mM H2O2. The growth of both strains was 
comparable in response to oxidative stress. (B) Growth of A. fumigatus !gliG 
and AF293 upon exposure to 2 mM H2O2. A. fumigatus !gliG exhibited a 
decrease in growth when exposed to 2 mM H2O2 after 67 hr (P < 0.01). All the 
data was analysed using two-way ANOVA analysis on three biological 
replicates (n = 3). Data display mean ± SD of three independent experiments. 
Incubation Period (hr) 
Wild-type  
!gliG  
!   
Incubation Period (hr) 
Wild-type  
!gliG  
!   
** 
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4.2.3.2 Phenotypic Analysis of A. fumigatus !gliG in response to Anti-
fungal Agents 
4.2.3.2.1 Phenotypic Analysis of A. fumigatus !gliG in response to 
Voriconazole  
A. fumigatus AF293 wild-type and !gliG were exposed to voriconazole 
(0.15 and 0.25 µg/ml). Radial growth was observed at 24 hr time periods 
(Figure 4.7). The data was analysed with two-way ANOVA on three biological 
replicates (n = 3). The growth rate between the two strains at 16 hr showed that 
A. fumigatus !gliG appeared to germinate slower, however after 26 hr this 
difference was gone. The growth rate at each time point thereafter was 
comparable with no statistically significant difference observed.  
 
4.2.3.2.2 Phenotypic Analysis of A. fumigatus !gliG in response to 
Amphotericin B 
A. fumigatus AF293 wild-type and !gliG were exposed to AmpB (1, 2 
and 5 µg /ml). Radial growth was observed at 24 hr time periods, however, no 
growth was observed for either A. fumigatus AF293 or !gliG (data not shown). 
This confirmed that the concentrations of AmpB used were inhibitory and that a 
lower concentration titration needs to be performed.  
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Figure 4.7. Susceptibility of A. fumigatus !gliG to the anti-fungal agent 
voriconazole. (A) Growth of A. fumigatus !gliG and AF293 upon exposure to 
0.15 µg/ml voriconazole. The growth of both strains were comparable in 
response to this concentration of the anti-fungal agent. (B) Growth of A. 
fumigatus !gliG and AF293 upon exposure to 0.25 µg/ml voriconazole. The 
growth rates of both strains was comparable in response to this concentration of 
the anti-fungal agent. All data were generated using two-way ANOVA analysis 
on three biological replicates (n = 3). 
Wild-type  
!gliG  
!   
Incubation Period (hr) 
Wild-type  
!gliG  
!   
Incubation Period (hr) 
A 
B 
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4.2.3.3 Phenotypic Analysis of A. fumigatus !gliG in response to Gliotoxin 
To investigate whether gliG played a role in self-protection against 
gliotoxin, both strains were exposed to a range of gliotoxin concentrations (10, 
30 and 50 µg/ml). As a positive control, A. fumigatus !gliT was used for 
comparison as this strain is sensitive to gliotoxin at 10 µg/ml and the use of this 
assay was sufficient in the identification of a role for gliT in self-protection 
against exogenous gliotoxin (Schrettl et al., 2010). Radial growth for all strains 
was monitored at 24 hr intervals (Figure 4.8). The data were analysed with two-
way ANOVA on two biological replicates (n = 2). Similar growth was observed 
for A. fumigatus AF293 and !gliG when exposed to three gliotoxin 
concentrations. This confirmed that gliG did not play a primary role in self-
protection against gliotoxin and contrasted to the reduced growth rate of A. 
fumigatus !gliT, in comparison to the ATCC46645 wild-type, observed upon 
exposure to three gliotoxin concentrations (P < 0.001). Images of all strains 
growing in the presence of gliotoxin is shown in Figure 4.9.  
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Figure 4.8. Sensitivity of A. fumigatus !gliG to gliotoxin. (A) Growth of A. 
fumigatus !gliG, AF293 and !gliT
46645
 upon exposure to gliotoxin (10 µg/ml). 
The growth of A. fumigatus !gliG and AF293 were comparable. A. fumigatus 
!gliT exhibited reduced growth in comparison to A. fumigatus !gliG and 
AF293 (P < 0.001). (B) Growth of A. fumigatus !gliG, AF293 and !gliT upon 
exposure to gliotoxin (30 µg/ml). The growth of A. fumigatus !gliG and AF293 
were comparable. The growth of A. fumigatus !gliT was completely inhibited at 
this concentration (P < 0.001). (C) Growth rate of A. fumigatus !gliG, AF293 
and !gliT upon exposure to gliotoxin (50 µg/ml). The growth rates of A. 
fumigatus !gliG and AF293 were comparable. The growth of A. fumigatus 
!gliT was completely inhibited at this concentration (P < 0.001). All the data 
were generated using two-way ANOVA analysis on two biological replicates (n 
= 2).  
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Figure 4.9. Sensitivity of A. fumigatus AF293, !gliG and !gliT to gliotoxin (0, 
10, 30 and 50 µg/ml). Conidia of AF293, !gliG and !gliT (5 x10
3 
conidia per 
spot) were point inoculated onto AMM plates containing the relevant gliotoxin 
concentration and incubated at 37 °C for 72 hr. Images were taken at 72 hr.  
AF293  !gliG
AF293
 !gliT 
46645 
AMM 
 
10 µg/ml 
 
30 µg/ml 
 
50 µg/ml 
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4.2.4 Comparative metabolite profiling of A. fumigatus !gliG and wild-type  
Phenotypic analysis of A. fumigatus !gliG in response to oxidative stress 
and anti-fungal susceptibility revealed comparable growth between both mutant 
and wild-type. Also phenotypic analysis of both strains in response to gliotoxin 
revealed that A. fumigatus !gliG was not sensitive to exogenous gliotoxin. This 
confirmed that gliG did not play a role in self-protection against gliotoxin and 
indicated an alternative role for gliG and led to the analysis of A. fumigatus 
!gliG and wild-type metabolite extracts by RP-HPLC analysis.  
 
4.2.4.1 Analysis of A. fumigatus !gliG!
akuB
 and !akuB metabolite profiles 
by RP-HPLC 
Culture supernatants of A. fumigatus wild-type (!akuB) and !gliG were 
collected after growth in AMM (24, 48, 72 hr; 37 °C). The supernatants were 
then subjected to organic extraction prior to RP-HPLC analysis (Section 2.2.10). 
In advance of the comparison of metabolic profiles from A. fumigatus wild-type 
(!akuB) and !gliG, pure gliotoxin was analysed by RP-HPLC (Section 2.2.10). 
Gliotoxin (2 µg) eluted with a retention time (RT) = 14.4 min (peak area 1320) 
(Figure 4.10). Comparison of the metabolite profiles from A. fumigatus !akuB 
and !gliG at 48 hr revealed that A. fumigatus !gliG did not produce gliotoxin. 
However, an alternative metabolite, initially termed M12.3, was evident with RT 
= 12.3 min instead of gliotoxin (Figure 4.11). Gliotoxin was evident in the RP-
HPLC profile at 48 hr of A. fumigatus !akuB (RT = 14.4 min) (Figure 4.11). 
The absence of gliotoxin in A. fumigatus !gliG coincided with the appearance 
of a new metabolite. This strongly indicated that gliG played a role in 
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biosynthesis of gliotoxin, since gliotoxin was completely absent in A. fumigatus 
!gliG and the appearance of an alternative metabolite represented a possible 
biosynthetic intermediate from the gliotoxin biosynthetic pathway.  
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Figure 4.10. RP-HPLC analysis of gliotoxin standard (Sigma-Aldrich). 
Gliotoxin (2 µg) elutes at a RT = 14.430 min with a peak area of 1320. 
Absorbance detection was performed at 254 nm.  
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Figure 4.11. Comparative RP-HPLC analysis of A. fumigatus !akuB (wild-
type) and !gliG!
akuB
 metabolite profiles. Organic extracts of culture 
supernatants (24, 48, 72 hr; 37°C) were subjected to HPLC analysis at 254 nm. 
(A) A. fumigatus !akuB wild-type strain at 24 hr showed a small amount of 
secreted gliotoxin (RT = 14.486 min). (B) A. fumigatus !gliG
!akuB at 24 hr did 
not secrete gliotoxin as evidenced by the lack of the metabolite at RT = 14.486 
min. (C) A. fumigatus !akuB wild-type strain at 48 hr secreted gliotoxin 
(Retention time 14.447 min). (D) A. fumigatus !gliG!
akuB
 at 48 hr did not 
secrete gliotoxin (*), but instead an alternative metabolite, M12.3, was detected 
(RT = 12.375 min). (E) A. fumigatus !akuB wild-type strain at 72 hr secreted 
gliotoxin (RT = 14.475 min). (F) A. fumigatus !gliG
!akuB at 72 hr did not secrete 
gliotoxin. The asterix indicates gliotoxin absence.  
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4.2.4.2 Analysis of A. fumigatus AF293 and !gliG
AF293
 metabolite extracts 
by RP-HPLC 
Culture supernatants of A. fumigatus wild-type (AF293) and !gliG were 
collected after growth in AMM (48 hr; 37 °C). The supernatants were then 
subjected to organic extraction prior to RP-HPLC analysis (Section 2.2.10). 
Comparison of the metabolite extracts from A. fumigatus AF293 and !gliG at 
48 hr revealed that A. fumigatus !gliG
AF293
 did not produce gliotoxin, as had 
been observed for A. fumigatus !gliG!
akuB
 (Section 4.2.4.1) The alternative 
metabolite, M12.3, was evident with RT = 12.4 min, instead of gliotoxin. 
Gliotoxin was present in the RP-HPLC profile of A. fumigatus AF293 at 48 hr 
(RT = 14.8 min) (AF293 gliotoxin production = 784.9 ± 869.88 µg/ml; large 
error bars are accounted for by the difference in gliotoxin production from each 
culture) (Figure 4.12). (Gliotoxin production was determined by comparing 
peak area to that of the gliotoxin standard Figure 4.10). This confirmed that the 
deletion of gliG in both !akuB and AF293 abolished gliotoxin production as 
gliotoxin was completely absent in both A. fumigatus !gliG metabolite extracts. 
Also the appearance of the new metabolite M12.3 in both A. fumigatus !gliG 
extracts identified this metabolite as a putative gliotoxin biosynthetic 
intermediate.  
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Figure 4.12. Comparative RP-HPLC analysis of A. fumigatus AF293 (wild-
type) and !gliG
AF293
 metabolite profiles. Organic extracts of culture 
supernatants (48 hr; 37°C) were subjected to HPLC analysis at 254 nm. (A) A. 
fumigatus AF293 (wild-type) HPLC profile showed secreted gliotoxin (RT = 
14.820 min) indicated by the solid black arrow. (B) A. fumigatus !gliG
AF293
 
HPLC analysis did not detect gliotoxin (*), but instead an alternative metabolite, 
M12.3, was evident (RT = 12.469 min) indicated by the dashed black arrow. 
Asterix indicates gliotoxin absence.  
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4.2.3.1 Analysis of A. fumigatus gliG
C
 metabolite profiles by RP-HPLC 
Culture supernatants of A. fumigatus gliG
C
 15.1, 15.4 and 17.1 were 
collected after growth in AMM (48 hr; 37 °C). The supernatants were subjected 
to organic exraction prior to HPLC analysis (Section 2.2.10). Comparison of the 
three metabolite profiles of A. fumigatus gliG
C
 revealed gliotoxin production 
was restored in the three complemented strains (Figure 4.13) (RT = 14.8 min). 
Gliotoxin production was calculated in each of the strains; A. fumigatus gliG
C
 
15.1 = 3158 ± 63.57 µg/ml, A. fumigatus gliG
C
 15.4 = 2244 ± 1622 µg/ml and 
A. fumigatus gliG
C
 17.1 = 2583 ± 1014.7 µg/ml (large error bars accounted for 
by the difference in gliotoxin production from each culture). This value was 
determined by comparison to the gliotoxin standard (Figure 4.10). The 
production of gliotoxin  coincided with the disappearance of M12.3, which 
confirmed A. fumigatus gliG is intimately involved in gliotoxin production. 
M12.3 represents either a gliotoxin biosynthetic intermediate, or shunt 
metabolite, which occurs due to gliG absence. Clearly, M12.3 is secreted, or 
released from A. fumigatus !gliG.  
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Figure 4.13. Comparative RP-HPLC analysis of A. fumigatus gliG
C
 15.1, 15.4 
and 17.1 metabolite extracts. Organic extracts of culture supernatants (48 hr; 
37°C) were subjected to HPLC analysis at 254 nm. (A) A. fumigatus gliG
C
 15.1 
HPLC profile showed secreted gliotoxin (RT = 14.824 min) indicated by the 
solid black arrow. (B) A. fumigatus gliG
C
 15.4 HPLC profile showed secreted 
gliotoxin (RT = 14.815 min) indicated by the solid black arrow. (C) A. 
fumigatus gliG
C
 15.4 HPLC profile showed secreted gliotoxin (RT = 14.811 
min) indicated by the solid black arrow. 
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4.2.5 Virulence testing of AF293 Wild-type, !gliG and gliG
C
  
To assess the role of gliG in the virulence of A. fumigatus the different 
strains were tested in G. mellonella larvae (Kavanagh and Reeves, 2004) 
(Section 2.2.25). G. mellonella (n = 10) were infected with a known lethal dose 
of conidia (1 x 10
7 
conidia/larvae) (Renwick et al., 2006)
 
for each of the 
following strains; A. fumigatus AF293, !gliG
AF293 
and the three gliG
C
 strains. 
Larvae were also injected with sterile PBS as a control (n = 10). Infected G. 
mellonella were incubated at 30 °C for up to 96 hr with survival rates observed 
at 24 hr time points (24, 48, 72 and 96 hr) (Section 2.2.25). Kaplan-Meier 
survival curves were generated using log-rank (Mantel-Cox) analysis for 
infection with A. fumigatus AF293 and A. fumigatus !gliG. This analysis was 
performed with a biological triplicate and with technical repeats (Figure 4.14) 
and although increased larval survival was observed following A. fumigatus 
AF293 infection compared to A. fumigatus !gliG infection, the difference was 
not statistically significant. Images of the infected G. mellonella larvae at 48 hr 
showed that larvae infected with A. fumigatus !gliG exhibited a higher degree 
of melanisation than those infected with AF293 wild-type or either of the 
complemented gliG
C
 strains (Figure 4.14). 
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Figure 4.14. Survival analysis of G. mellonella larvae infected with conidia of 
A. fumigatus !gliG, AF293 and gliG
C
 15.1, 15.4 and 17.1. (A) The survival 
percentage of G. mellonella infected with A. fumigatus !gliG
AF293
 and AF293 (n 
= 10). Upon observation more larvae infected with A. fumigatus AF293 
survived at each time point in comparison to larvae infected with A. fumigatus 
1 2 3 
4 5 6 
A 
B 
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!gliG
AF293
 however, this observation was not statistically significant (Log-rank 
Mantle-Cox). (B) Images of larvae infection at 48 hr. A higher degree of 
melanisation was observed in A. fumigatus !gliG
AF293
 infected larvae when 
compared to AF293 and the three gliG
C
 infected larvae.  
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4.3 Discussion 
The deletion of gliG independently from the genome of two A. fumigatus 
strains provided an opportunity to functionally investigate a role for gliG. GliG 
was confirmed as a GST with activity against CDNB and EPNP. Expression 
analysis confirmed gliG was expressed in both wild-type strains (!akuB and 
AF293), and the absence of gliG expression was confirmed in both mutant 
strains (A. fumigatus !gliG!
akuB
 and !gliG
AF293
). Restoration of gliG expression 
was observed in three gliG
C
 strains (15.1, 15.4 and 17.1). A role for gliG in 
oxidative stress and anti-fungal detoxification was eliminated and gliG is not 
involved in self-protection against exogenous gliotoxin, moreover A. fumigatus 
!gliG did not produce gliotoxin. Absence of gliotoxin production in !gliG 
coincided with the accumulation of an alternative metabolite, M12.3 and 
restoration of gliotoxin production was observed in the three A. fumigatus gliG
C
 
strains. No statistically significant difference was observed between G. 
mellonella infected with conidia from A. fumigatus AF293 (wild-type) and 
those infected with !gliG
AF293
. An alternative role for this GST became 
apparent, as neither phenotypic analysis identified a role for gliG in oxidative 
stress or anti-fungal detoxification. Absence of gliotoxin production in A. 
fumigatus !gliG coincided with the production of an alternative metabolite 
M12.3 and this metabolite may represent a on – or off – pathway gliotoxin 
biosynthetic intermediate.  
The data presented in this Chapter correlate with previously reported data 
where exogenous gliotoxin regulates the expression of genes within the 
gliotoxin gene cluster (Cramer et al., 2006). Expression of A. fumigatus gliG 
was evident in !akuB (wild-type) upon exposure to gliotoxin (5 µg/ml), no 
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expression of A. fumigatus gliG was evident in !gliG!
akuB 
upon exposure to 
gliotoxin (5 µg/ml), as expected. In contrast to gliotoxin-induced expression of 
A. fumigatus gliG in !akuB, expression of A. fumigatus gliG was detectable in 
AF293 (wild-type) without the addition of exogenous gliotoxin. Deletion of 
gliG resulted in the absence of expression in !gliG
AF293
 and expression was 
restored in the three gliG
C 
strains which contained the full gliG coding 
sequence. With respect to A. fumigatus gliT, Schrettl et al. (2010) identified the 
presence of two mutations (C23R and E160G) in the open reading frame of 
gliH, a flanking gene of gliT. Semi-quantitative RT-PCR confirmed that the two 
flanking genes, gliH and gliF, were both expressed in !gliT
26933
. Relatedly, 
expression of the two flanking genes, gliM and gliK, to gliG was confirmed in 
A. fumigatus !gliG
AF293
 by Northern analysis. This confirmed that the deletion 
of gliG did not affect the overall expression of flanking genes, however an 
increase in expression of gliM and gliK was observed in A. fumigatus 
!gliG
AF293
. Functional analysis performed on A. fumigatus gliK showed that it 
may be involved in the secretion of gliotoxin (Gallagher, 2010). The absence of 
A. fumigatus gliG directly affected the expression of both the putative gliM O-
methyltransferase and gliK. An up-regulation of expression in both genes was 
observed in A. fumigatus !gliG
AF293
 which was notable in comparison to the 
AF293 wild-type expression. The reason for this increase in gene expression 
will become apparent after full structural elucidation of M12.3 which implicates 
both genes in the production and secretion of M12.3 from A. fumigatus !gliG, 
this will be discussed in Chapter 5.  
Work performed prior to the commencement of the work described here 
confirmed through analysis of recombinant A. fumigatus GliG that it was a GST 
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(Carberry, 2008). Carberry (2008) showed rGliG exhibited GST activity against 
common GST substrates CDNB (SA: 0.21 U/mg) and DCNB (SA: 0.09 U/mg). 
This biochemical analysis confirmed the putative GST function. rGliG also 
exhibited low, but reproducible glutathione reductase activity (SA: 0.01 U/mg) 
(Carberry, 2008). Work presented here showed the activity of rGliG against an 
epoxide-containing substrate EPNP (SA: 2.3 ± 0.122 U/mg) which was 12-fold 
higher when compared to the activity against CDNB substrate (SA: 0.2 ± 0.1 
U/mg). This indicates that A. fumigatus gliG exhibits differential GST activity 
to other characterised GST in A. fumigatus (Burns et al., 2005). Enzyme studies 
of native GliG are important to fully assess the in vivo activity of the enzyme. 
GST enzymatic activity analysis was performed on protein lysates produced 
from A. fumigatus AF293 (wild-type) and !gliG
AF293
 using EPNP as a substrate. 
A. fumigatus !gliG
AF293
 protein lysates exhibited 17 % less GST activity when 
compared to the activity of the wild-type protein lysates. The reduced activity 
can be accounted for by the absence of native GliG from protein lysates. 
However, as A. fumigatus AF293 contains 26 putative GST, the activity 
observed in the !gliG
AF293
 can be attributed to some, or all, of the other 
predicted GST in the A. fumigatus genome (Appendix I) which were potentially 
present in both wild-type and mutant protein lysates.  
Comparative phenotypic analysis of A. fumigatus !gliG and AF293 wild-
type was performed against a range of compounds that were known to induce 
cellular stresses (H2O2 induced oxidative stress, anti-fungal susceptibility and 
gliotoxin sensitivity). Other GST from A. fumigatus (gstA and gstC), A. nidulans 
(gstA and gstB), S. pombe (gst1 and gst2) and S. cerevisiae (ure2), are known to 
be induced by H2O2 (Fraser et al., 2002; Veal et al., 2002; Rai et al., 2003; 
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Burns et al., 2005; Sato et al., 2009). The S. cerevisiae Gtt1p GST was shown 
not to be involved in protection against oxidative damage of membranes (Choi 
et al., 1998). No altered phenotype was observed in A. fumigatus !gliG upon 
exposure to 1 mM H2O2 and no altered phenotype was observed upon exposure 
to 2 mM H2O2 up to 48 hr. However, A. fumigatus !gliG
AF293
 exhibited a 
reduced growth rate at 67 hr (P < 0.01) upon exposure to 2 mM H2O2. Previous 
expression analysis showed that A. fumigatus gstA and gstB were induced up to 
three hr post-induction with H2O2 (5 mM) (Burns et al., 2005). This infers that 
an altered phenotype would be expected at earlier time points and would not be 
expected after 67 hr exposure. A. fumigatus AF293 and !gliG
AF293
 did not grow 
when exposed to 5 mM H2O2 indicating that this concentration was inhibitory to 
both strains.   
Veal et al. (2004) showed that three S. pombe GST (gst1, gst2 and gst3) 
were involved in anti-fungal detoxification as three separate deletions of each of 
these genes resulted in increased sensitivity to the anti-fungal drug fluconazole. 
Expression of A. fumigatus gliG was observed upon exposure to AmpB (0.32 
µg/ml) 1 hr post-induction, however no expression was observed 2 and 4 hr post 
induction (Figure 4.1) Reeves; unpublished). The role of A. fumigatus gliG in 
mediating an anti-fungal response towards voriconazole was eliminated as no 
altered phenotype was observed upon exposure to concentrations 0.15 and 0.25 
µg/ml. No growth of either A. fumigatus !gliG and wild-type was observed in 
the presence of AmpB, however the concentrations tested (1, 2 and 5 µg/ml) 
were more than likely inhibitory for growth. To eliminate gliG in mediating 
anti-fungal detoxification a more extensive range of anti-fungals need to be 
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tested, however the data presented in this chapter confirm it does not play a role 
in the detoxification of voriconazole.  
A. fumigatus gliG is not involved in protection against oxidative stress, or 
anti-fungal drug detoxification. However, the results presented here confirm a 
role for gliG in gliotoxin biosynthesis. Schrettl et al. (2010) and Scharf et al. 
(2010) have both shown that A. fumigatus gliT is directly responsible for 
oxidising and reducing gliotoxin, a process which is a key component in the 
self-protection against, and the biosynthesis, of gliotoxin. A. fumigatus !gliT 
exhibited sensitivity to exogenous gliotoxin (10 µg/ml) and restoration of gliT 
abrogated this sensitivity (Schrettl et al., 2010). Exposure of A. fumigatus 
!gliG
AF293
 to gliotoxin (10, 30 and 50 µg/ml) revealed no comparable difference 
between the mutant and wild-type strains. In this study, A. fumigatus !gliT was 
used as a positive control for gliotoxin sensitivity with the expected sensitivity 
of this strain observed at 10 µg/ml. The difference in A. fumigatus !gliT 
sensitivity to gliotoxin in comparison to the respective wild-type (ATCC 46645) 
was statistically significant (P < 0.001). This compared to the lack of sensitivity 
exhibited by A. fumigatus !gliG upon exposure to the same gliotoxin 
concentration (10 µg/ml) and confirms that A. fumigatus gliG does not play a 
role in self-protection against the toxic effects of gliotoxin.  
Neither A. fumigatus !gliG strains (!gliG
AF293
 and !gliG!
akuB
) produced 
gliotoxin and instead produced an alternative metabolite, M12.3. 
Complementation of the gliG coding sequence restored gliotoxin production in 
the three gliG
C
 strains. This confirms that the absence of gliotoxin and the 
production of M12.3 is due to the deletion of gliG and is the first report of the 
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identification of an on- or off-pathway gliotoxin biosynthetic intermediate. 
Moreover, the accumulation of this metabolite in the supernatant of !gliG 
cultures is the first identification of a biosynthetic intermediate of gliotoxin 
detectable in culture supernatants. This compound has undergone full structural 
elucidation, and this will be detailed in the Chapter 5.  
Earlier studies on the gliotoxin cluster involved the generation of 
gliotoxin-deficient gli mutant strains (gliP and gliZ) and focused on whether 
these mutant strains exhibited attenuated virulence (Bok et al., 2006; Cramer et 
al., 2006; Kupfahl et al., 2006; Sugui et al., 2007; Spikes et al., 2008). As A. 
fumigatus !gliG does not produce gliotoxin it was necessary to determine 
whether the absence of gliotoxin in this strain altered the virulence in the G. 
mellonella model. The pathogenicity of A. fumigatus tested in G. mellonella is 
equivalent to that seen in the mouse infection model (Slater et al., 2010). 
Survival analyses performed using the G. mellonella insect model showed no 
statistically significant differences upon infection with wild-type in comparison 
to !gliG which shows that gliG plays a minimal role in the virulence of A. 
fumigatus infected insect larvae. However, upon observation of infected larvae 
(Figure 4.14) slightly higher melanisation in A. fumigatus !gliG-infected G. 
mellonella was observed. Melanisation is the key defence of G. mellonella 
whereby the deposition of melanin on the microbe occurs within the 
haemolymph (Kavanagh and Reeves, 2004) and is utilised against a range of 
pathogens during infection. The observation of a tendancy towards a higher 
degree of melanisation caused by infection with the mutant strain indicates that 
the mutant strain may produce a slightly more toxic compound than gliotoxin. 
As this higher degree of melanisation indicates a faster immune response to 
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infection with A. fumigatus !gliG conidia, this observation may be directly 
related to the presence of M12.3 instead of gliotoxin and that perhaps this 
metabolite may elicit a protective immune response.  
In summary, gliG expression in A. fumigatus was observed in both !akuB 
and AF293 wild-type strains (with and without gliotoxin induction, 
respectively). A. fumigatus gliG was not expressed in !gliG!
akuB
 and !gliG
AF293
, 
as expected. Expression of gliG was restored in the three gliG
C
 complemented 
strains. GliG has been confirmed as a GST (Carberry, 2008) and shows a 12-
fold increase in activity against EPNP, when compared to CDNB. As mentioned 
in Chapter 1, substrate specificity is an important criterion for GST 
classification. So the confirmation of higher SA towards EPNP compared to 
CDNB may support an alternative metabolic role, which is hypothesised to be 
biosynthesis of gliotoxin for this GST. GliG does not play a role in H2O2 
induced oxidative stress and anti-fungal drug detoxification of voriconazole and 
no role in self-protection against exogenous gliotoxin has been detectable for 
gliG. The metabolic profile of A. fumigatus !gliG supernatant showed gliotoxin 
was absent and instead an alternative metabolite, M12.3 was produced. This 
confirms that the GST-conjugating activity of GliG has a biosynthetic role in 
gliotoxin production in A. fumigatus and represents a new role for GST which 
will assist in future classification of this enzyme. The nature of M12.3 will help 
identify the role of GliG in gliotoxin biosynthesis and confirm the specific role 
of gliG, a GST, within the gliotoxin cluster.  
  
 
 
 
Chapter 5 
 
 
Structural elucidation of M12.3 produced by A. 
fumigatus !gliG  
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5. Chapter 5 Characterisation of M12.3  
5.1 Introduction 
The deletion of A. fumigatus gliG resulted in a strain that did not produce 
gliotoxin (Chapter 4). Comparative phenotypic analysis revealed that A. 
fumigatus !gliG exhibited no sensitivity to the oxidizing agent H2O2 or to the 
antifungal compounds AmpB or voriconazole. The mutant strain showed no 
sensitivity to exogenous gliotoxin (10 – 50 µg/ml), confirming that GliG does 
not play a role in self-protection against gliotoxin (Schrettl et al., 2010). 
Comparative RP-HPLC analysis of A. fumigatus AF293 wild-type and !gliG 
culture extracts revealed the absence of gliotoxin production in the A. fumigatus 
!gliG strains. Instead, an alternative metabolite, M12.3 was identified by RP-
HPLC analysis in the culture extracts of A. fumigatus !gliG. Restoration of 
gliotoxin production coincided with complementation of A. fumigatus gliG into 
the !gliG mutant. Structural elucidation of M12.3 will determine whether the 
metabolite contains a disulphide bridge or thiol groups and will inform whether 
it is an on-pathway intermediate or an off-pathway shunt product of gliotoxin, 
produced in the absence of gliG. Ultimately, this will confirm the role A. 
fumigatus gliG plays in gliotoxin biosynthesis. (Bose et al., 1968a; Bose et al., 
1968b) 
Structural characterisation of metabolites, like gliotoxin, is usually 
performed using techniques such as HPLC, high-resolution mass spectrometry 
(HRMS), NMR and elemental analysis (Johnson et al., 1943; Beecham et al., 
1966; Kaouadji et al., 1990; Nielsen and Smedsgaard, 2003; Forseth and 
Schroeder, 2010). As discussed in Chapter 4, HPLC analysis confirms presence 
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or absence of metabolites based on comparative profile analysis (Frisvad, 1987). 
HRMS confirms the mass and chemical formula of the compound and NMR 
determines the structure by analysing bond coupling interactions between 
carbons and protons (Nielsen and Smedsgaard, 2003; Frisvad et al., 2009; 
Bothwell and Griffin, 2010). Elemental analysis (CHNS) determines the 
composition of the metabolite (i.e., the carbon, hydrogen, oxygen, nitrogen and 
sulphur content). The accumulation of data using these techniques reveals the 
structure of the metabolite of interest.  
Confirmation of gliotoxin production is performed by HPLC analysis 
and/or LC-MS analysis. LC-MS detection of gliotoxin involves identification of 
the gliotoxin parent ion, which has an m/z value of 327 (Bok et al., 2006; 
Kupfahl et al., 2006; Spikes et al., 2008; Scharf et al., 2010; Schrettl et al., 
2010), followed by the identification of fragment ions of gliotoxin, which have 
m/z values of 263, 245 and 227, respectively (Bok et al., 2006; Kupfahl et al., 
2006; Schrettl et al., 2010). The fragment ions of gliotoxin correspond to 
dethiogliotoxin, dethiogliotoxin with a neutral loss of water and dethiogliotoxin 
plus the neutral loss of two waters, respectively (Spikes et al., 2008). The 
presence of a molecular ion with a mass of 327 m/z is confirmation that 
gliotoxin is present. This is the standard LC-MS method for gliotoxin 
identification (Bok et al., 2006; Scharf et al., 2010; Schrettl et al., 2010).  
NMR spectroscopy is a technique used to structurally characterise 
compounds and was first carried out using 
1
H nuclei (spin state of 1/2) and later 
studied for 
13
C (spin state of 1/2) (Bruice, 2001). It has become a prominent 
technique for the structural determination of organic compounds, in particular, it 
has been applied to the characterisation of natural products such as secondary 
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metabolites produced by bacteria and fungi (Abel et al., 1999; Nielsen and 
Smedsgaard, 2003; Sumarah et al., 2008). NMR analysis has been used for the 
structural elucidation of gliotoxin and other ETP/DKP metabolites (Kaouadji et 
al., 1990; Guo et al., 2009; Wang et al., 2010). These analytical methods 
employed several different NMR experiments including; 
1
H, 
13
C, DEPT-135 
(distortionless enhancement by polarisation transfer), COSY (correlated 
spectroscopy), HMBC (heteronuclear multiple-bond correlation) and HMQC 
(heteronuclear multiple-quantum correlation) and the accumulation of data from 
all these NMR experiments confirms the structure of the compound of interest. 
1
H NMR spectra are generated from chemically equivalent protons which 
are in the same environment (Bruice, 2001). To identify the compound of 
interest a reference compound (e.g., Tetramethylsilane (TMS)) is mixed with 
the unknown compound. The signals for the compound of interest are compared 
to their distance from the TMS signals, this difference is termed the chemical 
shift (") and is measured within the range 0 – 10 ppm (Clayden et al., 2001). 
13
C 
NMR follows the same principle as 
1
H NMR, whereby the number of 
13
C 
signals in the spectrum informs as to how many different kinds of carbons are 
present in the compound. 
13
C NMR relies on the identification of the 
13
C isotope 
which has a natural abundance of 1.108 % and more advanced instrumentation 
allows for analysis of multiple scans of the 
13
C-containing compound which can 
be accumulated together to determine the different 
13
C signals. The main 
advantage of 
13
C NMR is that the chemical shift range is over approximately 
220 ppm and carbon atoms with no directly bonded H can be observed 
(McMurry, 2004). Relative positions of the signals depend on the same factors 
that determine 
1
H NMR signals. Carbon atoms in electron-dense environments 
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produce low frequency signals and those close to electron-withdrawing groups 
produce high frequency signals (Bruice, 2001).  
Two-dimensional (2-D) NMR is used to help determine the structure of 
more complex biomolecules (Clayden et al., 2001) which tend to have more 
complicated structures that can cause signal overlap and this makes structure 
determination more difficult. 
1
H and 
13
C spectra, discussed previously, have one 
frequency axis and one intensity axis, whereas 2-D NMR spectra have two 
frequency axes and one intensity axis. One of the most common 2-D spectra 
involves 
1
H – 
1
H shift correlations which identifies protons that are coupled to 
each other, this COrrelated SpectroscopY is more commonly known as COSY 
(
1
H – 
1
H COSY). The COSY spectrum presents a 2-D contour map, with each 
dimension representing proton chemical shifts and the contours indicating signal 
intensity (Forseth and Schroeder, 2010). The diagonal axis which runs from 
bottom left to top right shows peaks which are easily identifiable in the 1-D 
spectrum. Peaks off the diagonal axis are known as cross peaks. The cross peaks 
indicate pairs of protons that are coupled, information is obtained from cross 
peaks below the diagonal. The cross peaks above the diagonal give the same 
information as those below (Bruice, 2001). Heteronuclear single quantum 
coherence (HSQC) is used to follow 
1
H nuclei which are attached to 
13
C nuclei 
and the contour plots show the cross peaks and indicates the particular carbon 
and hydrogen bonding (Clayden et al., 2001). Heteronuclear multiple bond 
coherence (HMBC) is similar to HSQC and detects multiple-bond coupling over 
two or three bonds and can detect coupling over 4 bonds in conjugated systems 
(Bruice, 2001). 
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Another 
13
C NMR technique is distortionless enhancement by polarization 
transfer (DEPT) which can distinguish between methine (CH), methylene (CH2) 
and methyl (CH3) groups (Clayden et al., 2001) and carbons which are not 
attached to hydrogens disappear upon DEPT analysis (Bruice, 2001). There are 
three DEPT spectra which can be generated, DEPT-45, DEPT-90 and DEPT-
135 (Figure 5.1). The result of this analysis is a carbon spectrum that shows the 
multiplicities (CH, CH2 and CH3). Generally, there tends to be little confusion 
between the chemical shifts of CH and CH3 protons so DEPT-135 analysis is 
sufficient to discriminate between each type of carbon atom. Signals for 
methine and methyl groups are above the line and signals for methylene groups 
are below the line (Figure 5.1) (Bruice, 2001). 
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Figure 5.1. Schematic representation of distortionless enhancement by 
polarisation transfer (DEPT) analysis. This NMR method distinguishes between 
methine (CH), methylene (CH2), and methyl (CH3) signals Adapted from 
Bruice. (2001). 
13
C  
DEPT 45  
DEPT90 
DEPT135 
C     CH       CH2    CH3  
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Early investigation into the structure of gliotoxin employed 
1
H and 
13
C 
NMR (Figure 5.2). (Kaouadji et al., 1990) and confirmed the correct structure of 
gliotoxin and revised a previously reported structure (Cole and Cox, 1981). The 
1
H NMR spectrum identified proton signals (Table 5.1) in the diene at 4.82, 
5.79, 5.95 and 5.99 ppm which correlated with protons located at position 6, 9, 
8 and 7 respectively. Signals at 2.96, 3.76, 4.82 ppm revealed the location of the 
protons at position 10 and 5 in the five-membered ring. The protons in the  DKP 
ring were detected by signal at 3.21 ppm, which confirmed the CH3 group at 
position 2. Signals at 4.26 and 4.43 ppm illustrated the protons located at 
position 3 and the signal at 3.55 ppm confirmed the protons of the OH at 
position 3a (Kaouadji et al., 1990). 
13
C NMR (Table 5.1) revealed the carbons in 
the diene by signals in the spectrum at 73.1, 130.1, 123.3 and 120.2 ppm which 
corresponded to carbons 6 – 9 respectively. Carbons in the five-membered ring 
were illustrated by the detection of signals at 69.7, 130.8 and 36.6 ppm which 
correlated to carbons 5a, 9a and 10, respectively (Kaouadji et al., 1990). 
Carbons in the DKP ring with the disulphide bridge were identified by signals at 
166.0, 75.6, 60.7 and 165.1 ppm which corresponded to carbons at position 1, 3, 
3a and 4, respectively (Kaouadji et al., 1990).  
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Figure 5.2. Gliotoxin with the 
1
H annotation (Kaouadji et al., 1990).  
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Table 5.1. 
1
H and 
13
C NMR data of gliotoxin in CDCl3 (adapted from (Kaouadji 
et al., 1990).  
1
H  Gliotoxin "  ppm 
Me-2 3.21 
H-3aA 4.43 
H-3aB 4.26 
3a-OH 3.55 
H-5a 4.82 
H-6 4.82 
6-OH 5.81 
H-7 5.99 
H-8 5.95 
H-9 5.79 
H-10A 3.76 
H-10B 2.96 
 
 
 
13
C  Gliotoxin "  ppm 
C-1 166.0 
C-3 75.6 
C-3a 60.7 
C-4 165.3 
C5a 69.7 
C-6 73.1 
C-7 130.1 
C-8 123.3 
C-9 120.2 
C-9a 130.8 
C-10 36.6 
C-10a Under CDCl3 peak  
2-Me 27.5 
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The identification of bioactive metabolites from various fungal species 
has been improved with more sophisticated NMR techniques, such as more 
powerful instrumentation for 
1
H and 
13
C NMR and the use of 2-D 
1
H – 
1
H 
COSY and HMBC (Nielsen and Smedsgaard, 2003; Forseth and Schroeder, 
2010; Wang et al., 2010) which help with the more complex structural 
identification (Zhang et al., 2007). Isaka et al. (2005) employed the use of 
HRMS and NMR for the structural analysis of DKP dimers (vertihemiptellide A 
and B) (Figure 5.3) which were isolated from the insect pathogenic fungus, 
Verticillium hemipterigenum. HRMS determined the molecular formula of the 
two DKPs. Vertihemiptellide A had a molecular formula of C26H28N4O6S4 and 
vertihemiptellide B had a molecular formula of C25H26N4O6S4. 
1
H, 
13
C, and 
HMBC spectral data completed the structural analysis (Table 5.2), however, the 
13
C NMR for vertihemiptellide A identified only 11 signals in the spectrum 
indicating a symmetric homo-dimer structure. The NMR data confirmed that 
one half of the molecule had two amides (two carbonyls, "C 165.0 and 163.6; 
NH, "H 7.81; NCH3, "C 29.8, "H 2.84), a benzyl group, a hydroxymethyl group, 
and two quaternary carbons ("C 78.2 and 70.5). (Isaka et al., 2005). NMR 
analysis of vertihemiptellide B indicated that the structure was non-symmetrical 
and that it lacked the N(4#)-methyl group that vertihemiptellide B contained 
(Isaka et al., 2005). The 
1
H NMR spectrum for vertihemiptellide B assigned the 
protons to the various groups within the compound (Table 5.2).  
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Figure 5.3. Structure of vertihemiptellide A (1) and B (2) isolated from the 
insect pathogenic fungus V. hemipterigenum (Isaka et al., 2005). 
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Table 5.2. NMR data for vertihemiptellide B in DMSO (Isaka et al., 2005) 
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1
H NMR of vertihemiptellide B (Table 5.2) dissolved in DMSO 
confirmed the location of the protons within the compound. The signal at 2.86 
ppm is due to the proton of the (N)-CH3 group at position 4 and that at 4.84 ppm 
is due to the proton from the OH group at position 7. The protons at position 8 
generated two signals which on the spectrum are located at 3.29 and 3.66 ppm, 
while those from the aromatic ring, position 10 – 14, appear between 7.18 and 
7.21 ppm on the spectrum (Isaka et al., 2005). 
13
C NMR of vertihemiptellide B 
dissolved in DMSO confirmed the position of the carbons within the compound 
(Table 5.2). On the 
13
C spectrum the signal at 30.2 ppm is generated by the 
carbon of the (N)-CH3 group at position 4 (Table 5.2). The signal at 40.0, 69.3, 
78.7, 134.3 and 164.6 ppm is due to the carbons at position 8, 7, 3, 9 and 2, 
respectively (Table 5.2). The carbons on the aromatic ring are identified at 
130.0, 128.4 and 127.5 ppm which corresponds to the carbons at 10 and 14, 11 
and 13 and 12, respectively (Table 5.2) (Isaka et al., 2005). Two-dimensional 
NMR (HMBC) helped with the assignment of protons and carbons (Table 5.2) 
and the accumulated data confirmed the structure of vertihemiptellide B (Isaka 
et al., 2005).  
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Two-dimensional NMR analysis (
1
H – 
1
H COSY and HMBC) was used in the 
identification of thirteen thiodiketopiperazines (TDKP) (epicoccin I;Figure 5.4, 
ent-epicoccin G, epicoccin J – T) produced by the endophytic fungus 
Epicoccum nigrum (Wang et al., 2010). TDKP compounds are similar to the 
ETP class with the exception that TDKP are known to contain both a single 
sulphur and/or a disulphide bridge across the piperazine ring, whereas ETP 
compounds always contain a di- to polysulphide bridge across the piperazine 
ring (Wang et al., 2010). Therefore, gliotoxin can be classified as both a TDKP 
and an ETP. 2-D analysis, 
1
H – 
1
H COSY, of epicoccin I identified the presence 
of two isolated proton spin systems (Wang et al., 2010). The presence of 
1
H – 
1
H COSY cross peaks (Figure 5.5; red boxes) from H-5 ("H 5.93), H-6 ("H 
5.88), H-7 ("H 5.59), H-8 ("H 4.55) through to H-9 ("H 4.74) and subsequent 
HMBC correlations (Figure 5.6; red circles) from both H-5 ("H 5.93) and H-9 
("H 4.74) to C-4 ("C 133.6) confirmed the presence of a six-membered ring in 
epicoccin I (C4 – C9) (Wang et al., 2010). The second six-membered ring was 
also confirmed using the 
1
H – 
1
H COSY and HMBC correlations (Wang et al., 
2010). The accumulated NMR data confirmed the structure of all thirteen 
epicoccins isolated from E. nigrum (Wang et al., 2010) 
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Figure 5.4. Structure of epicoccin I isolated from E. nigrum (Wang et al., 
2010).  
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Figure 5.5. 
1
H – 
1
H COSY spectrum of epicoccin I isolated from E. nigrum 
(Wang et al., 2010). The 
1
H – 
1
H correlations for H5 through to H-9 are 
indicated by the red boxes.  
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Figure 5.6. HMBC Spectrum of epicoccin I isolated from E. nigrum (Wang et 
al., 2010). The H-5 and H-9 correlations to C-4 are both indicated by the red 
circles.  
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The overall objectives of the work presented in this Chapter were (i) 
employ HRMS to confirm the absence of gliotoxin in A. fumigatus !gliG 
culture extracts, (ii) perform chemical analysis on A. fumigatus !gliG culture 
extracts to determine whether M12.3 contained a disulphide bridge/thiols, (iii) 
develop and implement a purification strategy to isolate and purify M12.3 from 
A. fumigatus !gliG cultures, (iv) use high-resolution MS (HRMS) on pure 
M12.3 to determine the mass and chemical formula of the metabolite, (v) 
perform 
1
H, 
13
C, 
1
H – 
1
H COSY, DEPT-135, HMBC and HMQC NMR analysis 
on the purified M12.3 and determine the structure of the metabolite, (vi) 
perform CHNS elemental analysis on the purified M12.3 to confirm absence of 
sulphur atoms, (vii) perform feeding experiments with A. fumigatus !gliG 
cultures using 
13
C-phenylalanine as a substrate, (viii) confirm the incorporation 
of 
13
C-phenylalanine into M12.3 by HRMS and 
13
C and DEPT-135 NMR 
analysis, (ix) perform feeding experiments with A. fumigatus AF293 wild-type 
cultures using M12.3 as a substrate to determine whether the fungus takes up 
the metabolite which will confirm whether M12.3 is an on-pathway 
intermediate or an off-pathway shunt product.  
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5.2 Results 
5.2.1 HRMS (LC-ToF) analysis confirms the absence of gliotoxin in !gliG 
and the presence of gliotoxin in AF293 wild-type and gliG
C
.  
The deletion of gliG from A. fumigatus resulted in a strain that did not 
produce gliotoxin, as shown by RP-HPLC in Chapter 4. Instead, A. fumigatus 
!gliG produced an alternative metabolite, M12.3. Confirmation using HRMS of 
the absence of gliotoxin in the mutant strain was necessary. LC-ToF MS 
analysis further confirmed the absence of gliotoxin in A. fumigatus !gliG
AF293
. 
Gliotoxin was confirmed to be present in A. fumigatus AF293 wild-type and in 
A. fumigatus gliG
C
 15.1. All LC-ToF analysis was performed at the Department 
of Chemistry, NUI Maynooth. 
5.2.1.1 Extracted ion chromatogram (EIC) following LC-ToF MS analysis  
Absence of gliotoxin production in A. fumigatus !gliG
AF293
 was 
confirmed by LC-ToF MS. Briefly, organic extracts of A. fumigatus wild-type, 
!gliG
AF293
 and one complemented strain, gliG
C
 15.1 were subjected to LC-ToF 
MS anaysis (Section 2.2.23.1). Data acquisition was performed on the different 
extracts by searching for gliotoxin based on the chemical formula 
(C13H14N2O4S2). Extracted ion chromatograms (EICs) from A. fumigatus !gliG 
did not contain gliotoxin (Figure 5.7). EIC identified a metabolite at RT = 10.5 
min in the gliotoxin standard, AF293 wild-type and gliG
C 
15.1 (Figure 5.7). 
This 10.5 min metabolite was identified as gliotoxin, with subsequent mass 
determination described in Section 5.2.1.2. The overall profile of the A. 
fumigatus !gliG extract differed significantly to the other EIC from the 
gliotoxin standard, wild-type and complemented strain. 
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Figure 5.7. LC-ToF MS analysis of A. fumigatus AF293 wild-type, AF293 
gliG
C
 15.1 and !gliG organic extracts. (A) LC-ToF EIC of gliotoxin standard 
identified gliotoxin at a RT = 10.5 min. (B) LC-ToF EIC of A. fumigatus wild-
type identified gliotoxin at a RT = 10.5 min. (C) LC-ToF EIC of A. fumigatus 
gliG
C
 15.1 identified gliotoxin at a RT = 10.5 min. (D) LC-ToF EIC of A. 
fumigatus !gliG revealed a significantly different profile to the others and 
gliotoxin was absent.  
 
$ AF293 Wild-Type 
$ !gliG
AF293 
$ gliG
C
 15.1 
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5.2.1.2 MS spectra of the metabolite at RT = 10.5 min 
Extracted ion chromatograms (EIC) of gliotoxin standard, A. fumigatus 
AF293 wild-type and gliG
C
 15.1 confirmed gliotoxin presence by the 
identification of a metabolite at RT = 10.5 min, which was identified after a 
chemical formula search (Figure 5.8). This 10.5 min metabolite contained a 
molecular species with a mass of 327 m/z. Identification of gliotoxin using LC-
MS analysis requires the confirmation of the gliotoxin parent ion, 327 m/z (Bok 
et al., 2006; Kupfahl et al., 2006; Spikes et al., 2008; Scharf et al., 2010; 
Schrettl et al., 2010). High resolution LC-ToF MS analysis of the metabolite 
confirmed the presence of a molecular ion with a mass of 327 m/z (M+H)
+
 in 
the gliotoxin standard and in the extracts from A. fumigatus wild-type and gliG
C
 
15.1.  
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Figure 5.8. LC-ToF MS analysis of gliotoxin standard, A. fumigatus wild-type 
and gliG
C
 15.1. EIC identified gliotoxin at RT = 10.5 min in each of the three 
extracts, the mass spectra confirmed the presence of a molecular ion with a mass 
of 327.05 m/z (M+H)
+
. This molecular species is gliotoxin.  
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5.2.2  Structural Elucidation of metabolite M12.3 produced in the absence 
of A. fumigatus gliG. 
Once it was established with RP-HPLC and HRMS that A. fumigatus 
!gliG did not produce gliotoxin and instead produced an alternative metabolite, 
M12.3, it was critical to determine the nature of this metabolite. Full structural 
elucidation helped confirm the role of A. fumigatus gliG in gliotoxin 
biosynthesis.  
 
5.2.2.1 Reduction and alkylation of A. fumigatus culture extracts.  
To determine whether M12.3 contained a disulphide bridge or thiol 
groups a novel chemical assay was developed. This assay employed reduction 
of the disulphide bridge in gliotoxin followed by subsequent alkylation of thiols 
with an alkylation agent, 5’-iodoacetamidofluorescein (5’-IAF). Before the 
reduction and alkylation assay could be used for A. fumigatus organic extracts, 
validation was performed on pure gliotoxin (Sigma-Aldrich).  
 
5.2.2.1.1 Reduction and alkylation of pure gliotoxin  
Gliotoxin was subjected to sequential reduction and alkylation as 
described in Section 2.2.15.1, to produce labelled gliotoxin or di-
acetamidofluorescein-gliotoxin (GT-(AF)2). GT-(AF)2 was confirmed as di-
acetamidofluorescein-gliotoxin by MALDI-ToF MS, this will be discussed in 
more detail in Chapter 6. Briefly, sodium borohydride (NaBH4) reduces 
gliotoxin to the dithiol form, which is then labelled with the alkylation agent 5’-
IAF. GT-(AF)2 was then detected following RP-HPLC separation using the 
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gradient described in Table 2.10. RP-HPLC separation and absorbance detection 
at 254 nm identified GT-(AF)2 at RT =16.502 min (Figure 5.9). GT-(AF)2 was 
only detected with the addition of NaBH4. Unreacted 5’-IAF was also detected 
at RT =15.973 min. In the absence of NaBH4, GT-(AF)2 is absent and unreacted 
gliotoxin is detectable at RT =15.098 min (Figure 5.9).  
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Figure 5.9. RP-HPLC analysis of pure gliotoxin (Sigma-Aldrich) with and 
without NaBH4-mediated reduction prior to 5’ IAF labelling. (A) Gliotoxin + 
NaBH4 + 5’-IAF: Absorbance detection at 254 nm detected GT-(AF)2 with a 
A 
B 
GT-(AF)2  
5’ IAF 
5’ IAF 
GT 
% 
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retention time of 16.503 min. (B) Gliotoxin – NaBH4 + 5’-IAF: No labelling of 
gliotoxin is possible (indicated by the asterix) in the absence of NaBH4. 
Absorbance detection at 254 nm detected free gliotoxin with a retention time of 
15.089 min. 
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5.2.2.1.2 Reduction and alkylation of organic extracts from A. fumigatus 
cultures 
Reduction and alkylation of culture extracts from A. fumigatus AF293 
wild-type, !gliG and the three gliG
C
 complemented strains (15.1, 15.4 and 17.1) 
was performed (Section 2.2.20.3). Absorbance detection at 254 nm confirmed 
the absence of GT-(AF)2 in extracts from A. fumigatus !gliG (Figure 5.10). 
Metabolite M12.3 was detected at RT = 12.457 min. This chemical assay 
confirms that M12.3 does not contain a disulphide bridge or thiol group. 
Unreacted 5’-IAF was also evident at RT = 15.754 min. Absorbance detection at 
254 nm showed that GT-(AF)2 was present following RP-HPLC separation in 
culture extracts from A. fumigatus AF293 wild-type and in the three gliG
C
 
strains (15.1, 15.4 and 17.1). Absorbance detection at 254 nm identified GT-
(AF)2 at RT =16.34 min in each of the extracts (Figure 5.10).  
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Figure 5.10. RP-HPLC analysis of organic extracts from A. fumigatus AF293 
wt, !gliG and gliG
C
 15.1, 15.4 and 17.1 with NaBH4-mediated reduction prior 
to 5’ IAF labelling. (A) A. fumigatus wild-type + NaBH4 + 5’-IAF: Absorbance 
detection at 254 nm detected GT-(AF)2 with a retention time of 16.345 min. (B) 
A. fumigatus !gliG + NaBH4 + 5’-IAF: No GT-(AF)2 was detected (indicated 
by the asterix). Absorbance detection at 254 nm detected M12.3 at a RT = 
12.457 min. (C) A. fumigatus gliG
C
 15.1 + NaBH4 + 5’-IAF: Absorbance 
detection at 254 nm detected GT-(AF)2 with a retention time of 16.347 min. (D) 
E 
D 
GT-(AF)2  
GT-(AF)2  
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A. fumigatus gliG
C
 15.4 + NaBH4 + 5’-IAF: Absorbance detection at 254 nm 
detected GT-(AF)2 with a retention time of 16.340 min. (E) A. fumigatus gliG
C
 
17.1 + NaBH4 + 5’-IAF: Absorbance detection at 254 nm detected GT-(AF)2 
with a retention time of 16.346 min. 
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5.2.2.2 Purification strategy for M12.3 isolation 
Chemical analysis of A. fumigatus !gliG confirmed that M12.3 did not 
contain a disulphide bridge or thiol group. To determine the structure of M12.3, 
full structural elucidation was necessary. This required a significant amount of 
purified M12.3 (" 10 mg) (Personal communication Dr Dermot Brougham, 
Dublin City University). A purification strategy was developed to generate a 
large amount of pure material (Figure 5.11). This purification strategy employed 
the extraction and purification of M12.3 from culture extracts. Briefly, this 
involved scaling-up A. fumigatus !gliG cultures from 500 ml to 5 L (Section 
2.2.12). Fungal mycelia was harvested and the culture supernatant was collected 
in a clean duran and supernatants were organically extracted in an equal volume 
of chloroform. The chloroform extracts were dried using rotary evaporation 
(Section 2.2.13) and all the residual material was resuspended in methanol. An 
aliquot of the crude A. fumigatus !gliG extract was subjected to RP-HPLC 
analysis (Figure 5.12) and the crude methanol extract was then subjected to 
pTLC (Section 2.2.18). Once the pTLC plates were run in the solvent system, 
the M12.3 band was excised carefully and washed in acetone to solubilise 
M12.3. This acetone wash was dried using rotary evaporation. This entire 
procedure was performed repeatedly until a sufficient quantity of pure M12.3 
was obtained. To assess the purity of M12.3, an aliquot of the sample was 
subjected to HPLC analysis (Figure 5.12). The HPLC profile of purified M12.3 
confirmed that the sample was pure and therefore suitable for structural 
analysis. A total of 6.5 mg of M12.3 was generated and this was deemed a 
sufficient amount of material for subsequent analysis (Personal communication 
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Dr Ishwar Singh, Department of Chemistry, NUI Maynooth) and this was then 
used for (i) LC-ToF, (ii) NMR and (iii) Elemental analysis.  
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Figure 5.11 
!gliG 
(500 ml) 
!gliG (5 lt) 
Organic Extraction 
Rotary Evaporation 
Scale Up 
 
Figure 5.13. Purification strategy developed to isolate the required amount of M12.3 for structural elucidation. A. fumigatus !gliG cultures were scaled 
up to 5 L. The supernatant was organically extracted in CHCl3 twice. Organic extracts were dried and the crude sample subjected to pTLC. M12.3 was 
excised from the silica and washed in acetone to solubilise the compound. The acetone wash was dried under rotary evaporation. Once the compound 
was dried completely the purity was confirmed by HPLC.  
Rotary Evaporation 
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Figure 5.12. RP-HPLC profiles of A. fumigatus !gliG crude extracts and 
purified M12.3. (A) Crude extracts before pTLC purification. (B) Purified 
M12.3, which was used for structural characterisation. In total, 6.5 mg of 
purified material was obtained.  
M12.3 
A 
B 
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5.2.2.3 Structural Elucidation strategy 
After extraction and purification of M12.3, 6.5 mg of pure material was 
obtained. This material was then used to confirm the structure of the metabolite. 
Several techniques were used to ascertain the structure (Figure 5.13), (i) HRMS, 
(LC-ToF), (ii) NMR and (iii) CHNS elemental analysis. These three techniques 
determined the mass and chemical formula of the compound. 
1
H and 
13
C NMR 
spectroscopy was used to identify the different proton and carbon groups 
present in the compound. The percentage of C, H, N and S within the compound 
was determined using CHNS elemental analysis.  
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Figure 5.13. Structural Elucidation workflow. The combination of LC-MS, 
NMR and elemental analysis provided information to confirm the structure.  
Strategy Employed for the Structural Elucidation of M12.3  
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5.2.2.4 LC-ToF HRMS analysis of purified M12.3 
Mass determination of purified M12.3 was performed using LC-ToF 
analysis. The LC absorbance spectra (254 nm) identified a single molecular 
species at a RT = 9.1 min. HRMS analysis of the metabolite confirmed the 
presence of a molecular ion with a mass of 263.1027 m/z ((M+H)
+
) (Figure 
5.14). A predicted molecular formula of C13H14N2O4 was determined using 
Agilent Technologies Masshunter workstation software. The molecular formula 
lacked sulphur atoms. The presence of a sodium adduct was also evident, which 
had a mass of 285.0846 m/z ((M+Na)
+
). The absolute mass of M12.3 was 
determined to be 262.1026 u. The difference in mass between gliotoxin and 
M12.3 was 64 Da and it was recognised that this corresponded to the mass of 
two sulphur atoms.  
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Figure 5.14. LC-ToF HRMS analysis of purified M12.3 confirming the mass of 
the compound. (A) LC-ToF UV absorbance (254 nm) profile of M12.3 
(Injection volume: 10 µL) identified a single compound at RT 9.1 min. (B) Mass 
spectrum of M12.3  identified a single molecular species with a mass of 
263.1027 m/z ((M+H)
+
). The sodium adduct was also present which had a mass 
of 285.0846 m/z ((M+Na)
+
).  
B 
 
A 
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5.2.2.5 NMR Analysis of M12.3 
Several NMR experiments were carried out on the purified M12.3 
compound and conclusively confirmed the structure as 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione (Figure 5.15). NMR analysis was 
performed in collaboration with the Department of Chemistry, NUI Maynooth 
and Teagasc Ashtown Food Research Centre, Dublin. 
1
H NMR, 
13
C NMR, 
DEPT 135, COSY, HSQC and HMBC spectra were recorded in CDCN3 and 
CDCl3. The operating frequency for the 
1
H nucleus was 300 MHz and for the 
13
C nucleus 75 MHz (Bruker Avance AV300). Additional spectra were recorded 
at an operating frequency of 500 MHz for the 
1
H nucleus and 125 MHz for the 
13
C nucleus on a more powerful instrument (Bruker Avance III 500 MHz, 
Teagasc Ashtown Food Research Centre, Dublin). Chemical shifts are reported 
in ppm relative to the reference, TMS.  
The spectra revealed that the compound contained two amide carbonyl 
groups ("c 157.3 (CONH), 161.1 (CONOCH3)), a benzyl group ("c 46.5 
(CH2Ph)), a hydroxyl group at position 6 ("c 83.5 (NHCOC(OH)Bn), "H 4.93 
(NHCOC(OH)Bn)), a methoxy group ("c 62.2 (OCH3), "H 3.64 (OCH3)), and a 
1,1-disubstituted alkene ("c 100.1 (C=CH2), 134.2 (C=CH2), "H 5.00, 5.33 
(C=CH2)) (Table 5.3).  
 257 
 
 
 
 
Figure 5.15. The absolute structure of M12.3 confirmed as 6-benzyl-6-hydroxy-
1-methoxy-3-methylenepiperazine-2,5-dione. 
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Table 5.3. Table compiling all NMR and corresponding chemical shifts 
associated with the groups of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione. 
Chemical Group Chemical Shift Group 
Amide carbonyl "c 157.3 CONH 
Amide carbonyl "c 161.1 CONOCH3 
Benzyl "c 46.5 CH2Ph 
Hydroxyl (position 6) "c 83.5 NHCOC(OH)Bn 
 "H 4.93 NHCOC(OH)Bn 
Methoxy "c 62.2 OCH3 
 "H 3.64 OCH3 
1, 1-disubstituted alkene "c 100.1 C=CH2 
 "c 134.2 C=CH2 
 "H 5.00 C=CH2 
 "H 5.33 C=CH2 
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5.2.2.5.1 
1
H NMR of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione  
1
H NMR of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-
dione (CD3CN, 300 MHz) (Figure 5.16). The signals between 2.97 – 3.02 and 
3.39 – 3.44 ppm were generated by the CH2 at position 8. The signal at 3.63 
ppm is due to the (N)-OCH3 group at position 1. The signal at 4.93 ppm was 
caused by the–OH at position 6. The signals at 5.00 and 5.33 ppm are generated 
by the CH2 at position 7. The signals between 7.17 and 7.29 ppm are due to the 
H atoms at positions 10, 11, 12, 13 and 14 of the aromatic ring. The signal at 
7.23 ppm is due to the –NH at position 4.  
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Figure 5.16. 
1
H NMR of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione (CD3CN, 300 MHz). Protons at position 1, 4, 6, 
7, 8, 10, 11, 12, 13 and 14 were all identified in this spectrum. In this spectrum 
the CONH proton signal (7.23 ppm) overlaps with the signals from the protons 
of the aromatic ring (10 – 14).  
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5.2.2.5.2 DEPT 135 of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione  
DEPT 135 analysis (CD3CN, 75 MHz) determined how many CH, CH2 
and CH3 groups were present (Figure 5.17). The CH and CH3 groups are above 
the line and the CH2 groups are below the line. The signal at 46.5 ppm is due to 
the 
13
C atom of the CH2 at position 8. The signal at 62.2 ppm is generated from 
the 
13
C atoms of the CH3 of (N)-OCH3 at position 1. The signal at 100.1 ppm is 
generated from the 
13
C atom of the CH2 at position 7. The signals at 128.2, 
129.1 and 131.4 ppm are generated from the 
13
C atoms of the CH groups at 
positions 10 and 14, 11 and 13 and 12, respectively.  
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Figure 5.17. DEPT 135 NMR spectrum of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione (CD3CN, 75 MHz). The CH and CH3 groups are 
above the line and the CH2 groups are below the line. In total three CH, two 
CH2 and one CH3 groups are present in the compound. 
CH CH3  
CH2 
CH2 
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5.2.2.5.3 
13
C NMR of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione  
The 
13
C NMR identified signals for the different carbon atoms present in 
the compound when it was dissolved in deuterated acetonitrile (Figure 5.18) and 
deuterated chloroform (Figure 5.19). The signal at 46.5 ppm is due to the 
13
C 
atom of the CH2 at position 8, this signal was also evident in the DEPT-135 
spectrum (Figure 5.17). The signal at 62.2 ppm is generated from the 
13
C atom 
of the CH3  from (N)-OCH3 at position 1, this signal was also evident in the 
DEPT-135 spectrum (Figure 5.17). The signal at 83.5 ppm is generated from the 
13
C atom at position 6. The signal at 100.1 ppm is due to the 
13
C atom of the 
CH2 at position 7, this signal was also evident in the DEPT-135 spectrum 
(Figure 5.17). The signal at 128.2 ppm is generated from the 
13
C atom at 
position 12 of the aromatic ring, this signal was also evident in the DEPT-135 
spectrum (Figure 5.17). The signal at 129.1 ppm is generated from the 
13
C atom 
at position 11 and 13 of the aromatic ring, this signal was also evident in the 
DEPT-135 spectrum (Figure 5.17). The signal at 131.4 ppm is due to the 
13
C 
atom at position 10 and 14 of the aromatic ring, this signal was also evident in 
the DEPT-135 spectrum (Figure 5.17). The signal at 134.2 ppm is due to the 
13
C 
atom at position 3. The signal at 134.5 ppm is generated from the 
13
C atom at 
position 9. The signal at 157.3 ppm is generated from the 
13
C atom at position 5. 
The signal at 161.1 ppm is generated from the 
13
C atom at position 2. 
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Figure 5.18. 
13
C NMR of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione (CD3CN, 75 MHz). This spectrum identified all 
the 
13
C present in the compound. The signal from CD3CN appeared at 118.3 
ppm. Some of the signals were evident on the DEPT-135 spectrum (Figure 
5.19).  
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Figure 5.19. 
13
C NMR of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione (CDCl3, 75 MHz). 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione was dissolved in deuterated 
chloroform instead of deuterated acetonitrile. The signal from CDCl3 appeared 
at 77 ppm. The 
13
C signals on this spectrum are the same as those from the 
previous 
13
C NMR spectrum (CD3CN, 75 MHz). Only slight shifts in signal 
position was evident due to the different solvents, this was expected.  
 
 
CDCl3  
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5.2.2.5.4 COSY NMR analysis of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione  
COSY analysis was performed on the metabolite dissolved in CDCl3 to 
confirm that the methoxy group was located at position 1 and that the NH group 
was located at position 4. This was a necessary analysis as the possibility of an 
alternative structure to M12.3 needed to be either confirmed or eliminated. 
Observation of coupling between the 
1
H atom of the CONH signal (7.50 ppm) 
at position 4 and the 
1
H atoms from the CH2 group (5.00 and 5.33 ppm) at 
position 7 confirmed that the NH group was located at position 4 (Figure 5.20; 
red box). This long range coupling over four bonds, indicated that the NH group 
was located at position 4, adjacent to the disubstituted alkene. Location of the 
NH at position 1 would require a longer five bond coupling to the CH2 protons 
at position 7 in order to explain the cosy data. Such a five bond coupling is 
unlikely.  
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Figure 5.20. COSY NMR spectrum of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione (CDCl3, 300 MHz). Coupling (indicated by the 
red box) between the 
1
H atom of the CONH signal (7.50 ppm) at position 4 and 
the 
1
H atoms from the CH2 group (5.00 and 5.33 ppm) at position 7 confirmed 
that the NH group was located at position 4.  
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5.2.2.5.5 HMBC and HSQC NMR analysis of 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione 
HMBC and HSQC of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione (Figure 5.21, Figure 5.22 and Figure 5.23, 
respectively). Observation of coupling between the 
1
H atom of the CONH 
signal (CDCl3; 7.50 ppm and CDCN3; 7.23 ppm) at position 4 and the 
13
C atoms 
from the CH2 group (134.2 ppm) at position 3 and the 
13
C atoms from the CO 
group (161.1 ppm) at position 5 confirmed that the NH group was located at 
position 4 (Figure 5.21, Figure 5.22 and Figure 5.23; red circles). The 
alternative structure with the methoxy group at position 4 would be expected to 
show couplings between the CONH signal and the 
13
C at position  2 and the 
13
C 
at position 6. This was not observed. 
 
 269 
 
 
Figure 5.21. HMBC of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-
2,5-dione (CDCl3, 75 MHz). Observation of coupling (red circles) between the 
1
H atom of the CONH signal (7.50 ppm) at position 4 and the 
13
C atoms from 
the CH2 group at position 3 and the 
13
C atoms from the CO group at position 5 
confirmed that the NH group was located at position 4.  
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Figure 5.22. HMBC of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-
2,5-dione (CDCN3, 75 MHz). Observation of coupling (red circle) between the 
1
H atom of the CONH signal (7.23 ppm in CDCN3) at position 4 and the 
13
C 
atom from the CH2 group at position 3 confirmed that the NH group was located 
at position 4. 
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Figure 5.23. HSQC of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-
2,5-dione (CD3CN, 75 MHz). Observation of coupling (red circle) between the 
1
H atom of the CONH signal (7.23 ppm in CDCN3) at position 4 and the 
13
C 
atom from the CH2 group (134.2 ppm) at position 3 confirmed that the NH 
group was located at position 4. 
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5.2.2.6  Summary of the overall NMR data 
A full summary of all 
1
H, 
13
C and 2-D HMBC NMR is described in Table 
5.4.  
Table 5.4. NMR data generated for 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione analyses.  
Position 
1
H (mult, J in Hz) 
13
C (mult) HMBC (H to 
C) 
1(N)-OCH3 3.63 (s) 62.2 (q)  
2  157.2 (s)  
3  134.2 (s)  
4-NH 7.23
a
    
4-NH
d
 7.50
d
  C-5, 3
d
 
5  161.1 (s)  
6  83.5 (s)  
6-OH 4.93 (s)  C-6, 8 
7 5.00 (s), 5.33 (s) 100.1 (t) C-2, 3 
8 2.97-3.02 (d, 13.3) 
3.39-3.44 (d, 13.3) 
46.5 (t) C-5, 6, 9, 10, 14 
9  134.5 (s)  
10, 14 7.17-7.29 (m)
b
 131.4 (d)
c
  
11, 13 7.17-7.29 (m)
b
 129.1 (d)
c
  
12 7.17-7.29 (m)
b
 128.2 (d)  
a
 Overlapping the signals of the phenyl group.  
b
 Overlapping the NH signal.  
c
 Assignments of carbons are interchangeable. 
d
 In CDCl3 
 273 
5.2.2.7 Ferric Chloride Test  
The location of the OH group was confirmed at position 6 (C6, C-OH) 
and not at position 1 (N1, N-OH). This was achieved by the use of a ferric 
chloride assay (Shin et al., 1975). The lack of deep violet colour change 
indicated that the metabolite did not contain an N-OH group and that the OH 
must be elsewhere. We predict that the OH is on C6. According to Shin et al. 
(1975), if the OH group was on the N atom then a deep violet colour was 
expected, due to iron atom complexing because of the presence of the N-OH. 
This did not occur and allowed us to conclude C6 – OH presence.  
 
5.2.2.8 Elemental (CHNS) analysis 
Elemental (CHNS) analysis (Dr Ann Connolly, UCD by commercial 
arrangement) was carried out on purified 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione to further confirm the absence of sulphur. The 
pure sample was combusted on oxygen (1600 °C) and the combustion products 
were analysed. CHN content was confirmed as C = 55.97 %, H = 4.47 % and N 
= 9.06%. No sulphur content was present.  
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5.2.3 Determining whether 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione was an on-pathway intermediate or 
an off-pathway shunt 
Once the full structure of M12.3 was elucidated, it was necessary to 
determine if the metabolite was an on-pathway intermediate or an off-pathway 
shunt product. This involved two strategies, (i) production of 6-benzyl-6-
hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione with a 
13
C label 
incorporated into the structure that could be used to trace any potential uptake of 
the metabolite (Figure 5.24) and (ii) feeding the labelled 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione (with and without the 
13
C label) to A. 
fumigatus wild-type cultures to monitor potential uptake of the metabolite by 
the fungus and any subsequent enzymatic modification of it by other enzymes 
produced by the gliotoxin cluster (Figure 5.25). This process may afford the 
next on-pathway biosynthetic intermediate in gliotoxin biosynthesis. 
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Figure 5.24 
 
i  . 6. Production of 
13
C 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione by A. fumigatus !gliG. Schematic illustration of 
the design of the feeding experiments used for the production of 
13
C labelled 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione 
(
13
C-M12.3). A. fumigatus !gliG cultures were incubated for 24 hr at 37 °C before 
13
C-L phenylalanine was spiked into the cultures. Spiked 
cultures were incubated for a further 24 hr. Organic extracts were purified (Section 2.2.13) and confirmation of 
13
C incorporation was done via 
LC-MS and NMR analysis.   
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Figure 5.25 
 
Figure 5.27. Monitoring the uptake of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione by A. fumigatus wild-type. Schematic 
illustration of the uptake by A. fumigatus wild-type cultures. Pure compound was spiked into the cultures, incubated and removed at various time 
points (0, 15, 60 and 180 min). Extracts were monitored by HPLC for the disappearance of M12.3 and the appearance of new metabolites.  
Wild-type 
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5.2.3.1 Feeding experiments confirm L-phenylalanine is a precursor of 6-
benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione 
L-phenylalanine was confirmed as a precursor of 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione after it was successfully incorporated 
into the metabolite by feeding experiments with a 
13
C labelled phenylalanine 
(
13
C-L-phenylalanine) (Section 2.2.24.3). Briefly, A. fumigatus !gliG cultures 
were incubated for 24 hr at 37 °C. 
13
C-L-phenylalanine was spiked into the 
cultures and they were incubated for a further 24 hr before the 
13
C labelled 6-
benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione was extracted 
and purified. Confirmation that 
13
C-L-phenylalanine had successfully 
incorporated into the structure was performed with LC-MS and NMR analysis. 
 
5.2.3.1.1 LC-Tof Mass Spectrometric Analysis of 
13
C-M12.3 
LC-ToF analysis confirmed the incorporation of 
13
C-L-phenylalanine into 
6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione. Mass 
determination of purified 
13
C-M12.3 confirmed the metabolite had a mass of 
m/z 264.105 ((M+H)
+
)
 
(Figure 5.26). The presence of a molecular species with 
m/z 263.1025 was also present in the spectra. This is 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione which has been produced with L-
phenylalanine as an amino acid precursor instead of 
13
C-L-phenylalanine. The 
ratio of 
13
C labelled versus unlabelled 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione was calculated to be 54:46.  
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Figure 5.26. LC-ToF HRMS analysis of 
13
C-L-phenylalanine incorporated into 
6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione. The mass 
spectrum shows a molecular ion with a mass of 264.106 (M+H)
+
 and 263.102 
(M+H)
+
, which corresponds to 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione with 
13
C-L-phenylalanine incorporated, and 
without. 
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5.2.3.1.2 NMR Analysis of 
13
C-L-phenylalanine incorporated 6-benzyl-6-
hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione  
13
C and DEPT-135 NMR analysis confirmed the successful integration of 
the 
13
C-L-phenylalanine into 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione. The 
13
C NMR spectrum revealed an intense 
signal at 46.5 ppm (Figure 5.27). This was due to the CH2 group at position 8. 
The increase in intensity of this signal in comparison to 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione without 
13
C incorporated is 
accounted for by the 
13
C incorporated.  
DEPT-135 analysis also identified this signal at 46.5 ppm (Figure 5.28). 
Again, this was due to the CH2 group at position 8. Both NMR spectra confirm 
that L-phenylalanine is a precursor of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione.  
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Figure 5.27. 
13
C NMR of 
13
C labelled 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione (CD3CN, 125 MHz). The intense signal at 46.5 
ppm is due to the 
13
C atom of the CH2 group at position 8. This 
13
C originated 
from 
13
C-L-phenylalanine that was spiked into !gliG cultures. This NMR 
spectrum confirms that L-phenylalanine is a precursor of 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione.  
 
CD3CN                   CD3CN 
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Figure 5.28. DEPT 135 NMR of 
13
C labelled 6-benzyl-6-hydroxy-1-methoxy-
3-methylenepiperazine-2,5-dione (CD3CN, 125 MHz). The signal at 46.5 ppm is 
due to the 
13
C atom of the CH2 group at position 8. This 
13
C originated from 
13
C-L-phenylalanine that was spiked into !gliG cultures. This NMR spectrum 
also confirms that L-phenylalanine is a precursor of 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione. 
CH2  
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5.2.3.2 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione is 
an off pathway shunt product  
It was confirmed that 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione was an off-pathway shunt intermediate and not 
an on-pathway intermediate through feeding experiments. Purified metabolite 
was spiked into A. fumigatus wild-type cultures/protoplasts and the uptake of 
the compound was monitored by HPLC analysis.  
 
5.2.3.2.1 Monitoring the uptake of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione by A. fumigatus ATCC 46645 
mycelia. 
Pure 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione 
was not taken up by A. fumigatus ATCC46645 wild-type cultures (Figure 5.29). 
On independent occasions and with two different amounts, purified 6-benzyl-6-
hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione (15/150 µg) (Section 
5.2.2.2) was spiked into cultures of a low-gliotoxin producing strain, A. 
fumigatus ATCC46645 (Section 2.2.24.1). Culture supernatant was removed 
before spiking and at 0, 15, 60 and 180 min after spiking with the metabolite. 
Organic extracts of each time point were subjected to HPLC analysis. Peak area 
of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione was 
monitored at the various time points to asses the uptake of the metabolite by the 
fungus. No reduction in the peak area for the two different amounts over the 
time period was observed (Figure 5.29).  
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5.2.3.2.2 Monitoring the uptake of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione by A. fumigatus AF293 mycelia. 
Purified 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione 
(150 µg) (Section 5.2.2.2) was spiked into A. fumigatus AF293 cultures (Section 
2.2.24.1). Culture supernatant was removed before spiking and at 0, 15, 60 and 
180 min after spiking with the metabolite. Organic extracts of each time point 
were subjected to HPLC analysis. Peak area of 6-benzyl-6-hydroxy-1-methoxy-
3-methylenepiperazine-2,5-dione was monitored at the various time points to 
asses the uptake of the metabolite by the fungus. No decrease in the peak area 
over the time period was observed (Figure 5.29). 
 
5.2.3.2.3 Monitoring the uptake of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione by A. fumigatus AF293 
protoplasts. 
Purified 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione 
(150 µg) (Section 5.2.2.2) was spiked into the wild-type protoplast suspension 
(Section 2.2.24.2). An aliquot of the suspension was removed before and at 1, 3 
and 24 hr after spiking with the metabolite. Organic extracts from the protoplast 
pellet and the supernatant (Section 2.2.24.2) were subjected to HPLC analysis. 
Peak area of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione 
was monitored at the various time points to assess the uptake of the metabolite 
by the fungus. No decrease in the peak area over the time period was observed 
(Figure 5.29). 
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Figure 5.29. Incubation of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione with A. fumigatus ATCC 46645 and AF293 
wild-type cultures and an A. fumigatus AF293 protoplast suspension. (A) No 
decrease in the peak area of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione (50 µg) was observed in the supernatant of A. 
fumigatus ATCC 46645 cultures. Therefore, no uptake of the metabolite by the 
fungus was observed. (B) No decrease in the peak area of 6-benzyl-6-hydroxy-
1-methoxy-3-methylenepiperazine-2,5-dione (150 µg) in the supernatant of A. 
fumigatus ATCC 46645 cultures. Therefore, no uptake of the metabolite by the 
A       B 
C         D 
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fungus was observed. (C) No decrease in the peak area of 6-benzyl-6-hydroxy-
1-methoxy-3-methylenepiperazine-2,5-dione (150 µg) in the supernatant of A. 
fumigatus AF293 cultures. No decrease in the peak area of the metabolite by the 
fungus was observed. (D) No decrease in the peak area of 6-benzyl-6-hydroxy-
1-methoxy-3-methylenepiperazine-2,5-dione (150 µg) incubated with of A. 
fumigatus AF293 protoplasts. Therefore, no uptake of the metabolite by the 
fungus was observed. 
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5.3 Discussion 
Previous studies on gliotoxin biosynthesis has not identified any 
biosynthetic intermediates or shunt metabolites (Suhadolnik and Chenoweth, 
1958; Winstead and Suhadolnik, 1960; Bose et al., 1968a; Bose et al., 1968b; 
Bulock and Ryles, 1970; Johns and Kirby, 1971; Bu'Lock and Leigh, 1975; 
Kirby et al., 1978; Bok et al., 2006; Cramer et al., 2006; Kupfahl et al., 2006; 
Sugui et al., 2007; Spikes et al., 2008; Schrettl et al., 2010). The metabolite 
M12.3 was herein detected in A. fumigatus !gliG and the mass of the 
metabolite confirmed to be 263 m/z. Reduction and alkylation confirmed that 
M12.3 lacked a disulphide bridge and/or thiols. CHNS elemental analysis also 
confirmed the absence of sulphur atoms. NMR confirmed the structure of 
M12.3 to be 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione. 
Feeding experiments confirmed incorporation of L-phenylalanine into the 
metabolite, which has been previously confirmed for gliotoxin (Suhadolnik and 
Chenoweth, 1958). NMR analysis of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione revealed that the metabolite contained two 
amide carbonyl groups, a hydroxyl group, a methoxy group and an exocyclic 
alkene. In comparison to the structure of gliotoxin it did not contain the 
disulphide bridge, the hydroxyl group on the aromatic ring, the methyl group 
attached to the N on the piperazine ring, the CH2OH group on the piperazine 
ring and the five-member ring which connects the aromatic ring and the 
piperazine ring is closed in gliotoxin whereas it is an open ring conformation in 
6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione. Feeding 
experiments using 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-
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dione did not detect any uptake of this metabolite by AF293 mycelia of 
protoplasts.  
The use of HRMS has been employed for the confirmation that different 
gli mutant strains (!gliP, !gliZ and !gliT) do not produce gliotoxin (Bok et al., 
2006; Kupfahl et al., 2006; Sugui et al., 2007; Spikes et al., 2008; Scharf et al., 
2010; Schrettl et al., 2010). The gliotoxin parent ion, 327 m/z, was absent in 
each of these gli mutant strains. Restoration of gliotoxin production was evident 
in the complemented gli strains. This confirmed that gliP, gliZ and gliT each 
played roles in gliotoxin biosynthesis, regulation of expression and self-
protection, respectively. Absence of gliotoxin production in A. fumigatus !gliG 
and the confirmation of gliotoxin production in both A. fumigatus wild-type and 
complemented strains was confirmed in Chapter 4 by RP-HPLC analysis. This 
was also confirmed by HRMS in this Chapter. LC-ToF analysis of A. fumigatus 
!gliG culture extracts confirmed the absence of the gliotoxin parent ion (327 
m/z) and therefore confirmed that this strain did not produce gliotoxin. 
Gliotoxin was detected in extracts of A. fumigatus AF293 wild-type and gliG
C
 
15.1 by the presence of a molecular ion with a mass of 327 m/z and this 
confirmed that both wild-type and complemented strains produced gliotoxin.  
Once it was confirmed that A. fumigatus !gliG did not produce gliotoxin 
and instead produced M12.3 (6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione will continued to be referred to as M12.3) it was 
necessary to determine whether this metabolite contained the disulphide bridge 
or thiols. A novel chemical assay was developed to confirm the 
presence/absence of a disulphide bridge or thiols. This chemical analysis 
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employed reduction and alkylation of the disulphide bridge of gliotoxin. 
Reduction of gliotoxin with NaBH4 has been previously described (Woodcock 
et al., 2001; Schrettl et al., 2010) and the two thiol groups of dethiogliotoxin 
were subsequently labelled with the alkylation agent 5’-IAF. This produced a 
stable GT-(AF)2 product which was detectable by RP-HPLC. Following 
reduction and alkylation of A. fumigatus AF293 wild-type culture extracts, GT-
(AF)2 was detected by HPLC which confirmed that gliotoxin was produced by 
the wild-type strain. Reduction and alkylation of extracts from the three A. 
fumigatus gliG
C
 strains (15.1, 15.4 and 17.1) followed by HPLC analysis also 
detected GT-(AF)2. This confirmed gliotoxin production was restored in the 
three complemented strains. However, reduction and alkylation of A. fumigatus 
!gliG extracts did not detect GT-(AF)2 and so demonstrated that the mutant 
strain did not produce gliotoxin and that M12.3 did not contain a disulphide 
bridge and/or thiol groups. This novel approach for the detection of a disulphide 
bridge was further evaluated for the detection of gliotoxin in A. fumigatus 
culture supernatants. This will be discussed in more detail in Chapter 6.  
Confirmation of structure using NMR requires a significant amount (! 10 
mg) of pure material (Personal communication Dr Ishwar Singh, Chemistry 
Department, NUI Maynooth and Dr Dermot Brougham, Dublin City 
University). A strategy was developed to scale up A. fumigatus !gliG cultures, 
subsequently extract and purify M12.3 from crude culture extracts and repeated 
several times (n = 5) until 6.5 mg of M12.3 was generated. The purified material 
was subjected to HRMS and NMR analysis. Structural characterisation of novel 
metabolites by NMR required the generation of several spectra; 
1
H, 
13
C, DEPT-
135, 
1
H – 
1
H COSY, HSQC and HMBC. The detection of three novel DKP 
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(compound 1, 2 and 3) from A. fumigatus Fresenius employed HRMS, 
1
H, 
13
C, 
DEPT and HMQC analysis (Zhao et al., 2010). HRMS confirmed the chemical 
formulas of compound 1, 2 and 3 to be C13H16N2O4, C13H15N2O4 and 
C12H12N2O4, respectively. 
1
H NMR confirmed the protons present in the 
aromatic ring by signals on the NMR spectrum between 7.22 and 7.27 ppm for 
compounds 1 and 2 and between 7.35 and 7.48 ppm for compound 3 (Zhao et 
al., 2010). 
1
H NMR of the protons of the diene of the DKP, vertihemiptellide B 
isolated from V. hemipterigenum were identified on the NMR spectrum 
between 7.18 and 7.21 ppm (Figure 5.3 and Table 5.2) (Isaka et al., 2005). This 
was in contrast to the signals of the diene of gliotoxin (Figure 5.2 and Table 5.1) 
(Kaouadji et al., 1990). The 
1
H NMR of gliotoxin identified protons in the 
aromatic ring between 4.82 and 5.99 ppm (Kaouadji et al., 1990). This 
difference in signals is due to the presence of the OH group on the diene of 
gliotoxin and this subsequently changes the chemical environment of these 
protons, which is reflected in the 
1
H spectroscopy. The protons (position 10, 11, 
12, 13 and 14) in the aromatic ring of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione were identified in the 
1
H NMR spectrum by 
signals emitted between 7.17 and 7.29 ppm (Figure 5.15, Figure 5.16 and Table 
5.4). This spectroscopy correlated to previously reported NMR data for protons 
in the aromatic rings of isolated DKP metabolites (Isaka et al., 2005; Zhao et al., 
2010).  
Isaka et al. (2005) confirmed the NH group in the piperazine ring of 
vertihemiptellide B by the identification of a signal at 7.70 ppm in the 
1
H 
spectrum (Figure 5.3 and Table 5.2). The location of the NH group at position 4 
(piperazine ring) of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-
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dione (Figure 5.15) was confirmed after the metabolite was dissolved in CDCl3. 
This signal appeared at 7.50 ppm on the 
1
H – 
1
H COSY spectrum (Figure 5.20). 
The 
1
H NMR spectrum of M12.3 in CD3CN identified a signal at 7.23 ppm 
(Figure 5.16), however the protons from the aromatic ring (7.17 – 7.29 ppm) 
overlapped with the NH proton.  
The piperazine ring of gliotoxin is bridged with a disulphide bond 
(Kaouadji et al., 1990; Gardiner and Howlett, 2005). 6-benzyl-6-hydroxy-1-
methoxy-3-methylenepiperazine-2,5-dione (Figure 5.15) does not contain this 
disulphide bridge and instead contains a hydroxyl group at position 6 of the 
piperazine ring ("C 83.5, NHCOC(OH)Bn; "H 4.93, NHCOC(OH)Bn) and a 1, 
1-disubstituted alkene ("C 100.1, C=CH2; 134.2, C=CH2; "H 5.00, 5.33, C=CH2) 
at position 7 (Table 5.3). The location of the hydroxyl group at position 6 was 
also confirmed using a ferric chloride test (Shin et al., 1975). Gliotoxin does not 
contain this hydroxyl group and instead one of the sulphur atoms that form the 
disulphide bridge is attached at the equivalent position instead (Kaouadji et al., 
1990). King et al. (2003) and Buysens et al. (1996) observed almost identical "C 
values of 82.9 and 87.2 for C-6 carbons in DKP compounds that have similar 
structure to 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione. 
The presence of the hydroxyl group at position 6 is crucial for GliG-mediated 
sulphur incorporation and this will be discussed in more detail in Chapter 7.  
 13
C and DEPT-135 NMR analysis confirmed the carbons in the aromatic 
ring ("C 128.17, 129.12 and 131.41 which corresponded to the CH at position 10 
and 14, 11 and 13 and 12, respectively). Three CH (10/14 and 11/13 have 
equivalent signals on the spectrum), two CH2 and one CH3 was confirmed 
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present in M12.3. Unlike M12.3, gliotoxin does not contain a methoxy (O-CH3) 
group (Johnson et al., 1943; Beecham et al., 1966; Kaouadji et al., 1990). Zhao 
et al. (2010) identified an O-CH3 group in the DKP compounds (1 and 2) of A. 
fumigatus Fresenius. This O-CH3 group was identified in the 
1
H NMR spectrum 
at 3.26 and 3.32 ppm of compound 1 and 2, respectively (Zhao et al., 2010). A 
methoxy group was identified at 3.63 ppm in the 
1
H NMR spectrum of 6-
benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione (Figure 5.15, 
Figure 5.16 and Table 5.4). The slight difference in "H is due to the bonding of 
the methoxy group of M12.3 to a nitrogen atom in the piperazine ring which is 
in comparison to the bonding of the methoxy group to a carbon of the 
piperazine ring of compound 1 and 2 isolated from A. fumigatus Fresenius 
(Zhao et al., 2010). Interestingly, expression analysis (Chapter 4) of the A. 
fumigatus gliG flanking gene, gliM, revealed higher expression in the A. 
fumigatus !gliG strain when compared to the A. fumigatus AF293 wild-type. In 
silico analysis predicted A. fumigatus gliM to be an O-methyl transferase which 
could be responsible for the addition of the O-CH3 group of M12.3. Similarly, 
A. fumigatus gliK expression was higher in A. fumigatus !gliG when compared 
to the AF293 wild-type expression and it is believed that gliK is involved in 
gliotoxin transport (Gallagher, 2010) and therefore may play a role in the 
extracellular transport of M12.3. The possibility of an alternative structure for 
M12.3 where the methoxy group could be located at position 4 and the NH 
located at position 1 was eliminated with COSY and HMBC analysis (Figure 
5.20, Figure 5.21 and Figure 5.23). Long range coupling over four bonds was 
observed between protons of CONH and C=CH2, the alternative structure would 
require long range coupling over five bonds. 
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Once the structure of 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione was established, the resemblance to gliotoxin 
was apparent (Figure 5.30 and Figure 5.31). The main differences between 
gliotoxin and M12.3 are listed in Table 5.5. The accumulation of M12.3 in A. 
fumigatus !gliG cultures and the structural elucidation confirmed that the 
metabolite was produced during gliotoxin biosynthesis in the absence of A. 
fumigatus gliG. Early investigations into gliotoxin biosynthesis determined that 
phenylalanine and serine were the amino acid precursors (Bu'Lock and Leigh, 
1975). This was made possible by various feeding experiments using 
radiolabelled isotopes (Winstead and Suhadolnik, 1960; Bose et al., 1968a; 
Bose et al., 1968b; Bulock and Ryles, 1970; Johns and Kirby, 1971) such as 
phenylalanine and serine. L-phenylalanine is an amino acid precursor of both 
gliotoxin (Bu'Lock and Leigh, 1975) and M12.3, the latter of which was 
confirmed in this Chapter by 
13
C-L-phenylalanine feeding experiments (Figure 
5.31). However, feeding experiments using 
13
C-M12.3 (Figure 5.26, Figure 5.27 
and Figure 5.30) revealed no uptake of the metabolite by A. fumigatus wild-type 
mycelia or protoplasts. However, this did not eliminate the possibility that 
M12.3 may undergo enzymatic modification by one of the gliotoxin 
biosynthetic enzymes and converted to the next intermediate produced during 
gliotoxin biosynthesis. In order to determine if this was possible, future in vitro 
analysis using heterologously expressed gliotoxin biosynthetic enzymes or 
isolated native enzymes from A. fumigatus protein lysates should be performed. 
 293 
 
 
 
Figure 5.30. Structure of gliotoxin and M12.3. The differences in the two 
structures are highlighted in green (gliotoxin) and red (M12.3).   
 
 
 
 
Table 5.5. Structural differences between gliotoxin and M12.3  
 Gliotoxin  M12.3 
1 Disulphide Bridge No disulphide bridge 
2 N-Methyl  NH 
3 Hydroxy methylene  1, 1-disubstituted alkene 
4 Closed 5-member ring N-Methoxy 
5 No hydroxyl Hydroxyl  
6 Diene and a hydroxyl group Aromatic ring 
 
 
     Gliotoxin            M12.3  
1 
2 
2 
3 3 
4 4 
5 
6 
6 
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Gliotoxin  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.31 
+ 
M12.3 
L-phenylalanine   
L-serine 
i  . 3.  Schematic illustration of the amino acid precursors, L-phenylalanine and L-serine, of gliotoxin and M12.3. The incorporation of L-
phenylalanine into gliotoxin has been previously reported and the work in this thesis confirms the incorporation of L-phenylalanine into M12.3. 
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In summary, the absolute mass of M12.3 was confirmed to be 262 u. A 
novel reduction and alkylation assay for the detection of a disulphide bridge 
and/or thiols confirmed that M12.3 did not contain a disulphide bridge or thiol 
groups. NMR analysis confirmed the structure of M12.3 as 6-benzyl-6-hydroxy-
1-methoxy-3-methylenepiperazine-2,5-dione and the structure closely 
resembled gliotoxin with the exception of the disulphide bridge and several 
other important group differences. M12.3 contained two amide carbonyls, a 
benzyl, a hydroxyl, a methoxy and a 1, 1-disubstituted alkene group, the last 
three are not evident in gliotoxin. It did not contain a disulphide bridge, the N-
methyl group, the hydroxy methylene or the hydroxyl group on the benzene 
ring. Feeding experiments confirmed that L-phenylalanine was an amino acid 
precursor of M12.3, which has also previously been confirmed for gliotoxin 
(Bu'Lock and Leigh, 1975). No uptake of the metabolite by A. fumigatus wild-
type mycelia or protoplasts. These data have led to the current hypotheses for 
gliotoxin biosynthesis, both of which will be discussed in Chapter 7.  
 
  
 
 
 
Chapter 6  
 
 
Reduction and alkylation of gliotoxin  
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6. Chapter 6 Reduction and alkylation of Gliotoxin.  
6.1 Introduction 
As previously mentioned in Chapter 5, an assay was developed using 
reduction and alkylation in an effort to determine whether M12.3 produced by 
A. fumigatus !gliG contained either a disulphide bridge or thiol groups. 
Gliotoxin produced by A. fumigatus AF293 wild-type cultures was reduced and 
alkylated yielding a stable labelled gliotoxin product, GT-(AF)2, which was 
detected by RP-HPLC as described in Chapter 5. The use of reduction and 
alkylation confirmed that M12.3 did not contain a disulphide bridge or thiol 
groups. Validation of several parameters such as reagents and incubation times 
helped optimise reaction conditions. Initial validation was performed on pure 
gliotoxin to establish optimal conditions, which can subsequently be used to 
detect native gliotoxin produced by A. fumigatus. 
ETP toxins are produced by a range of phylogenetically diverse 
filamentous fungi and contribute to the infection of several animals and plants 
(Gardiner et al., 2005b; Fox and Howlett, 2008). The first reported and best 
characterised ETP is gliotoxin. As mentioned in Chapter 1, the role of this toxin 
in the virulence of A. fumigatus has been studied extensively (Kwon-Chung and 
Sugui, 2009). The disulphide bridge feature of gliotoxin plays an important role 
in the toxicity of this molecule and subsequently the virulence of A. fumigatus 
(Gardiner and Howlett, 2005; Gardiner et al., 2005b). The toxicity of ETP 
compounds is conferred through direct inactivation of essential protein thiols. 
The redox cycling between oxidised and reduced forms of gliotoxin also leads 
to oxidative stress and gliotoxin has been shown to be involved in the disruption 
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of NADPH oxidase assembly (Waring et al., 1995; Yoshida et al., 2000; 
Tsunawaki et al., 2004; Kwon-Chung and Sugui, 2009). Phylogenetic analysis 
of ETP clusters within filamentous fungi identified 14 ascomycete taxa where 
these clusters are present (Patron et al., 2007). Phylogenetic analysis in Chapter 
3 identified putative ETP producing fungi, 5 of which had not been identified 
before. ETP secreting fungi include L. maculans, Sirodesmin diversum, N. 
fischeri, Penicillium lilacinoechinulatum, A . clavatus, Trichoderma reesei, 
Magnaporthe grisea, Trichoderma virens, A . terreus, A . flavus, A . oryzae, 
Gibberella zeae, Chaetomium globosum , F. verticilliodes, M. graminicola, M. 
gypseum, T. equinum, T. tonsurans, T. rubum and A. fumigatus. The detection 
of specific fungal metabolites particularly gliotoxin and other ETP compounds 
represents an emerging strategy for reliable diagnosis of fungal infections. 
Gliotoxin is normally detected by RP-HPLC using wavelengths of 220-
260 nm (Balibar and Walsh, 2006; Cramer et al., 2006; Kupfahl et al., 2006; 
Sugui et al., 2007; Spikes et al., 2008; Scharf et al., 2010; Schrettl et al., 2010). 
Immunological detection of gliotoxin by ELISA has been reported where the 
limit of detection (LOD) was 10 µg/ml (Fox et al., 2004). The presence of 
gliotoxin in sera and lungs of mice with experimentally induced IA was 
detected by LC-MS analysis (Lewis et al., 2005a). These authors also used LC-
MS analysis to show gliotoxin was detectable in cancer patients with probable 
or proven IA.  
The disulphide bridge of gliotoxin can be reduced to two thiol groups 
following reaction with reductant compounds such as dithiothreitol (DTT), 
tris(2-carboxyethyl)phosphine (TCEP) and sodium borohydride (NaBH4) 
(Woodcock et al., 2001; Balibar and Walsh, 2006; Scharf et al., 2010; Schrettl 
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et al., 2010). GSH-mediated reduction of gliotoxin is possible but results in the 
formation of mixed disulphides (Bernardo et al., 2001; Bernardo et al., 2003). 
Reductants may require removal once the reaction is complete (Hansen and 
Winther, 2009). The reduction of a disulphide bridge is mediated by a reactive 
nucleophile from the reductant (Figure 6.1).  
Dithiothreitol (DTT) is one of the most commonly used thiol reductants. 
DTT reduces disulphides and is then converted to a stable intramolecular cyclic 
disulphide (Figure 6.1). DTT offers the advantage of being a strong reducing 
agent in comparison to others (Cleland, 1964). The SH group of DTT will 
compete directly with protein thiols in the attachment of the thiol reactive 
reagents. There are also problems associated with cross-reactivity of thiol 
detection agents with DTT (Hansen et al., 2007). 
Phosphines are another class of reductant and in particular the 
trialkylphosphines such as TCEP. Reduction is mediated through a rate-limiting 
step where the reactive nucleophile from the phosphine group attacks the 
disulphide bond and forms a thiophosphonium salt. Hydrolysis rapidly releases 
the second thiol group and the phosphine oxide (Figure 6.2). Once the 
hydrolysis event has occurred the reaction is irreversible (Burns et al., 1991). 
Phosphines have the advantage of not reacting with certain thiol alkylation 
agents (e.g. benzofurazans) meaning that reduction and alkylation can take place 
simultaneously, reducing overall reaction time (Hansen and Winther, 2009). 
The use of TCEP has also been employed in the reduction of gliotoxin (Scharf 
et al., 2010) where the dithiol form was used as a substrate in a series of 
gliotoxin oxidase activity assays.  
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Figure 6.1. Schematic illustrations (A) the nucleophillic attack of the thiolate 
anion which causes the cleavage of the disulphide bridge (Hansen and Winther, 
2009). (B) DTT-mediated reduction of disulphides (Hansen and Winther, 2009). 
The nucleophilic thiolate anion in DTT attacks the target disulphide bridge and 
reduces it to the dithiol form. DTT then forms a stable intramolecular cyclic 
disulphide.  
A 
B 
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Figure 6.2. Trialkylphosphine mediated reduction of disulphides. (A) Structure 
of TCEP. (B) Mechanism of the reduction reaction (Hansen and Winther, 2009). 
A 
B 
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The use of NaBH4 in gliotoxin reduction has been previously described 
(Woodcock et al., 2001). Woodcock et al. (2001) demonstrated that NaBH4-
mediated reduction of gliotoxin, followed by electrospray MS was used to 
confirm the interaction of NaBH4 reduced gliotoxin, or sporidesmin A, with 
metal ions such as Zn
2+,
 Cd
2+
 and Hg
2+
 (Woodcock et al., 2001). Elsewhere, 
NaBH4 has been used in the reduction of gliotoxin where the inhibitory effects 
of reduced gliotoxin was observed on the mutant strain A. fumigatus !gliT 
(Schrettl et al., 2010). This effect was subsequently alleviated by the addition of 
exogenous GSH. Also, NaBH4 has been used in the complete reduction and 
thiol quantification of carboxypeptidase Y in the picomolar range (9 – 90 pmol) 
(Hansen et al., 2007). 
Once efficient disulphide reduction has been achieved the detection of the 
thiol can be performed in different ways. This can be performed through the use 
of reagents with relevant spectrophotometric properties or by using alkylation 
reagents that contain fluorophores. The use of fluorescent compounds to label 
free thiols followed by the chromatographic separation offers an extremely 
sensitive method for the detection of thiols. The iodoacetamido derivatives of 
fluorescein contain a sulfhydral-reactive iodoacetyl group, at C5 or C6 
(Hermanson, 2008). Under slightly alkaline conditions this iodoacetyl group 
reacts with sulphydrals producing a stable thioether bond (Figure 6.3).  
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Figure 6.3. The use of 5’ Iodoacetamidofluorescein (5’ IAF) in the modification 
of thiol-containing compounds creates a thioether bond (Hermanson, 2008).  
R      SH + 
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The diagnosis of infections caused by, or associated with, ETP producing 
fungi remains poor (Mennink-Kersten et al., 2004b; Jegorov et al., 2006) and 
the detection of a fungal-specific peptide biomarker such as gliotoxin represents 
an emerging strategy for the reliable diagnosis of fungal infections. 
Development of an assay that may improve gliotoxin detection in culture 
supernatant may eventually lead to the development of a diagnostic tool for 
fungal infection.  
The overall objectives of this chapter are (i) to explore potential 
reductants to reduce gliotoxin, (ii) to label both thiol groups in reduced gliotoxin 
producing a stable GT-(AF)2 product, (iii) to detect the presence of the GT-
(AF)2 using HPLC, TLC and MALDI-ToF MS and, (iv) to use reduction and 
alkylation to detect native gliotoxin in the supernatant of A. fumigatus  cultures.  
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6.2 Results  
6.2.1 Reduction and alkylation of pure gliotoxin.  
Pure gliotoxin was successfully reduced using NaBH4, DTT or TCEP. 
Subsequent thiol modification in all cases was performed with the alkylation 
agent 5’-IAF producing stable GT-(AF)2. GT-(AF)2 was then detected by RP-
HPLC at 254 nm. Spectral properties of GT-(AF)2 were enhanced in 
comparison to unlabelled gliotoxin, this will be discussed in Sections 6.2.1.1, 
6.2.1.2, 6.2.1.3. NaBH4 did not require removal prior to alkylation and this 
offered an advantage as it did not add to the methodology or the incubation time 
of the assay.  
 
6.2.1.1 NaBH4-mediated reduction of gliotoxin and subsequent alkylation 
Gliotoxin was subjected to sequential reduction and alkylation as 
described in (Section 2.2.15.1). Briefly, sodium borohydride (NaBH4) reduces 
gliotoxin to the dithiol form, which is then labelled with the alkylation agent 5’ 
IAF. This di-acetamidofluorescein-gliotoxin (GT-(AF)2) was then detected 
following RP-HPLC separation. The removal of the reducing agent is not 
required prior to alkylation. RP-HPLC separation and absorbance detection at 
254 nm identified GT-(AF)2  at RT =15.243 min (Figure 6.4). GT-(AF)2 was 
only detected following reduction of gliotoxin and subsequent alkylation with 5’ 
IAF. Unreacted 5’-IAF was also detected at RT =15.056 min. Fluorescence 
detection showed the presence of GT-(AF)2 at RT = 15.270 min (Figure 6.4). In 
the absence of NaBH4, GT-(AF)2 is absent and oxidised gliotoxin is detectable 
at RT =14.418 min. This was also confirmed with fluorescence detection (Figure 
 305 
6.4). A negative control, where gliotoxin was absent, demonstrated no GT-
(AF)2. The amount of gliotoxin (2 µg) used in both reduced and non-reduced 
samples was identical, however the absorbance of GT-(AF)2 (peak area = 8772 
± 606; n = 3) was enhanced relative to unlabelled gliotoxin (peak area = 1287 ± 
122; n = 3) (Figure 6.5 and Table 6.1). This difference represents a 6.8-fold 
higher absorbance at 254 nm for GT-(AF)2 than equivalent amounts of 
unlabelled gliotoxin.  
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Figure 6.4. RP-HPLC analysis of pure gliotoxin (Sigma-Aldrich) with and 
without NaBH4-mediated reduction prior to 5’ IAF labelling. (A) Gliotoxin + 
NaBH4 + 5’-IAF: Absorbance detection at 254 nm detected GT-(AF)2 with a 
retention time of 15.243 min. (B) Gliotoxin + NaBH4 + 5’-IAF: GT-(AF)2 was 
detectable by fluorescence detection (excitation/emission; 492/518 nm) with a 
retention time of 15.270 min. (C) Gliotoxin – NaBH4 + 5’-IAF: No labelling of 
gliotoxin is possible (indicated by the asterix) in the absence of NaBH4. 
Absorbance detection at 254 nm detected free gliotoxin with a retention time of 
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14.418 min. (D) Gliotoxin – NaBH4 + 5’-IAF: No labelling of gliotoxin is 
possible therefore, GT-(AF)2 was absent with fluorescence detection 
(excitation/emission; 492/518 nm). (E) Methanol + NaBH4 + 5’-IAF: No GT-
(AF)2 present.  
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6.2.1.2 DTT-mediated reduction of gliotoxin and subsequent alkylation 
To identify the optimal reductant to be used in this assay DTT was 
substituted in place of NaBH4. Gliotoxin was subjected to sequential reduction 
and alkylation as described in Section 2.2.15.2 Briefly, DTT reduces gliotoxin 
to the dithiol form, which is then labelled with the alkylation agent 5’ IAF. GT-
(AF)2 can then be detected following RP-HPLC separation. Absorbance at 254 
nm detected GT-(AF)2, which was only present in the reduced and alkylated 
sample at RT =15.246 min. Unreacted 5’ IAF is also visible in the chromatogram 
at RT =15.059 min. Fluorescence detection shows the presence of GT-(AF)2 at 
RT = 15.250 min. In the absence of DTT-mediated reduction GT-(AF)2 is not 
detected and instead intact oxidised gliotoxin is evident at RT =14.418 min. The 
amount of gliotoxin (2 µg) used in both reduced and non-reduced samples was 
identical, however the absorbance of the labelled gliotoxin (peak area = 3580) 
was enhanced relative to the unlabelled form (peak area = 1287) (Figure 6.6 and 
Table 6.1).  
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Figure 6.5. RP-HPLC analysis of pure gliotoxin (Sigma-Aldrich) with and 
without DTT-mediated reduction prior to 5’-IAF labelling. (A) Gliotoxin + DTT 
+ 5’-IAF: Absorbance at 254 nm detected GT-(AF)2 with a retention time of 
15.246 min and a peak area equal to 3580. (B) Gliotoxin + DTT + 5’-IAF: 
Fluorescence detection (excitation/emission; 492/518 nm) detected GT-(AF)2 
with a retention time of 15.250 min. (C) Gliotoxin – DTT + 5’-IAF: No 
labelling of gliotoxin possible (indicated by the asterix) in the absence of DTT. 
Absorbance detection at 254 nm detected free gliotoxin with a retention time of 
14.418 min. (D) Methanol + DTT + 5’-IAF: No GT-(AF)2 present.  
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6.2.1.3 TCEP-mediated reduction of gliotoxin and subsequent alkylation 
A final choice of reductant, TCEP, was used to reduce pure gliotoxin. 
Gliotoxin was subjected to sequential reduction and alkylation as described in 
Section 2.2.15.3. Briefly, TCEP reduces gliotoxin to the dithiol form, which is 
then labelled with the alkylation agent 5’-IAF. GT-(AF)2 can then be detected 
following RP-HPLC separation. Absorbance detection at 254 nm detected GT-
(AF)2, which was only present in the reduced and alkylated sample at RT 
=15.466 min. Unreacted 5’-IAF is also detected at RT =15.197 min. 
Fluorescence detection shows the presence of GT-(AF)2 at RT = 15.470 min. In 
the absence of TCEP-mediated reduction GT-(AF)2 is not present. Intact 
oxidised gliotoxin is evident at RT =14.366 min. The amount of gliotoxin (2 µg) 
used in both reduced and non-reduced samples was identical, however the 
absorbance of the GT-(AF)2 (peak area = 11260) was enhanced relative to the 
unlabelled form (peak area = 1160) (Figure 6.7 and Table 6.1).  
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Figure 6.6. RP-HPLC analysis of gliotoxin (Sigma-Aldrich) with and without 
TCEP-mediated reduction prior to 5’-IAF labelling. (A) Gliotoxin + TCEP + 5’-
IAF: Absorbance detection at 254 nm detected GT-(AF)2 with a retention time 
of 15.466 min. (B) Gliotoxin + TCEP + 5’-IAF: Fluorescence detection 
(excitation/emission; 492/518 nm) detected GT-(AF)2 with a retention time of 
15.470 min. (C) Gliotoxin – TCEP + 5’-IAF: No labelling of gliotoxin is 
possible (indicated by the asterix). Absorbance detection at 254 nm detected 
free gliotoxin with a retention time of 14.418 min. (D) Methanol + TCEP + 5’-
IAF. No GT-(AF)2 present.  
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Table 6.1. Summary of amount, peak areas and retention times of GT-(AF)2 and 
unlabelled gliotoxin generated by the use of different reductants (NaBH4, DTT 
and TCEP).  
Reductant NaBH4  DTT TCEP 
Amount Gliotoxin (µg)   2  2  2  
Gliotoxin unreduced Peak Area (mAU) 1287 1287 1160 
GT-(AF)2 Peak Area (mAU) 8772 3580 11260 
Retention time (min) 15.243 15.246 15.466 
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6.2.2 NaBH4 reduction of gliotoxin occurs after 15 min 
To determine the optimal time required to reduce gliotoxin a time course 
study monitoring the rate of gliotoxin reduction using NaBH4 was performed 
over 120 min (Section 2.2.19). RP-HPLC analysis of reduced gliotoxin at 
specific time intervals (T = 0, 15, 30, 60 and 120 min) was carried out. NaBH4-
mediated reduction of gliotoxin was complete within a maximum of 15 min 
(mean ± SD = 1.5 ± 0.23 µg; n = 3). Reduced gliotoxin was evident at T = 0 min 
(RT= 13.155 min) and at each time interval up to and including T = 120 min 
(RT= 13.198 min) (mean ± SD = 1.5 ± 0.11 µg; n = 3) (Figure 6.7). 
Furthermore, NaBH4-reduced gliotoxin does not exhibit any evidence of re-
oxidation for up to 2 hr post-reduction (Figure 6.7).  
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Figure 6.7. RP-HPLC analysis of NaBH4-reduced gliotoxin. (A) The reduction 
of gliotoxin occurs immediately (T = 0 min), and reduced gliotoxin is detected 
at RT = 13.155 min. (B) Reduced gliotoxin (RT =13.198 min) is still evident 120 
min after the addition of NaBH4. Absorbance detection at 254 nm. 
Reduced Gliotoxin 
T = 120 min 
Reduced Gliotoxin 
T= 0 min 
 
A 
B 
Retention Time  
A
b
so
rb
an
ce
 
Retention Time  
A
b
so
rb
an
ce
 
 318 
6.2.3 Labelled gliotoxin is detectable by MALDI-ToF MS 
The detection of gliotoxin by MALDI-ToF MS is confounded by the 
small molecular size of the metabolite and by ionisation-induced fragmentation 
(Peterson, 2007). MALDI-ToF analysis of GT-(AF)2 showed the appearance of 
a species with an m/z of 1103.472. This corresponded precisely to the mass of 
the GT-(AF)2 ie., (326.9 + (2 x 388.35)) (Figure 6.8 and Table 6.2). GT-(AF)2 is 
a stable molecular species detectable by MALDI-ToF MS. No product was 
detectable by MALDI-ToF MS either without prior reduction or in the absence 
of 5’-IAF (Figure 6.8).  
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Table 6.2 Calculation of the molecular mass of GT-(AF)2. The mass of 1103.6 
Da shows that both thiol groups have been labelled with 5’ IAF to produce GT-
(AF)2 which is detectable with absorbance detection at 254 nm.  
Molecular Species Molecular mass 
Gliotoxin 326.9 
Reduced gliotoxin   328.9 
Iodoacetamidofluorescein 515.25   (Atomic mass iodine: 126.90) 
Iodoacetamidofluorescein – Iodine 388.35 
Gliotoxin 2-IAF (GT-(AF)2) 326.9* + (2x(388.35)) = 1103.6 
* gliotoxin loses two H atoms upon labelling with acetamidofluorescein groups. 
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Figure 6.8. MALDI-ToF mass spectrum of GT-(AF)2 prepared by NaBH4-
mediated reduction and alkylation of gliotoxin. (A) A molecular species of m/z 
1103.472 is detectable which corresponds precisely to the molecular mass of the 
diacetamidofluorescein form of gliotoxin, GT-(AF)2. (B) GT-(AF)2 was not 
present either (i) in the absence of prior reduction (NaBH4) or, (ii) the absence 
of 5’-IAF.  
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6.2.4 GT-(AF)2 is detectable by TLC 
GT-(AF)2 can be detected by TLC in 30 min using a 
dichloromethane:methanol solvent system described in Section 2.2.17. (A) GT-
(AF)2 (Gliotoxin: 300 ng (1 nmol)) was evident in lane 1. Free 5’-IAF was 
evident in lane 2. No GT-(AF)2 was detectable without prior NaBH4-mediated 
reduction in lane 3. (B) GT-(AF)2 (Gliotoxin: 150 ng (0.5 nmol)) was evident in 
lane 1. Free 5’-IAF was evident in lane 2. No GT-(AF)2 was detectable without 
prior NaBH4-mediated reduction in lane 3 (Figure 6.9). 
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Figure 6.9. Thin Layer Chromatography analysis of labelled and unlabelled 
gliotoxin. Solvent system was dichloromethane:methanol (90:10), containing 
1% (v/v) acetic acid. (A) Lane 1: Gliotoxin (300 ng) + NaBH4 + 5’-IAF: GT-
(AF)2 was detected. Lane 2: 5’-IAF only. Lane 3: Gliotoxin – NaBH4 + 5’-IAF: 
No GT-(AF)2 was detected. (B) Lane 1: Gliotoxin (150 ng) + NaBH4 + 5’-IAF: 
GT-(AF)2 was detected. Lane 2: 5’-IAF only. Lane 3: Gliotoxin – NaBH4 + 5’-
IAF: No GT-(AF)2 was detected. 
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6.2.5 Limit of detection for Reduction and Alkylation of Gliotoxin  
A calibration curve for the detection of GT-(AF)2 was generated by 
performing a reduction and alkylation titration on a range of gliotoxin amounts 
(0 – 2000 pmol) with subsequent separation by RP-HPLC (Table 2.8 and 
Section 2.2.14.1). The corresponding peak areas (mean ± SD; 93 ± 2.828) were 
plotted with respect to the labelled gliotoxin amount. The limit of detection for 
free gliotoxin is 125 pmol which corresponds to 50 ng (Figure 6.10).  
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Figure 6.10. Limit of detection of GT-(AF)2. A range of gliotoxin amounts 
were subjected to sequential reduction and alkylation. The limit of detection is 
125 pmol which equates to 50 ng gliotoxin (peak area mean ± SD; 93 ± 2.828; 
error bars represent the standard deviation).  
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6.2.6 Reduction and alkylation of native gliotoxin produced by A. fumigatus 
using three different methods 
Reduction and alkylation of native gliotoxin produced by A. fumigatus 
was performed using different amounts of 5’-IAF and different RP-HPLC 
methods (Table 2.8 and Table 2.10). A summary of these differences is 
described in (Table 6.3). Changes in gradient (% ! B/min) facilitated better 
resolution of GT-(AF)2 from free 5’-IAF. Method 1 (Section 2.2.20.1) 
employed the gradient described in Table 2.8 (4.75 % ! B/min), which resulted 
in poor resolution of GT-(AF)2 from free 5’ IAF. Method 2 (Section 2.2.20.2) 
used the gradient described in Table 2.10 (4 % ! B/min). A modest 
improvement in resolution of GT-(AF)2 from free 5’IAF. However, excessive 
free 5’IAF impaired the resolution. To improve this, method 3 (Section 
2.2.20.3) reduced the amount of 5’ IAF from 400 nmol to 120 nmol. This 
combined with the gradient described in Table 2.10 (4 % ! B/min) resulted in 
optimal baseline resolution of GT-(AF)2 from free 5’-IAF.  
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Table 6.3. Methods developed for optimal reduction and alkylation of native gliotoxin produced by A. fumigatus with prior organic extraction. 
Method 3 is the fully optimised method developed for this purpose.  
 Volume of Organic Extracts (µl)  IAF Amount (nmol) HPLC Gradient 
Method 1 100 400 Gradient 1 (Table 2.8) 
4.75 % ! B/min 
Method 2 100 400 Gradient 3 (Table 2.10) 
4 % ! B/min 
Method 3 100 120 Gradient 3 (Table 2.10) 
4 % ! B/min 
         % ! B/min refers to the change in % of acetonitrile over 1 min.   
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6.2.6.1 Reduction and alkylation of native gliotoxin produced by A. 
fumigatus: Method 1. 
Detection of native gliotoxin produced by A. fumigatus was achieved 
using the previously established method for the detection of gliotoxin. Organic 
extracts from A. fumigatus cultures (Section 2.2.11) were obtained and 
subjected to sequential reduction and alkylation (Section 2.2.20.1). RP-HPLC 
separation (Table 2.8) with absorbance detection at 254 nm identified native 
GT-(AF)2 at RT = 15.218 min (Figure 6.11). However, resolution of GT-(AF)2 
was poor, due to the similar retention time of 5’ IAF.  
 
6.2.6.2 Reduction and alkylation of native gliotoxin produced by A.    
fumigatus: Method 2. 
Improved separation of GT-(AF)2 from 5’-IAF was achieved using a 
different HPLC gradient (Table 2.10). Organic extracts from A. fumigatus 
cultures (Section 2.2.11) were obtained and subjected to sequential reduction 
and alkylation (Section 2.2.20.2). RP-HPLC separation (Table 2.10) with 
absorbance detection at 254 nm identified native GT-(AF)2 at RT = 16.745 min 
(Figure 6.12). Resolution of GT-(AF)2 from free 5’IAF improved using this 
method. However, further optimisation was required.  
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Figure 6.11. Method 1 separation of GT-(AF)2. RP-HPLC chromatogram of 
reduced and alkylated organic extracts of A. fumigatus AF293 culture 
supernatant. Absorbance detection at 254 nm identified GT-(AF)2 at RT = 
15.218 min.  
GT-(AF)2 
1
5
.2
1
8
 
Retention Time  
A
b
so
rb
an
ce
 
 330 
    
 
 
 
 
 
 
 
 
 
 
 
Figure 6.12. Method 2 separation of GT-(AF)2. RP-HPLC chromatogram of 
reduced and alkylated organic extracts of A. fumigatus AF293 culture 
supernatant. Absorbance detection at 254 nm identified GT-(AF)2 at RT = 
16.745 min. 
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6.2.6.3 Reduction and alkylation of native gliotoxin produced by A.  
fumigatus: Method 3. 
Improved separation of GT-(AF)2 from 5’-IAF was achieved using less 
5’-IAF and HPLC gradient 3 (Table 2.10). This method achieved baseline 
resolution between GT-(AF)2 and free 5’-IAF. Organic extracts from A. 
fumigatus cultures (Section 2.2.11) were obtained and subjected to sequential 
reduction and alkylation (Section 2.2.20.3). Absorbance detection at 254 nm 
identified native GT-(AF)2 at RT = 16.345 min (Figure 6.13). A reduced amount 
of 5’ IAF (120 nmol) decreased the peak area of free 5’ IAF which had 
previously affected the resolution of GT-(AF)2 from 5’-IAF. Table 6.4 
summarises Method 3.  
 
 Table 6.4. Optimised method 3 used for the reduction and alkylation of native 
gliotoxin produced by A. fumigatus with prior organic extraction. 
 Volume of Organic 
Extracts (µl)  
IAF Amount (nmol) HPLC Gradient 
Method 3 100 120 Gradient030  3           
(Table 2.10) 
4 % ! B/min 
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Figure 6.13. Method 3 separation of GT-(AF)2. RP-HPLC chromatogram of 
reduced and alkylated organic extracts of A. fumigatus AF293 culture 
supernatant. Absorbance detection at 254 nm identified GT-(AF)2 at RT = 
16.345 min. Baseline resolution between 5’IAF (RT = 15.766 min) and GT-
(AF)2 was achieved.  
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6.2.7 Detection of gliotoxin spiked into A. fumigatus culture supernatants 
without prior organic extraction.  
Reduction and alkylation of gliotoxin spiked into A. fumigatus culture 
supernatants, without prior organic extraction, was achieved (Section 2.2.21). 
pH adjusted supernatants were spiked with gliotoxin to a final concentration of 
327 µg/ml. The spiked supernatant was then reduced (NaBH4 ; 50 mM or 500 
mM) and subsequently alkylated.  
 
6.2.7.1 Detection of GT-(AF)2 from culture supernatant (without organic 
extraction) which had been spiked with gliotoxin  
Reduction (NaBH4; 50 mM) and alkylation of pH adjusted supernatants 
which had been spiked with a known amount of gliotoxin without organic 
extraction identified GT-(AF)2 (Section 2.2.21.1). Briefly, A. fumigatus culture 
supernatants were pH adjusted to pH 7.5 followed by the addition of gliotoxin. 
DMSO was added to the reaction mixture to maintain the solubility of unreacted 
5’ IAF. Reduction (NaBH4; 50 mM) of the gliotoxin spiked supernatant and 
alkylation was performed. The pH adjusted culture supernatants were not 
organically extracted. Absorbance detection at 254 nm identified GT-(AF)2 at 
RT = 15.520 min (Figure 6.14).  
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6.2.7.2 Detection of GT-(AF)2 from culture supernatant (without organic 
extraction) which had been spiked with gliotoxin  
Reduction (NaBH4; 500 mM) and alkylation of pH adjusted supernatants 
which had been spiked with a known amount of gliotoxin without organic 
extraction identified GT-(AF)2 (Section 2.2.21.2). Briefly, A. fumigatus culture 
supernatants were pH adjusted to pH 7.5 followed by the addition of gliotoxin. 
DMSO was added to the reaction mixture to maintain the solubility of unreacted 
5’ IAF. Reduction (NaBH4; 500 mM) of the gliotoxin spiked supernatant and 
alkylation was performed. Absorbance detection at 254 nm identified GT-(AF)2 
at RT = 15.519 min (Figure 6.14). The use of NaBH4 at a concentration of 500 
mM suppressed the absorbance of free 5’ IAF. 
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Figure 6.14. RP-HPLC analysis of reduced and alkylated A. fumigatus pH 
adjusted supernatant spiked with gliotoxin without organic extraction. (A) A. 
fumigatus AF293 supernatant pH 7.5, spiked to a final gliotoxin concentration 
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(327 µg/ml), following NaBH4 (50 mM) reduction and subsequent labelling 
with 5’-IAF. Absorbance detection at 254 nm identified GT-(AF)2 with a RT = 
15.520 min. (B) A. fumigatus AF293 supernatant pH 7.5, spiked with a final 
gliotoxin concentration (327 µg/ml), following NaBH4 (500 mM) reduction and 
subsequent labelling with 5’-IAF. Absorbance detection at 254 nm identified 
GT-(AF)2 with a RT = 15.519 min. The use of NaBH4 at a concentration of 500 
mM suppressed the absorbance of free 5’ IAF. 
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6.2.8  Detection of GT-(AF)2 (without organic extraction) following 
reduction (500 mM NaBH4) and alkylation of A. fumigatus culture 
supernatant.  
Reduction (NaBH4; 500 mM) and alkylation of pH adjusted supernatants 
without the need for organic extraction identified GT-(AF)2 (Section 2.2.22). A. 
fumigatus culture supernatants were pH adjusted to pH 7.5. Reduction (NaBH4; 
500 mM) followed by alkylation with 5’-IAF was performed. Culture 
supernatants were not organically extracted. GT-(AF)2 was identified at RT = 
16.793 min (Figure 6.15). The use of NaBH4 at a concentration of 500 mM 
suppressed the absorbance of free 5’ IAF. GT-(AF)2 was absent when NaBH4 
was not added (Figure 6.15). A summary of the optimised conditions for 
detection of gliotoxin in supernatant is presented in Table 6.5. 
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Table 6.5. Method developed for optimal reduction and alkylation of native gliotoxin in A. fumigatus culture supernatant without prior organic 
extraction.  
 
 
 
 
 
 
pH Adjusted Supernatant 
(pH 7.5) (µl) 
500 mM NaBH4 (µl) 5’-IAF Amount (nmol) HPLC Gradient 
100 2.5 120 Gradient 3 (Table 2.10) 
4 % ! B/min 
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Figure 6.15. RP-HPLC analysis of reduced and alkylated A. fumigatus pH 
adjusted supernatant without organic extraction. (A) A. fumigatus AF293 
supernatant pH 7.5, following NaBH4 (500 mM) reduction and subsequent 
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labelling with 5’-IAF. Absorbance detection at 254 nm identified GT-(AF)2 with 
a RT = 16.793 min. (B) A. fumigatus AF293 supernatant pH 7.5, without NaBH4 
reduction and with subsequent labelling using 5’-IAF. Absorbance detection at 
254 nm identified no GT-(AF)2, but identified gliotoxin with a RT = 15.493 min.  
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6.3 Discussion 
A novel method for the detection of gliotoxin has been developed. Firstly, 
it has been demonstrated that NaBH4 is a superior choice of reductant, when 
compared to DTT and TCEP. NaBH4 does not require removal prior to 
alkylation of thiols using 5’ IAF. Secondly, GT-(AF)2 offers a higher molar 
absorption (6.8 – fold increase) in comparison to unlabelled gliotoxin. The 
detection of GT-(AF)2 is possible with RP-HPLC or TLC analysis and can also 
be detected by MALDI-ToF MS, where the GT-(AF)2 compound has been 
shown to exhibit a molecular mass of 1103.47. The detection of native A. 
fumigatus gliotoxin in organic extracts and in pH-adjusted culture supernatants 
is possible. An increase in the molar excess of NaBH4 during native gliotoxin 
reduction in culture supernatants appears to suppress free 5’ IAF interference 
during RP-HPLC analysis. Overall a more convenient method for gliotoxin 
detection has been developed which offers a higher sensitivity and specificity 
compared to current methods.  
 The diagnosis of infection by A. fumigatus has proven to be particularly 
difficult which in part is due to the trouble associated with culturing of A. 
fumigatus clinical samples (Tarrand et al., 2005). Diagnosis relies primarily on 
PCR-based and carbohydrate (galactomannan) detection methods (Mennink-
Kersten et al., 2004a; White et al., 2010). The detection of ETP produced by 
filamentous fungi offers the potential for application in a clinical setting and in 
particular, the early diagnosis of invasive fungal infection of A. fumigatus 
(Lewis et al., 2005a). Lewis et al. (2005) reported the detection of gliotoxin in 
the lungs (3.976 ng/g tissue) and sera (36.5 ng/ml) of mice with experimentally 
induced invasive aspergillosis (IA). Currently there are two methods of choice 
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for the detection of gliotoxin, RP-HPLC and LC-MS analysis; RP-HPLC 
measures the absorbance of the compound in the UV spectrum (Scharf et al., 
2010; Schrettl et al., 2010), while LC-MS analysis is a more sensitive approach 
to gliotoxin detection as it identifies the gliotoxin parent ion and associated 
daughter ions (Bok et al., 2006; Kupfahl et al., 2006; Spikes et al., 2008). 
Although these two methods of detection can conclusively detect gliotoxin, they 
both involve expensive equipment and sample preparation can be quite time-
consuming. The use of commercial assays such as the Microtox® test (Alba et 
al., 2009) for the detection of gliotoxin and related ETP offer detection limits of 
0.35 – 0.37 µg/ml (Nieminen et al., 2002; Alba et al., 2009) and 18 – 20 ng/well 
(Grovel et al., 2006). Although this detection limit is quite low the specificity of 
the Microtox® test to gliotoxin is not clear (Alba et al., 2009). The sequential 
reduction and alkylation of gliotoxin followed by TLC, RP-HPLC or MALDI-
ToF detection offers a new direction for the detection of gliotoxin and 
consequently related ETP. The molar absorption of GT-(AF)2 (2 µg gliotoxin; 
peak area = 8772) generated via NaBH4-mediated reduction is almost seven-
fold higher when compared to the unlabelled gliotoxin (2 µg gliotoxin; peak 
area = 1287). This is due to the increased molar extinction coefficient and 
enhanced spectral properties of GT-(AF)2 when compared to gliotoxin. NaBH4 
is the optimal reductant used in the generation of GT-(AF)2 as it requires no pH 
adjustment, unlike TCEP, and it does not require removal prior to alkylation. 
TCEP-generated GT-(AF)2 exhibits higher spectral properties (2 µg gliotoxin; 
11260) in comparison to NaBH4 generated  GT-(AF)2 (8772). This is most 
likely due to the buffering with TCEP, which reduces more gliotoxin. 
Therefore, TCEP reduction of gliotoxin produces more GT-(AF)2. Fluorescence 
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of the GT-(AF)2 compound is also observed, however the fluorescence of this 
compound appears to be significantly quenched, as the fluorescein quantum 
yield (QY) can be adversely affected by environments below pH 7.0 
(Hermanson, 2008). Exposure to light also significantly quenches fluorescence 
and this quenching effect can be as much as 50 % when the fluorescein 
derivative is conjugated to proteins (Hermanson, 2008). However, absorbance 
detection is the primary focus of this Chapter as enhanced spectral properties of 
GT-(AF)2 are observed at 254 nm. The enhancement of sensitivity for the 
detection of thiol-containing compounds has not been observed before (Hansen 
et al., 2009), and this assay may find use in other disulphide bridge containing 
compounds (e.g. sirodesmin, sporidesmin) (Gardiner et al., 2005b).  
The use of NaBH4 in the reduction of disulphides has been previously 
demonstrated (Hansen et al., 2007; Schrettl et al., 2010). Hansen et al. (2007) 
used NaBH4 reduction of protein disulphides and subsequent reaction with 4,4’-
dithiodipyridine, where the quantitation of a liberated 4-thiopyridone enabled 
pmol levels of detection of protein thiols. This approach required several 
experimental considerations; firstly the addition of hexanol to prevent foaming 
during reduction (a by-product of NaBH4). Secondly, incubation of the reaction 
at 50 °C for 30 min. Thirdly, the destruction of excess NaBH4 by acidification 
prior to the addition of 4,4’-dithiodipyridine. The use of NaBH4 confers instant 
reduction of gliotoxin (T = 0 min), which is maintained up to and including 120 
min post addition and no elevated temperature requirement was necessary as 
this reduction occurs at room temperature (20 °C). Interestingly, it was observed 
that the use of excess NaBH4 in the reduction and alkylation of native gliotoxin 
appears to minimise the interference of free 5’-IAF with GT-(AF)2, which can 
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otherwise hinder HPLC resolution. Reduction and alkylation is specific towards 
gliotoxin and other disulphide bridge compounds, which is in contrast to 4-
thiopyridone liberation as this method is an indirect measure of thiol 
quantitation and could result from the non-specific reduction of 4,4’-
dithiodipyridine (Hansen et al., 2007). 
In summary, the detection of GT-(AF)2 was possible by HPLC, TLC and 
MALDI-ToF MS. Optimal reduction of gliotoxin was achieved with NaBH4, 
followed by alkylation with 5’-IAF to yield GT-(AF)2. Stable GT-(AF)2 
exhibited enhanced spectral properties when compared to unlabelled gliotoxin 
(6.8 – fold higher). Fluorescence detection of GT-(AF)2 was also confirmed, 
however fluorescent quenching of the gliotoxin product was observed. Unlike 
free gliotoxin, GT-(AF)2 is detectable by MALDI-ToF MS. The detection of 
gliotoxin in culture supernatant without organic extraction was achieved (mean 
± SD 3.55 ± 0.07 mg/ 100 ml; n = 2) and GT-(AF)2 was also detectable by TLC 
(150 ng; 500 pmol). Further optimisation of this assay to reduce the limit of 
detection could afford application within a clinical environment. Ultimately, this 
could allow for the specific detection of A. fumigatus infection and allow for 
administration of the correct anti-fungal agents before the advancement of 
fungal infection.  
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7. Final Discussion 
The work presented in this thesis describes the characterisation of a GST, 
gliG, which forms part of the co-regulated gliotoxin gene cluster in the 
opportunistic human fungal pathogen A. fumigatus. The development of a novel 
diagnostic assay for the detection of a disulphide bridge or thiol groups was also 
described.  
IA is the most common form of invasive infection caused by A. fumigatus 
(Thompson and Patterson, 2008), and it accounts for 4 % of all hospital-based 
deaths in European hospitals (Brookman and Denning, 2000). The status of A. 
fumigatus infection has changed over the last few decades due to the rise in 
immunosuppressive therapies (Latge, 2001), which causes prolonged 
neutropenia in the treatment of cancer and leukemia individuals. IA is the most 
devastating A. fumigatus infection targeting this patient cohort (Dagenais and 
Keller, 2009), and it usually results in a mortality rate of 80 – 95 % (Brakhage 
and Langfelder, 2002; Rementeria et al., 2005). The use of aggressive anti-
fungal agents are not successful as a curative treatment with mortality usually 
occurring 7 – 14 days post-diagnosis (Denning, 1996). Diagnosis usually 
involves PCR-based and galactomannan detection methods (Mennink-Kersten 
et al., 2004a; White et al., 2010), which can be hampered by difficult in 
culturing of the fungus from clinical samples (Tarrand et al., 2005). As infection 
by A. fumigatus is multigenic and involves the cross talk between SM and the 
immune state of the host (Ben-Ami et al., 2010; Wezensky and Cramer, 2011), 
the detection of SM, and in particular gliotoxin, offer the potential for the early 
diagnosis of A. fumigatus infection. It has been demonstrated that the 
expression of the gliotoxin gene cluster occurs at the onset of invasive 
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aspergillosis (McDonagh et al., 2008), and it has been confirmed that gliotoxin 
can be detected in the lungs and sera of mice which had been experimentally 
induced to develop IA (Lewis et al., 2005), these authors also confirmed that it 
has been detected in the sera of patients with aspergillosis. One aspect of the 
work performed for this thesis described a novel diagnostic assay for the 
detection of disulphide bridges and thiols. Chapter 6 described the use of this 
assay for the detection of gliotoxin in A. fumigatus culture extracts and 
supernatants. This assay could be applied for the detection of gliotoxin which is 
produced during A. fumigatus infection (Lewis et al., 2005; McDonagh et al., 
2008), and therefore could assist with the correct and early diagnosis of ETP-
secreting fungi. Further optimisation of this assay on other ETP compounds 
(e.g., sirodesmin) may afford a simple and accurate method for fungal diagnosis 
and in particular for the early detection of IA. 
The detection of mycotoxins produced by A. fumigatus is an important 
tool for diagnosing fungal infection, however uncovering the complex 
biosynthesis behind the production of these SM warranted further investigation 
(Kamei and Watanabe, 2005). Comparative genomics and sequence analysis of 
the A. fumigatus genome identified the 13-member gene cluster responsible for 
gliotoxin production (Gardiner and Howlett, 2005; Schrettl et al., 2010). A. 
fumigatus gliG forms part of this co-regulated gene cluster (Gardiner and 
Howlett, 2005). In silico analysis predicted gliG to be a GST (Gardiner and 
Howlett, 2005) and work carried out prior to the commencement of this thesis 
confirmed that gliG exhibited GST activity (Carberry, 2008). Previously, 
speculation as to the role of A. fumigatus gliG identified a potential role in the 
self-protection or the biosynthesis of gliotoxin (Gardiner et al., 2004; 
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McGoldrick et al., 2005; Gardiner et al., 2005b). The work presented in this 
thesis confirms a biosynthetic role but not a self-protection role for A. fumigatus 
gliG. Support for this is based on several observations throughout this work.  
Firstly, phylogenetic analysis of the A. fumigatus gliG against 104 other 
sequenced fungal genomes confirmed that A. fumigatus gliG did not group with 
other GST from the A. fumigatus genome, instead, it grouped with other ETP 
producing fungi. This observation suggested that A. fumigatus gliG must exhibit 
differential GST activity within the co-regulated gliotoxin gene cluster.  
Secondly, targeted gene deletion allowed for the functional 
characterisation of A. fumigatus gliG, which lead to the following observations; 
A. fumigatus !gliG did not exhibit sensitivity to exogenous gliotoxin (10 – 50 
µg/ml), unlike the sensitivity of A. fumigatus !gliT in the presence of gliotoxin 
(10 µg/ml) which was confirmed as the gliotoxin reductase (Schrettl et al., 
2010). This eliminated the possibility that A. fumigatus gliG played a role in 
self-protection against gliotoxin. Comparative HPLC of culture extracts 
identified M12.3 and not gliotoxin in the A. fumigatus !gliG extract.  
Thirdly, structural elucidation identified a resemblance between M12.3 and 
gliotoxin, with the most significant difference being that M12.3 did not contain 
a disulphide bridge or thiol groups. Notably, M12.3 contained a hydroxyl group 
located at position 6 and a 1, 1-disubstituted alkene at position 7. The presence 
of this hydroxyl group has supported the hypothesis for gliG-mediated sulphur 
incorporation into gliotoxin, which subsequently lead to a new biosynthetic 
pathway for gliotoxin production Figure 7.1.  
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Figure 7.1. Proposed gliotoxin biosynthetic pathway. Following GliP-mediated 
conjugation of L-phenylalanine and L-serine, a set of hydroxylation and 
dehydration events produce an acyl imine intermediate (7). Thiolation occurs 
through GliG-mediated glutathionylation. This may be followed by GliJ 
peptidase activity and subsequent GliI thioesterase activity, leaving the 
sulphurised intermediate which undergoes GliT-mediated oxidation to produce 
gliotoxin (1). Compound 4, 6-benzyl-6-hydroxy-1-methoxy-3-
methylenepiperazine-2,5-dione is an off-pathway shunt product produced in the 
absence of gliG.  
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The hypothesis for gliG-mediated incorporation of sulphur using GSH as 
a substrate is as follows; M12.3 is not an on-pathway intermediate but it is an 
off-pathway shunt product, which accumulates in the absence of A. fumigatus 
gliG, however, without the identification and characterisation of this metabolite 
this hypothesis would not have been possible. Due to the structural similarity of 
M12.3 (4) to gliotoxin (1) and cyclo-L-Phe-L-Ser (2) it is likely that 4 is a shunt 
metabolite from the gliotoxin biosynthetic pathway. It is proposed that 2 
undergoes hydroxylation at C6 which is believed to be catalysed by the putative 
cytochrome P450 monoxygenase (GliC/GliF) to yield 5. The subsequent 
hydroxylation of 5 at N1 (GliC/GliF) followed by O-methylation (possibly 
catalysed by the putative O-methyltransferase; gliM) and finally the elimination 
of water from C3/C7 would give the shunt metabolite 4. The incorporation of 
the O-CH3 at N1 may occur off-pathway as a self-protection mechanism against 
the reactive on-pathway intermediates. The proposed GliC/GliF-catalysed 
hydroxylation of 5 at C3 would produce compound 6 in the biosynthetic 
pathway. This metabolite (5) can lose two water molecules to yield the 2, 5-
pyrazinedione (7). This intermediate contains the reactive acyl imine, which is 
key to gliG GSH-mediated sulphur incorporation. This acyl imine intermediate 
would undergo GliG-catalysed addition of two GSH molecules yielding 8. The 
putative dipeptidase, A. fumigatus GliJ is proposed to catalyse hydrolytic 
removal of the Glu residues in 8 to give 9. This GliJ-mediated deprotection of 
the cysteine amino groups allows the condensation with GliI-bound PLP. In this 
biosynthetic pathway it is proposed that GliI catalyses two pyridoxal-mediated 
", #-elimination reactions of 9 to afford 6-benzyl-3-hydroxymethylpiperazine-
2.5-dione-3, 6-thiol (10). Subsequent GliN-catalysed N4 methylation of 10 with 
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epoxidation of the aromatic ring (catalysed by GliC/GliF) and the epoxide 
opening of N1 would afford reduced gliotoxin (3). Reduced gliotoxin has been 
confirmed to undergo GliT-mediated oxidation to produce gliotoxin (1) (Scharf 
et al., 2010; Schrettl et al., 2010; Li and Walsh, 2011).  
A second hypothesis was also considered for the A. fumigatus gliG-
mediated sulphur incorporation to gliotoxin with GSH as a substrate. This 
second hypothesis considered the epoxide conjugating activity exhibited by 
GliG (Chapter 4) and the presence of the 1,1-disubstituted alkene at position 7 
as key factors in sulphur incorporation. It was proposed that the CH2OH of L-
serine undergoes dehydration during biosynthesis and that this exocyclic alkene 
was essential for thiolation of M12.3 by co-ordinated epoxidation and s-
transferase activity. As discussed in Chapter 4, A. fumigatus GliG has been 
shown to exhibit considerably higher epoxide conjugating GST activity when 
compared to the other GST substrates. Based on this observation, it was 
proposed that thiolation of M12.3 occurred at position 3. This was thought to 
occur through monoxygenase-mediated epoxidation (Perry and Smith, 2006; 
Lonsdale et al., 2010) of the C3-C7 alkene followed by GliG-mediated 
thiolation, using GSH as a substrate, and the simultaneous regeneration of the –
CH2OH moiety. This hypothesis was supported by two factors (i) the presence 
of two cytochrome P450 monoxygenase genes (gliC/gliF) within the gli cluster 
and, (ii) this monoxygenase functionality to yield reactive intermediates has 
been previously demonstrated (Guengerich, 2003; Lonsdale et al., 2010). It was 
also proposed that thiolation at position 6 occurred after thiol incorporation at 
position 3. Dehydration at C6-C8 would result in alkene formation, and 
subsequent GliG-mediated thiolation in the same manner as proposed to occur 
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at position 3. Following GliG-mediated thiol incorporation into M12.3 it was 
proposed that A. fumigatus GliI may provide the thioesterase activity required to 
cleave the C-S bond after GSH-mediated thiol incorporation. A. fumigatus gliI 
has a putative function as an aminocyclopropane-I carboxylic acid synthetase, in 
silico analysis identified a cystine lyase domain which is known to exhibit 
thioesterase activity (Fox and Howlett, 2008). It was postulated that A. 
fumigatus GliI could provide the activity required for the formation of 
dithiogliotoxin, prior to A. fumigatus GliT-mediated oxidation of gliotoxin 
(Scharf et al., 2010; Schrettl et al., 2010). The inactivation of aflatoxin B1 by 
mammalian systems exhibits a similar mechanism of epoxidation and GST-
mediated GSH conjugation (Raney et al., 1992; Guengerich, 2003).  
However, the presence of an acyl imine reactive intermediate was 
considered to be a more likely hypothesis. The presence of this acyl imine 
reactive intermediate (7) has received some attention in earlier gliotoxin 
biosynthetic studies (Sammes, 1975; Herscheid et al., 1979). Sammes (1975) 
postulated that sulphur incorporation may be mediated via an acyl imine 
intermediate, however these authors did not have an explanation as to how these 
reactive intermediates are formed in vivo. It was later proposed by Herscheid et 
al. (1979) that oxidation of the amide nitrogen, such as those in the piperazine 
ring, forms hydroxamic acids, which subsequently undergo dehydration to the 
reactive acyl imines. These authors successfully synthesised a sulphur-bridged 
dioxopiperazine using H2S/ZnCl2 as a source of sulphur. Interestingly, they 
identified stability issues with the reactive acyl imine intermediates which 
confirms that in the absence of A. fumigatus gliG the shunt metabolite M12.3 
accumulates and the N1 functionalisation with the O-Me group could be an off-
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pathway or a self-protection mechanism by the fungus against the highly 
reactive acyl imine intermediates generated during gliotoxin biosynthesis which 
may be deleterious to the cell. 
Investigation into gliotoxin biosynthesis began after it was isolated in 1936 
(Weindling and Emerson, 1936) and studies into the biosynthesis of gliotoxin 
confirmed phenylalanine and serine as the amino acid precursors (Suhadolnik 
and Chenoweth, 1958; Winstead and Suhadolnik, 1960; Bu'Lock and Leigh, 
1975).  The availability of the sequenced genome of A. fumigatus and the 
identification of the gliotoxin gene cluster (Gardiner and Howlett, 2005; 
Nierman et al., 2005) has allowed characterisation of the in vivo enzymes 
responsible for gliotoxin biosynthesis. A. fumigatus gliP and gliT have been 
confirmed as responsible for the first and last biosynthetic step in gliotoxin 
formation, respectively (Balibar and Walsh, 2006; Scharf et al., 2010; Schrettl 
et al., 2010). This thesis described a novel detection method used to detect 
gliotoxin in the culture supernatant of A. fumigatus and it has also described the 
functional genomics approach to confirm the function of a gene within the 
gliotoxin cluster. We propose that sulphur incorporation into gliotoxin is 
mediated by the A. fumigatus GST gliG via an acyl imine intermediate using 
GSH as a substrate. This function of a fungal GST is the first reported case that 
this class of enzyme is involved in biosynthesis and represents a new direction 
in GST biochemistry. The significance of these findings will have an impact on 
future work performed on other ETP biosynthesis (e.g., sirodesmin, 
sporidesmin) (Gardiner et al., 2005b) and may allow for the design of inhibitors 
of homologues of A. fumigatus gliG. These inhibitors may lessen the symptoms 
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and effects of gliotoxin in vivo and they may alleviate the symptoms of other 
fungal ETP toxins.  
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9. Appendix I 
Table 9.1 Putative GST in the A. fumigatus genome (AF293). A. fumigatus gliG is 
highlighted in bold (CADRE identification; AFUA_6G09690). 
Cadre Identifier 
AFUA_1G01370 
AFUA_1G07030 
AFUA_1G17010 
AFUA_1G17120 
AFUA_2G04240 
AFUA_2G00590 
AFUA_2G08370 
AFUA_2G02490 
AFUA_2G15770 
AFUA_2G17300 
AFUA_3G00730 
AFUA_3G07930 
AFUA_3G10830 
AFUA_4G01440 
AFUA_4G14100 
AFUA_4G11770 
AFUA_4G14530 
AFUA_6G00760 
AFUA_6G03390 
AFUA_6G04260 
AFUA_6G04570 
AFUA_6G09690 
AFUA_7G05500 
AFUA_7G06460 
AFUA_8G00580 
AFUA_8G02500 
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Fungal Species  URL Address where the genome is available from 
Agaricus bisporus var bisporus (H97) http://genome.jgi-psf.org/Agabi_varbisH97_2/Agabi_varbisH97_2.download.ftp.html 
Agaricus bisporus var. burnettii JB137-S8 http://genome.jgi-psf.org/Agabi_varbur_1/Agabi_varbur_1.download.ftp.html 
Allomyces macrogynus http://www.broadinstitute.org/annotation/genome/multicellularity_project/MultiDownloads.html 
Alternaria brassicicola ATCC 96836 http://genomeportal.jgi-psf.org/Altbr1/Altbr1.download.ftp.html 
ashbya_gossypii_ATCC_10895 http://www.ebi.ac.uk/integr8/FtpSearch.do?orgProteomeId=982&currentclicked=DOWNLOADS 
Aspergillus carbonarius http://genome.jgi-psf.org/Aspca3/Aspca3.download.ftp.html 
Aspergillus clavatus http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiDownloads.html 
Aspergillus flavus http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiDownloads.html 
Aspergillus fumigatus Af293 http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiDownloads.html 
Aspergillus nidulans FGSCA4 http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiDownloads.html 
Aspergillus niger CBS 513.88 http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiDownloads.html 
Aspergillus oryzae RIB40 http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiDownloads.html 
Aspergillus terreus NIH 2624 http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiDownloads.html 
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Batrachochytrium dendrobatidis JEL423 http://genome.jgi-psf.org/Batde5/Batde5.download.ftp.html 
Blastomyces dermatitidis http://www.broadinstitute.org/annotation/genome/blastomyces_dermatitidis/MultiDownloads.html 
Botryotinia cinerea  http://www.broadinstitute.org/annotation/genome/botrytis_cinerea.2/MultiDownloads.html 
Candida albicans SC5314 http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiDownloads.html 
Candida dubliniensis ftp://ftp.sanger.ac.uk/pub/pathogens/Candida/dubliniensis 
Candida glabrata CBS 138 http://www.genolevures.org/download.html#cagl 
Candida guilliermondii  http://www.broadinstitute.org/annotation/genome/candida_group/MultiDownloads.html 
Candida lusitaniae ATCC 42720 http://www.broadinstitute.org/annotation/genome/candida_group/MultiDownloads.html 
Candida parapsilosis CDC317 http://www.broadinstitute.org/annotation/genome/candida_group/MultiDownloads.html 
Candida tropicalis MYA3404 http://www.broadinstitute.org/annotation/genome/candida_group/MultiDownloads.html 
Chaetomium globosum CBS 148.51 http://www.broadinstitute.org/annotation/genome/chaetomium_globosum.2/MultiDownloads.html 
Coccidioides immitis RS http://www.broadinstitute.org/annotation/genome/coccidioides_group/MultiDownloads.html 
Coccidioides posadasii str. Silveira http://www.broadinstitute.org/annotation/genome/coccidioides_group/MultiDownloads.html 
Cochliobolus heterostrophus ftp://ftp.jgi-psf.org/pub/JGI_data/Cochliobolus_heterostrophus_C5/v1.0/ 
Coprinopsis cinerea (strain Okayama7 / 
130 / FGSC 9003) 
http://www.broadinstitute.org/annotation/genome/coprinus_cinereus/MultiDownloads.html 
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Cryphonectria parasitica http://genomeportal.jgi-psf.org/Crypa1/Crypa1.download.ftp.html 
Cryptococcus gattii R265 (neoformans 
Serotype B) 
http://www.broadinstitute.org/annotation/genome/cryptococcus_neoformans_b/MultiDownloads.ht
ml 
Cryptococcus neoformans var. grubii H99 http://www.broadinstitute.org/annotation/genome/cryptococcus_neoformans/MultiDownloads.html 
Debaryomyces hansenii CBS767 http://www.genolevures.org/download.html#deha 
Fusarium graminearum http://www.broadinstitute.org/annotation/genome/fusarium_graminearum/MultiDownloads.html 
Fusarium oxysporum f. sp. lycopersici http://www.broadinstitute.org/annotation/genome/fusarium_graminearum/MultiDownloads.html 
Fusarium verticillioides  http://www.broadinstitute.org/annotation/genome/fusarium_graminearum/MultiDownloads.html 
Heterobasidion annosum ftp://ftp.jgi-psf.org/pub/JGI_data/Heterobasidion_annosum/ 
Histoplasma capsulatum (strain NAm1 / 
WU24)  
http://www.broadinstitute.org/annotation/genome/histoplasma_capsulatum/MultiDownloads.html 
Kluyveromyces lactis NRRL Y1140 http://www.genolevures.org/download.html#klla 
Kluyveromyces waltii NCYC 2644  http://fungalgenomes.org/data/PEP/ 
Laccaria bicolor (strain S238NH82) http://genome.jgi-psf.org/Lacbi1/Lacbi1.download.ftp.html 
Lachancea thermotolerans CBS 6340 ftp://ftp.ncbi.nih.gov/genomes/Fungi/Lachancea_thermotolerans_CBS_6340/ 
Lodderomyces elongisporus http://www.broadinstitute.org/annotation/genome/candida_group/MultiDownloads.html 
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Magnaporthe grisea 7015 http://www.broadinstitute.org/cgi-bin/annotation/magnaporthe/download_license.cgi 
Malassezia globosa (strain CBS 7966)  http://genome.jgi-psf.org/Malgl1/Malgl1.download.ftp.html 
Melampsora laricis-populina http://genome.jgi-psf.org/Mellp1/Mellp1.download.ftp.html 
Microsporum canis CBS 113480 http://www.broadinstitute.org/annotation/genome/microsporum_gypseum/MultiDownloads.html 
Microsporum gypseum CBS 118893 http://www.broadinstitute.org/annotation/genome/microsporum_gypseum/MultiDownloads.html 
Moniliophthora perniciosa ftp://ftp.ncbi.nih.gov/refseq/release/fungi/ 
Mucor circinelloides f. lusitanicus http://genome.jgi-psf.org/Mucci1/Mucci1.download.ftp.html 
Mycosphaerella fijiensis CIRAD86 http://genome.jgi-psf.org/Mycfi1/Mycfi1.download.ftp.html 
Mycosphaerella graminicola IPO323 ftp://ftp.jgi-psf.org/pub/JGI_data/Mycosphaerella_graminicola/v2.0/downloads/ 
Nectria haematococca mpVI ftp://ftp.jgi-psf.org/pub/JGI_data/Nectria_haematococca/annotation/v2.0/ 
Neosartorya fischeri (NRRL 181) http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiDownloads.html 
Neurospora crassa OR74A http://www.broadinstitute.org/annotation/genome/neurospora/MultiDownloads.html 
Neurospora discreta FGSC 8579 http://genomeportal.jgi-psf.org/Neudi1/Neudi1.download.ftp.html 
Neurospora tetrasperma FGSC 2508 http://genomeportal.jgi-psf.org/Neute1/Neute1.download.ftp.html 
Paracoccidioides brasiliensis Pb01 http://www.broadinstitute.org/annotation/genome/paracoccidioides_brasiliensis/MultiDownloads.ht
ml 
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Penicillium_chrysogenum_Wisconsin_54
-1255 
 http://fungalgenomes.org/data/PEP/ 
Penicillium_marneffei_ATCC_18224  http://fungalgenomes.org/data/PEP/ 
Phaeosphaeria nodorum http://www.broadinstitute.org/annotation/genome/stagonospora_nodorum.2/MultiDownloads.html 
Phanerochaete chrysosporium RP78  http://genome.jgi-psf.org/Phchr1/Phchr1.download.ftp.html 
Phycomyces blakesleeanus  http://genome.jgi-psf.org/Phybl2/Phybl2.download.ftp.html 
Pichia pastoris ftp://ftp.ncbi.nih.gov/genomes/Fungi/Pichia_pastoris_GS115/ 
Pichia stipitis CBS 6054  http://genome.jgi-psf.org/Picst3/Picst3.download.ftp.html 
Pleurotus ostreatus http://genome.jgi-psf.org/PleosPC15_1/PleosPC15_1.download.ftp.html 
Podospora anserina DSM 980 http://podospora.igmors.u-psud.fr/download.php 
Postia placenta (strain ATCC 44394 / 
Madison 698R) 
http://genome.jgi-psf.org/Pospl1/Pospl1.download.ftp.html 
Puccinia graminis f. sp. tritici http://www.broadinstitute.org/annotation/genome/puccinia_group/MultiDownloads.html 
Pyrenophora triticirepentis strain 
Pt1CBFP 
http://www.broadinstitute.org/annotation/genome/pyrenophora_tritici_repentis.3/MultiDownloads.h
tml 
Rhizopus oryzae RA 99880 http://www.broadinstitute.org/annotation/genome/rhizopus_oryzae/Info.html 
Saccharomyces bayanus MCYC 623 http://downloads.yeastgenome.org/sequence/fungal_genomes/S_bayanus/MIT/orf_protein/ 
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Saccharomyces castelli http://downloads.yeastgenome.org/sequence/fungal_genomes/S_castellii/WashU/orf_protein/ 
Saccharomyces cerevisiae S288c http://downloads.yeastgenome.org/sequence/ 
Saccharomyces kluyveri NRRL Y12651 http://www.genolevures.org/download.html#sakl 
Saccharomyces kudriavzevii IFO 1802 http://downloads.yeastgenome.org/sequence/fungal_genomes/S_kudriavzevii/WashU/orf_protein/ 
Saccharomyces mikatae IFO 1815 http://downloads.yeastgenome.org/sequence/fungal_genomes/S_mikatae/MIT/orf_protein/ 
Saccharomyces paradoxus NRRL Y17217 http://downloads.yeastgenome.org/sequence/fungal_genomes/S_paradoxus/MIT/orf_protein/ 
Schizophyllum commune H48 ftp://ftp.jgi-psf.org/pub/JGI_data/Schizophyllum_commune/v1.0/ 
schizosaccharomyces cryophilus oy26 http://www.broadinstitute.org/annotation/genome/schizosaccharomyces_group/MultiDownloads.ht
ml 
Schizosaccharomyces japonicus (strain 
yFS275 / FY16936) 
http://www.broadinstitute.org/annotation/genome/schizosaccharomyces_group/MultiDownloads.ht
ml 
Schizosaccharomyces octosporus yFS286 http://www.broadinstitute.org/annotation/genome/schizosaccharomyces_group/MultiDownloads.ht
ml 
Schizosaccharomyces pombe 972h ftp://ftp.ncbi.nih.gov/genomes/Fungi/Schizosaccharomyces_pombe/ 
Sclerotinia sclerotiorum (strain ATCC 
18683 / 1980 / Ss1) 
http://www.broadinstitute.org/annotation/genome/sclerotinia_sclerotiorum/MultiDownloads.html 
Serpula lacrymans S7.3 http://genome.jgi-psf.org/SerlaS7_3_2/SerlaS7_3_2.download.ftp.html 
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Spizellomyces punctatus http://www.broadinstitute.org/annotation/genome/multicellularity_project/MultiDownloads.html 
Sporobolomyces roseus IAM 13481 http://genome.jgi-psf.org/Sporo1/Sporo1.download.ftp.html 
Sporotrichum thermophile http://genomeportal.jgi-psf.org/Spoth1/Spoth1.download.ftp.html 
Talaromyces stipitatus ftp://ftp.ncbi.nih.gov/refseq/release/fungi/ 
Thielavia terrestris http://genome.jgi-psf.org/Thite1/Thite1.download.ftp.html 
Tremella mesenterica http://genome.jgi-psf.org/Treme1/Treme1.download.ftp.html 
Trichoderma atroviride IMI 202040 ftp://ftp.jgi-psf.org/pub/JGI_data/Trichoderma_atroviride/v1.0/ 
Trichoderma reesei QM6a http://genome.jgi-psf.org/Trire2/Trire2.download.ftp.html 
Trichoderma virens Gv298 ftp://ftp.jgi-psf.org/pub/JGI_data/Trichoderma_virens/v1.0/download_files/ 
trichophyton equinum CBS127.97 http://www.broadinstitute.org/annotation/genome/dermatophyte_comparative/MultiDownloads.html 
Trichophyton rubrum http://www.broadinstitute.org/annotation/genome/dermatophyte_comparative/MultiDownloads.html 
Trichophyton tonsurans http://www.broadinstitute.org/annotation/genome/dermatophyte_comparative/MultiDownloads.html 
Uncinocarpus reesii http://www.broadinstitute.org/annotation/genome/candida_group/MultiDownloads.html 
Ustilago maydis 521 http://www.broadinstitute.org/annotation/genome/ustilago_maydis.2/MultiDownloads.html 
Vanderwaltozyma_polyspora_DSM_7029
4 
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=genome&Cmd=ShowDetailView&TermToSearch=5
801 
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Verticillium alboatrum VaMs.102 http://www.broadinstitute.org/annotation/genome/verticillium_dahliae/MultiDownloads.html 
Verticillium dahliae VdLs.17 http://www.broadinstitute.org/annotation/genome/verticillium_dahliae/MultiDownloads.html 
Yarrowia lipolytica CLIB122 http://www.genolevures.org/download.html#yali 
Zygosaccharomyces rouxii  http://www.genolevures.org/download.html#zyro 
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